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Abstract
Overwhelming evidence from clinical epidemiology and experimental studies indicates that
the prenatal environment is fundamental in determining developmental trajectories and
lifelong physiology. In particular, the in utero glucocorticoid (GC) milieu has been
identified as a key regulator of organ and system development. Excess GC exposure during
this period can have detrimental effects in offspring and alter the sensitivity to later
pathophysiology, including psychological disorders, metabolic syndrome, type 2 diabetes,
obesity and hypertension, a phenomenon described as 'programming'. 11 (3-hydroxysteroid
dehydrogenase type 2 (11 (3-HSD2) rapidly inactivates GCs within the placenta and other
fetal tissues, hence serving as a 'barrier' to limit exposure of the fetus to maternal GCs,
ensuring an appropriate fetal milieu for normal development.
The synthetic GC, dexamethasone (DEX) is thought to bypass the 11 (3-HSD2 'barrier' due
to poor substrate specificity. Prenatal administration in rats has been shown to programme
low birth weight and anxiety, associated with hypothalamic pituitary adrenal (HPA) axis
hyperactivity and the decreased hippocampal gene expression of corticosteroid receptors,
an effect thought to underlie the observed behavioural phenotype. Studies described here
extend previous findings and show that prenatal DEX programmes stress-potentiatiated
anxiety.
Similar to most paradigms investigating prenatal GC programming, a significant limitation
of our rodent model is the unavoidable maternal manipulation. In contrast, we have used a
second model of GC programming which involves crossing mice heterozygous for 11(3-
HSD2-null allele, generating offspring of three genotypes in the same litter (11 (3-HSD2+/+,
+/- and -/-), allowing direct study of excessive fetal exposure to GCs, independent of
altered maternal physiology and/or behaviour, thus providing a unique programming
model. In our studies, 11 (3-HSD2 null mutants displayed reduced birthweight, increased
anxiety-related behaviour and mild cognitive deficits, despite normal circulating
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corticosterone and limbic expression of HPA axis-associated genes. However,
dysregulated expression of these candidate genes during the early postnatal period was
evident, indicative of an altered developmental trajectory. In addition to programmed
effects on the brain and behaviour, 11J3-HSD2 null mice exhibit reduced fat deposition,
acute weight maintenance deficits and spontaneous hypoactivity despite evidence of normal
glucose homeostasis, including normal glucose tolerance and the unaltered hepatic mRNA
expression and activity of phospholenolpyruvate carboxykinase. These metabolic findings
emphasize the crucial interactions of early-life programming effects of GCs with the adult
GC environment.
In conclusion, we have identified 11 (3-HSD2 knockout mice as a valuable tool with which
to elucidate enzyme function and highlight its importance as a feto-placental 'barrier' to
GCs, despite the confounding influence of altered GC metabolism and enzyme deficiency
from mineralocorticoid target tissues. Our novel findings extend knowledge of prenatal GC
programming, a rapidly developing axiom.
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During the last few decades, substantial evidence has emerged from both clinical and
experimental studies that the fetal and neonatal environments can have a significant
impact upon lifelong physiology. The glucocorticoid (GC) stress hormones play an
important role in developmental maturation and under normal conditions are tightly
regulated. Overexposure to GCs both in utero and during the neonatal period may alter
the ontogenetic trajectory with lifelong effects on offspring physiology. In this chapter
we shall start by introducing GCs: pre-receptor metabolism, receptor-mediated effects
and overall functions. We will then describe the phenomenon of prenatal programming,
the involvement of GCs and animal modelling through maternal manipulation.
1.1 Stress and glucocorticoids
It is of primary importance that an organism is able to mount an appropriate response to
a changing external or physiological environment. The mechanism by which this
occurs has been referred to as allostasis, defined as the achievement of stability through
change (McEwen, 1998; McEwen and Wingfield, 2003). A central feature in allostasis
is the classically termed stress response, which involves activation of both the
sympathetic nervous system (SNS) and the hypothalamic pituitary adrenal (HPA) axis.
These play integral roles in the adaptive restoration of homeostasis. SNS activation and
subsequent release of catecholamines mediates many of the rapid 'fight or flight'
responses to noxious stimuli including increased cardiovascular tone, mobilisation of
energy stores and immune activation. GCs are released as the end result of HPA axis
activation and play a lead role in the management of whole body physiology, through a
diverse set of actions on a wide variety of target organs and cells. These hormones are
involved in the regulation of developmental, metabolic, immunological, reproductive,
cardiovascular, cognitive and emotional functions by affecting cells in the liver, kidney,
thymus, gonads, blood, vasculature, heart and brain.
The nature of these GC actions can be several. Permissive actions are present before the
appearance of stressful stimuli and prime the organism to respond. Stimulatory and
suppressive actions occur following stress exposure and mediate the response to stimuli,
but also dampen the extended response to prevent over-shooting. Preparative actions do
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not participate in an acute stress response, but modulate the response to future stressors,
and may be mediating or suppressive in character (Sapolsky et al., 2000). It is the
integration and symphony of these actions that permit an organism to mount an
appropriate reaction to, sufficiently recover from, and crucially prepare itself for any
further insult, thereby facilitating homeostasis. Whilst allostasis is a critical
physiological mechanism to appropriately respond to acute stimuli, when insults are
excessive in intensity, duration and/or frequency, an allostatic overload is placed on the
body. Under these circumstances the adaptive response may be detrimental to
homeostasis and predispose an individual to pathophysiology (McEwen, 2004), through
dysregulation of the HPA axis.
1.2 The hypothalamic pituitary adrenal (HPA) axis
GCs are the final effectors of the hypothalamic pituitary adrenal (HPA) axis which is a
highly auto-regulated system mediating the normal diumal rhymicity and stress-induced
elevations (Figure 1.1). The paraventricular nucleus (PVN) integrates signals from
extrahypothalamic sites to synthesise corticotrophin releasing hormone (CRH) and
arginine vasopressin (AVP) in parvocellular neurones. These peptides travel along axon
projections to the external layer of the median eminence where they are released into the
hypophyseal circulation. Following travel to the anterior lobe of the pituitary the
peptides bind to the CRHi and Vib receptors on corticotrophs, respectively. CRH and
AVP act synergistically to stimulate the proteolytic cleavage of proopiomelanocortin
(POMC) into adrenocorticotropic hormone (ACTH) which is then released into the
general circulation. ACTH binds to receptors located in the zona fasiculata of the
adrenal cortex to stimulate the secretion of species-specific GCs (Cortisol in humans and
primates; corticosterone (CORT) in rodents). The HPA axis provides an elegant
example of an intricately regulated negative feedback system. GCs released into the
bloodstream bind to corticosteroid receptors within the PVN and pituitary to
downregulate further synthesis and release of CRH and ACTH. The hippocampus, due
to abundant corticosteroid receptor expression provides extrahypothalamic negative
feedback to the PVN. Additionally, ACTH receptors are also present in the PVN,
which bind the hormone ligand to further downregulate release of CRH and AVP
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(reviewed in Aguilera, 1994). In addition to their role as HPA axis secretagogues, CRH
and AVP can act as extrahypothalamic neuropeptides where they modulate a wide array
of behavioural responses to stress (reviewed in Carrasco and Van de Kar, 2003).
1.3 Corticosteroid receptors
GCs mediate the majority of actions through their binding to two intracellular receptors.
The type I, or mineralocorticoid receptor (MR) binds both aldosterone and the species-
specific corticosteroid with similar affinity (Kd = 0.5nM). The type II, or
glucocorticoid receptor (GR) binds corticosteroids although with 10-fold lower affinity
than MR (Kd » 5.0 nM), although aldosterone is not a natural ligand for the GR
(reviewed in Meijer and de Kloet, 1998). This subtype dichotomy in binding affinity is
of particular importance in GC action under different physiological conditions. Under
normal conditions with low basal circulating corticosteroid levels the higher affinity
MR is partially ligand-bound and activated, whilst the low affinity GR is largely
unoccupied. However, in situations of elevated GC levels seen at the diurnal peak and
during stress GR will be occupied and activated, in addition to MR. The MR is
therefore thought to be responsible for the 'tonic' corticosteroid effects, akin to the
permissive actions previously described. GR appears to be more involved in mediating
the 'phasic' activity of corticosteroids, similar to the stimulatory, suppressive and
preparatory actions. The relative distribution of the two receptor subtypes within
individual cells is an important determinant of the net result of GC action, an integral
feature of GC hormone function (de Kloet et al., 1998).
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Figure 1.1 The HPA axis in rodents
5-HT = serotonin; NA = noradrenaline; PVN = paraventricular nucleus; CRH = corticotrophin
releasing hormone; AVP = arginine vasopressin; ACTH = adrenocorticotrophic hormone
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The corticosteroid receptors belong to a family of nuclear steroid hormone receptors
which predominantly function as ligand-activated transcription factors. In the absence
of ligand, these proteins are localised to the cytoplasm complexed with chaperones,
including the heat shock protein 90 (Hsp90) and FK506 binding protein 51 (Fkbp5)
(reviewed in Pratt and Toft, 1997). Ligand binding precipitates complex dissociation
and translocation of the bound receptor to the nucleus. Following dimerization the
receptor-ligand complex attaches to palindromic DNA sequences known as
glucocorticoid response elements (GREs) located in the regulatory regions of target
genes. Depending on the specific gene, binding to the GRE enhances or represses
transcription (reviewed in Schoneveld et al., 2004). Another molecular mechanism of
GR-mediated transcriptional control has been identified. Activation of GR has been
observed to initiate protein-protein interactions with a number of other transcription
factors, including nuclear factor-kappaB, activator protein-1 (reviewed in de Bosscher et
al., 2003) and Stat5 (Stocklin et al., 1996). No direct protein-protein interactions have
thus far been observed between the MR and other transcription factors. In addition to
the influence of GCs on transcriptional activity, non-genomic actions have also been
reported which can modulate ion permeability, as well as the release of neurohormones
and neurotransmitters (reviewed in McEwen, 1991). This 'fast' feedback was initially
identified in the pituitary and hypothalamus (Jones et al., 1977) and evidence suggests
that these GC effects may be mediated by membrane-bound corticosteroid receptors
(reviewed in Dallman, 2005). It has become clear from increasing evidence that
complex reciprocal interactions exist between GCs and neurotransmitter systems
including the dopaminergic, noradrenergic and serotonergic systems (reviewed in
Chaouloff, 2000; Carrasco and Van de Kar, 2003; Van Craenenbroeck et al., 2005).
1.3.1 Corticosteroid receptor expression
The GR is ubiquitously expressed throughout peripheral tissues and the brain. In
contrast, the MR has a more limited distribution. Peripherally, the MR has been
localised to epithelial tissue including the kidney (Funder et al., 1972; Farman et al.,
1991), colon (Pressley and Funder, 1975; Rafestin-Oblin et al., 1984), lung (Hirasawa
et al., 1997) and skin (Kenouch et al., 1994), mineralocorticoid target tissues protected
by virtue of pre-receptor inactivation of GCs (reviewed in Funder, 2005). Expression of
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MR is also evident in non-epithelial tissues including the heart (Pearce and Funder,
1987; Lombes et al., 1995), vasculature (Lombes et al., 1992), mononuclear
lymphocytes (Armanini et al., 1985) and the brain. In the brain, MR expression is
restricted to limbic regions and discrete areas involved in salt appetite and water balance
(Ahima et al., 1991; Herman, 1993; Pietranera et al., 2001). MR and GR are abundantly
expressed in the hippocampus in all species studied including the rat (Herman et al.,
1989; van Eekelen et al., 1988), mouse (Patacchioli et al., 1990; Kretz et al., 2001),
hamster (Sutanto et al., 1988), tree shew (Meyer et al., 1998), non-human primate
(Johnson et al., 1996; Patel et al., 2000; Pryce et al., 2005) and human (Seckl et al.,
1991). In this structure, the receptors play a role in the modulation of neuronal
excitability, the HPA axis, memory and emotion (reviewed in de Kloet et al., 2005).
Genetic polymorphisms of GR have been identified in the human population. These
have been associated with altered GC sensitivity and changes in body composition and
metabolic parameters, but also cognition and the development of depression (DeRijk et
al., 2002; Bray and Cotton, 2003; van Rossum and Lamberts, 2004; 2006). Similarly,
human polymorphisms ofMR been linked to altered stress responsiveness and
hypertension (DeRijk et al., 2006). As a consequence of the ubiquitous expression of
the corticosteroid receptors, circulating GCs can have a widespread effect on whole
body physiology highlighted by the pathophysiology as a result of these
polymorphisms.
1.3.2 Corticosteroid receptor mutant and transgenic studies
1.3.2.1 Glucocorticoid receptor
The generation of transgenic mice with global, regional or tissue-specific modulation of
functional corticosteroid receptor expression has permitted more intricate analysis of
their subtype-specific roles (reviewed in Wintermantel et al., 2005). Mice lacking
functional GR expression died shortly after birth from respiratory failure (Cole et al.,
1995; Finotto et al., 1999). These newborn mice had a reduced capacity to upregulate
gluconeogenic enzymes in the liver and displayed adrenal hypertrophy, elevated CORT
and ACTH, presumably due to impaired central feedback (Cole et al., 1995). Mice with
the disrupted ability to dimerise GR (GRdim) displayed full survival indicating critical
GC actions in the lung are mediated independently of GRE binding (Reichardt et al.,
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1998a; 1998b). In adulthood, GRdim were also impaired in hepatic gluconeogenic
enzyme induction, suggesting that dimerisation is however involved in GR signalling
within the liver. GR function within the liver was investigated in transgenic mice with a
hepatocyte-specific GR mutation and found them to be growth retarded at 4 weeks of
age (Tronche et al., 2004). The mice had normal glucose levels although were
hypoglycaemic following starvation as a result of impaired phosphoenolpyruvate
carboxykinase (PEPCK) induction. In addition, hyperglycaemia resulting from
streptozocin-induced diabetes was prevented in these mutant mice (Opherk et al., 2004).
These studies indicate a key role for GR-mediated glucose homeostasis within the liver
through induction of PEPCK and gluconeogenesis.
Transgenic mice expressing GR antisense were found to have significantly attenuated
central GR signalling (Pepin et al., 1992). These mice have been well-studied with
consequences of reduced GR signalling observed in their HPA axis activity, behaviour
and energy balance (Muller et al., 2002; Barden, 2004). In brief, GR antisense-
expressing mice displayed a reduction in negative feedback and HPA axis
hyperresponsiveness (Stec et al., 1994; Montkowski et al., 1995; Barden et al., 1997;
Karanth et al., 1997), decreased anxiety-related behaviour (Strohle et al., 1998) and
cognitive deficits (Montkowski et al., 1995; Steckler et al., 1999) in association with
reduced long-term potentiation (Steckler et al., 2001). Of interest was the observation
that despite elevated CORT levels the GR antisense-expressing mice were found to be
less anxious. Similar results were observed following CNS-specific GR deletion, which
resulted in elevated HPA axis activity, reduced anxiety and altered fat deposition similar
to that observed in the human Cushing's syndrome (Tronche et al., 1999). Time-
specific disruption of forebrain GR in early adulthood exacerbated HPA axis
hyperactivity and impaired feedback, and decreased anxiety- and depressive-like
behaviours (Boyle et al., 2005; 2006).
Ubiquitous GR overexpression lead to a reduction of basal CORT levels and a blunted
stress response, in addition to a suppression of inflammatory actions (Reichardt et al.,
2000). Forebrain-specific GR overexpression resulted in heightened anxiety and
depressive-like behaviours, despite normal basal and stress HPA axis activity (Wei et
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al., 2004). The studies in GR transgenic mice provide evidence that central GR
activation is a key mediator of anxiety and depression, whilst GR-mediated
hippocampal signalling is an important feature of HPA axis negative feedback.
1.3.2.2 Mineralocorticoid receptor
Mutant mice null for MR die shortly after birth with symptoms resembling
pseudoaldosteronism (Berger et al., 1998), although they could be rescued with salt
administration (Bleich et al., 1999; Berger et al., 2000) and GC-mediated GR activation
(Schulz-Baldes et al., 2001). The salt-rescued MR null mice displayed an upregulation
in the HPA axis activity and initial experiments suggested the animals displayed
increased anxiety (Gass et al., 2001). Forebrain-specific MR inactivation resulted in
impaired learning in the water maze and hyperactivity towards a novel object, but no
change in anxiety-like behaviour. Hippocampal GR mRNA was elevated in these mice,
but basal and stress CORT levels were normal (Berger et al., 2006). Findings in these
animals further support the importance of MR in HPA axis regulation, and anxiety-
related and cognitive behaviour.
Transgenic mice overexpressing human MR exhibited abnormal morphology in the
kidney and heart, despite normal blood pressure (Le Menuet et al., 2001). These mice
were also found to display abnormalities in the electrolyte balance following sodium
and potassium-modified diet administration (Le Menuet et al., 2004). Cardiac
overexpression of MR resulted in ion channel remodelling, the precipitation of
ventricular arrhythmias and sudden death, which could be blocked by the MR
antagonist spironolactone (Ouvrard-Pascaud et al., 2005). Conditional antisense-
mediated knockdown ofMR within the heart also produced detrimental effects,
precipitating reversible cardiac fibrosis and failure (Beggah et al., 2002). Investigation
of these tissue-specific transgenic mice has provided strong evidence that MR is a vital
component of normal cardiac physiology.
Investigations in mice with functional manipulation of corticosteroid receptor
expression have provided further evidence of their importance in lung maturation, HPA
axis regulation, memory, emotion, energy homeostasis, renal and cardiac function.
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1.4 Pre-receptor modulation of GC signalling
In addition to the control of GC release from the adrenal cortex, a number of other pre-
receptor mechanisms may modulate ligand activation of the corticosteroid receptors.
Corticosteroid-binding globulin (CBG) in the circulation binds corticosteroids with high
affinity to regulate the tissue availability of free ligand (Breuner and Orchinik, 2002).
Furthermore, 11P-hydroxysteroid dehydrogenase (11P-HSD) enzymes metabolise GCs
and regulate the intracellular hormone levels. These enzymes modulate the amount of
ligand accessible to the corticosteroid receptors and thereby subsequent GC action. The
existence of corticosteroid interconversion was first demonstrated by Amelung et al.
(1953). Dehydrogenase activity was then observed within the placenta and kidney,
whilst reductase activity was observed in the liver. The existence of two distinct 11(3-
HSD types was later postulated (Monder and Shackleton, 1984), which was supported
by the finding of lower cortisol/cortisone ratios from renal venous, compared to hepatic
venous human blood (Walker et al., 1993). Purification and cloning of lip-HSD
confirmed the presence of two isozymes (Agarwal et al., 1994), catalysing opposite
reactions, at least in vivo, to interconvert active and inactive (11-dehydrocorticosterone







Figure 1.2 Species-specific interconversion of corticosteroids by the
11 P-hydroxysteroid dehydrogenase enzymes
CORT = corticosterone; 11-DHC = 11-dehydrocorticosterone
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1.4.1 11p-HSD2
1.4.1.1 Expression in the adult
11P-HSD2 was originally purified and cloned from the sheep kidney (Agarwal et al.,
1994), although has since been cloned from other species including the human (Albiston
et al., 1994), rat (Zhou et al., 1995) and mouse (Condon et al., 1997). Localised to the
endoplasmic reticulum, with a cytosolic active site and co-factor binding domain, the
enzyme displays unidirectional, NAD-dependent dehydrogenase activity, converting
corticosteroids to their inactive 11-keto derivatives. 11P-HSD2 binds its substrate
(Cortisol in humans; CORT in rodents) with approximately 100-fold higher affinity than
the type 1 enzyme suggesting it may play a more dominant role in CORT metabolism in
locations where the two enzymes are co-expressed (reviewed in Draper and Stewart,
2005). In contrast to the widespread distribution of the type 1 enzyme, abundant
expression of 11P-HSD2 is limited to mineralocorticoid target tissues including the
kidney (Roland et al., 1995a), colon (Whorwood et al., 1994; 1995), salivary glands
(Roland and Funder, 1996) and skin (Kenouch et al., 1994). The enzyme was found to
co-localise with MR in renal collecting ducts and distal tubules (Roland et al., 1995a).
Significant expression has also been detected in the adrenal gland (Shimojo et al., 1996)
and vasculature (Christy et al., 2003; Hadoke et al., 2006b). In the rat brain 11P-HSD2
mRNA expression was identified in ventromedial nucleus of the hypothalamus,
amygdala, locus coeruleus and nucleus tractus solitarius (NTS) (Roland et al., 1995b;
Robson et al., 1998), areas identified to be involved in aldosterone actions on BP and
salt appetite (reviewed in Gomez-Sanchez and Gomez-Sanchez, 2003). The distribution
within the murine brain appeared to be even more limited, as expression was only
observed within the NTS (Holmes and Seckl, 2006), consistent with a decreased
aldosterone dependence on salt regulation within this species compared to the rat
(Rowland and Fregly, 1988). CORT has a high affinity for 11P-HSD2 and coupled with
a high capacity for its inactivation the enzyme provides an effective 'barrier' to
intracellular corticosteroid activity at the receptor level. Therefore, despite the 100-fold
lower circulating aldosterone levels, 11 (3-HSD2 confers mineralocorticoid-selectivity in
tissues where the enzyme and MR are co-expressed.
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1.4.1.2 Apparent mineralocorticoid excess (AME)
A distinct subset of patients has been described that possess hypertension associated
with apparent mineralocorticoid excess (AME). This clinical syndrome has proven rare
with only approximately 100 cases reported worldwide (Draper and Stewart, 2005).
Patients present as children or young adults with severe hypertension and an underlying
phenotype of hypokalaemia, suppressed renin activity and an extended half-life of
Cortisol (White et al., 1997). Initially, elevated mineralocorticoid action was thought to
be a determining factor as the MR antagonist, spironolactone, or a low salt diet rescued
the observed hypertension. However, circulating aldosterone levels were found to be
normal in patients, promoting defective peripheral Cortisol metabolism as an alternative
hypothesis to explain the clinical symptoms (Ulick et al., 1979; Stewart et al., 1988). At
present, over 33 different mutations in the 11P-HSD2 gene have been identified giving
rise to partial or total attenuation of enzyme activity. In all cases, identified mutations
have been found on both alleles indicating the disorder to be autosomal recessive
(Draper and Stewart, 2005). In addition to severe hypertension, patients have displayed
clinical features of intrauterine growth restriction (IUGR), short stature, thirst, polyuria
and altered postnatal growth (Draper and Stewart, 2005).
1.4.1.3 Expression in the placenta and fetus
In addition to expression within adult mineralocorticoid target tissues, 11P-HSD2 is
highly expressed in fetal tissues and the placenta. This enzyme was found to be
abundant in placental trophoblast cells in all species studied, including the rat (Waddell
et al., 1998), mouse (Brown et al., 1996b), baboon (Pepe et al., 1999) and human
(Brown et al., 1993; Krozowski et al., 1995; Stewart et al., 1995; Sun et al., 1997).
Expression of this corticosteroid inactivating enzyme within this major site of maternal-
fetal transfer provides a 'barrier' to maternal GCs gaining access to the fetus, strictly
regulating the fetal hormone environment during development. The functional
significance of placental 11P-HSD2 is highlighted by the observation that the tissue is
the most abundant source of the enzyme (Shams et al., 1998). A further layer of
regulation exists in developing fetal tissues that express 11P-HSD2. This internal
'sieve' may function to provide intricate self-control, permitting the cell to fine-tune its
own transient GC requirements. During embryonic and early post-natal life the
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expression of GC metabolising enzymes and the corticosteroid receptors is delicately
balanced to provide an optimal internal GC environment for development, which shall
be described in more detail later in this chapter (Section 1.5).
1.4.1.4 11P-HSD2 null mutant and transgenic mice
The role of the 11 (3-HSD2 in adult physiology has been investigated through null
deletion of the enzyme (see Chapter 2, page 62). These mice display a similar
phenotype to the human syndrome of AME, confirming impaired 11 (3-HSD2 function in
the underlying pathological mechanism. On an outbred MF1 background,
approximately one-half of 11 (3-HSD2 null mutants die within the first 48 hrs of birth
(Kotelevtsev et al., 1999). Mice that survived until adulthood displayed electrolyte
imbalance (hypokalemia and hypochloremia), hypotonic polyuria and marked
hypertension. Furthermore, an altered renal histology was seen, with hyperplasia and
hypertrophy of the distal nephron in line with persistent MR activation (Kotelevtsev et
al., 1999). Transfer of the targeted mutation to the C57BL/6J genetic background
resulted in similar electrolyte imbalance, hypotonic polyuria, although with less severe
hypertension and an absence of neonatal mortality (Bailey et al., unpublished
observations). The contribution of renal and a vascular dysfunction to the etiology of
the disease was investigated. Impaired sodium excretion, through increased activity of
the epithelial sodium channel (ENaC) was evident during the first few months of life,
but by 120 days of age this normalised. In contrast, hypertension was observed at all
timepoints, even though mice remained volume contracted throughout (Holmes et al.,
2006a; Bailey et al., unpublished observations). Whilst vascular responsiveness to
vasoactive peptides was unaltered in 11P-HSD2 null mutants, circulating
catecholamines were elevated and the hypertensive phenotype was acutely rescued with
al-adrenoreceptor blockade (Bailey et al., unpublished observations). These findings
suggest that the hypertensive phenotype may shift from a renal to vascular condition
due to the enhanced activity of the SNS possibly through maintained hypernatremia.
The consequence of enzyme loss on the vasculature may be strain-dependent though, as
earlier studies in 11P-HSD2 null mutants on a MF1 background reported impaired
vascular responsiveness to vasoactive stimuli compared to wild-type controls (Hadoke
et al., 2001). However, the 'illicit' MR activation due to 11P-HSD2 loss from
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endothelium was not deemed responsible for the observed findings (Christy et al.,
2003). It is thought that this altered vascular structure may underlie the sporadic sudden
death observed in the 11P-HSD2 null mice on the MF1 background, particularly within
females during pregnancy, through rupture of the aortic arch (Paterson et al., 2005).
AME appears to be a dominant feature of the 11P-HSD2 mutant mice although the
severity seen was found to differ between strains, being less apparent but still present in
the C57BL/6J. However, this global deletion of 11P-HSD2 will also remove the
presence of the enzyme from the placental and fetal tissues, where it is thought to
function as a key regulator of the fetal GC milieu during prenatal life. The 11P-HSD2
null mutant mice will therefore also exhibit consequences of prenatal GC programming,
which shall be discussed later (Section 1.6.3).
Tissue-specific 11P-HSD2 expression, often in sites where the enzyme is not normally
localised has been employed as a tool to not only elucidate the specific role of the
enzyme in these tissues, but also to artificially downregulate GC action. Adipocyte-
specific expression of the human 11P-HSD2 was generated in mice by utilising the aP2
promoter (aP2-HSD2). These transgenic mice were resistant to high-fat diet (HFD)-
induced weight gain, as a result of impaired adipose deposition (Kershaw et al., 2005).
This protection was associated with decreased food intake, increased energy
expenditure, improved insulin sensitivity and glucose tolerance (Kershaw et al., 2005).
These observations are broadly similar to those seen in the 11P-HSD1 null knockout
(Morton et al., 2001; Morton et al., 2004b), and further implicate GC-mediated effects
within adipose tissue in the pathological mechanism of the metabolic syndrome. 11P-
HSD2 expression within the heart is generally below the level of detection (Condon et
al., 1997; Moore et al., 2000), despite the presence ofMR in this tissue (Lombes et al.,
1995). Transgenic expression of 11P-HSD2 within cardiomyocytes precipitated marked
cardiac hypertrophy and fibrosis, resulting in heart failure and premature death (Qin et
al., 2003). The involvement ofMR was confirmed by the attenuation of pathology by
MR, but not GR blockade. The importance of GC-mediated actions in bone formation
has been investigated using two separate transgenic mouse lines overexpressing 11P-
HSD2 in osteoblast cells. One line displayed alterations in bone volume and
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architecture (Sher et al., 2004). The other was normal under basal conditions, although
displayed protection from exogenous high CORT-mediated detrimental effects (O'Brien
et al., 2004). These investigators explored other cells within bone and found that
osteoclast-specific 11 (3-HSD2 expression elicited similar effects on GC responsiveness
(Jia et al., 2006). These findings indicate that a balanced intracellular GC level is
important in regulating proper bone formation.
1.4.2 11P-HSD1
11P-HSD1 was observed to be bidirectional in vitro when originally purified and
cloned from liver (Lakshmi and Monder, 1985; 1988; Agarwal et al., 1989), although
more recently was found to act predominantly, if not exclusively, as a reductase when
cloned into mammalian COS-7 cells (Low et al., 1994), in rat hepatocytes (Jamieson et
al., 1995), in cultured hippocampal cells (Rajan et al., 1996) and in vivo (Jamieson et al.,
2000). The physiological unidirectionality is believed to be a functional consequence of
the intracellular localisation of the catalytic domain within the lumen of the
endoplasmic reticulum and co-factor availability. In the reductase reaction with
NADPH as a co-factor, 1 lp-HSDl acts to convert 11-DHC to CORT (cortisone to
Cortisol in humans) and regenerate the active hormone. The enzyme is thus thought to
provide intracellular amplification ofGC action. It has been identified as the sole 11P-
reductase in vivo, as 11-DHC infusion in adrenalectomized 11 p-HSDl null mice did not
result in 11-DHC conversion and CORT generation (Kotelevtsev et al., 1997). The
enzyme is broadly distributed, frequently co-localised with GR (Whorwood et al.,
1992). Appreciable expression has been observed in the liver, adipose, skeletal and
vascular smooth muscle, and the brain (Monder and Lakshmi, 1990; Rajan et al., 1995).
Centrally, 11P-HSD1 has been localized to a number of regions including the cortex,
hippocampus, hypothalamus, amygdala, cerebellum and pituitary (Moisan et al., 1990;
Lakshmi et al., 1991; Roland et al., 1995a).
Polymorphisms of the 1 lp-HSDl gene have been identified in the human population
and have been associated with Alzheimer's disease (de Quervain et al., 2004), HPA axis
regulation (Gambineri et al., 2006) and type 2 diabetes, although not obesity (Draper et
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al., 2002; Nair et al., 2004). These findings point to a role for 11P-HSD1 in modulating
cognition, stress reactivity and glucose homeostasis.
1.4.2.1 11P-HSD1 null mutant mice
A transgenic approach has been elegantly employed to permit more specific elucidation
of 11P-HSD1 enzyme function. Mice null for 11P-HSD1 alleles were generated by
replacement of exons 3 and 4 with a neomycin resistance cassette by homologous
recombination in a 129 embryoic stem cell to generate chimeras (Kotelevtsev et al.,
1997). 129 chimeras were crossed with the robust outbred MF1 strain to generate 11P-
HSD1 null mutant which displayed approximately 2-fold elevation of circulating ACTH
and CORT at the diurnal nadir and altered circadian CORT rhymicity, associated with
adrenal hyperplasia (Harris et al., 2001). An elevated and prolonged stress response
was evident, despite unaltered hippocampal corticosteroid receptor mRNA expression
(Harris et al., 2001). Despite evident HPA axis hyperactivity lip-HSDl null mice
displayed attenuated age-related cognitive decline, allied with lower intrahippocampal
CORT (Yau et al., 2001).
The metabolic phenotype of 11P-HSD1 null mice has been investigated, and enzyme
loss has resulted in generally protective effects. 11P-HSD1 knockout mice had an
increased hepatic and adipose insulin sensitivity, improved glucose tolerance and a
favourable lipoprotein profile (Morton et al., 2001; 2004a). Furthermore, these mice
were more resistant to HFD-induced weight gain, even despite hyperphagia (Morton et
al., 2004a) and displayed reduced hyperglycaemia following a HFD or novelty stress
(Kotelevtsev et al., 1997). In addition, 11(3-HSD1 knockouts had attenuated induction
of the key gluconeogenic enzymes, PEPCK and glucose-6-phosphatase within the liver
following starvation (Kotelevtsev et al., 1997). The HFD-diet induced hyperphagia,
detected in 11P-HSD1 null mice, has been further explored. 1lp-HSDl null mice
displayed an enhance ability to transiently elevate the orexigenic agouti gene related
peptide within the arcuate nucleus in response to HFD, an effect associated with
reduced opioid inhibitory tone (Densmore et al., 2006). This suggests that altered
signalling within central appetite-regulating regions may play a mechanistic role in the
metabolic consequence of lip-HSDl enzyme deletion.
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While 11P-HSD1 null mice have a normal birthweight, postnatal development and
growth trajectory (Kotelevtsev et al., 1997), they exhibited impaired lung morphology
with decreased surfactant protein, consistent with reduced GR-mediated development
(Hundertmark et ah, 2002). In obstetric practice the role for GR activation in lung
maturation is exploited by administration of steroids to hasten development in pre-term
infants (Seckl and Meaney, 2004). Bone formation has also been studied in response to
11P-HSD1 null deletion. Although there were no significant changes in bone mass,
adipocytes were absent suggestive of an altered differentiation pattern (Justesen et al.,
2004).
1.4.2.2 11p-HSD1 transgenic mice
11P-HSD1 overexpression has been studied in a number of tissues including the liver,
adipose and forebrain. 11 p-HSDl expression under the control of the enhancer-
promoter region of the adipocyte fatty acid binding protein (aP2) gene (aP2-HSDl)
(Masuzaki et ah, 2001) led to a 2- to 3-fold increase in mRNA expression specifically
within adipose tissue. The modest increase in CORT regeneration precipitated a
marked metabolic phenotype of obesity, hyperlipidemia, hyperphagia despite
hyperleptinemia, glucose intolerance and insulin-resistant diabetes (Masuzaki et ah,
2001) as well as hypertension (Masuzaki et ah, 2003). The increased blood pressure
(BP) is thought to be driven by a chronically activated renin-angiotensin aldosterone
system (RAAS), with increased angiotensinogen mRNA expression within adipocytes
and elevated circulating renin and angiotensin II (Masuzaki et ah, 2003). Despite
normal circulating CORT, a three-fold elevation within the portal blood was measured
in aP2-HSDl mice (Masuzaki et ah, 2001), suggesting that the metabolic effects may
be, at least partially, mediated through elevated intra-hepatic GC action. To address this
possibility, transgenic mice overexpressing lip-HSDl in the liver were generated using
an HSD1 transgene driven by the apoE gene promoter (apoE-HSDl) (Paterson et ah,
2004). These mice were found to exhibit features of the metabolic syndrome (insulin
resistance, fatty liver, dyslipidemia and hypertension) but without obesity (Paterson et
ah, 2004). The hypertension was found to be correlated with hepatic angiotensinogen
mRNA expression indicating a mechanistic involvement of the RAAS (Paterson et ah,
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2004). Recently an involvement of intrahepatic GC metabolism has been implicated in
HPA axis regulation. The intercrossing of 1 lp-HSDl knockout (on a C57BL/6J
background) and apoE-HSDl transgenic mice completely rescued (Paterson et al.,
2007) the HPA axis dysregulation previously observed (Harris et al., 2001). The
central expression of corticosteroid receptors has yet to be analysed, but these surprising
findings indicate a role for hepatic GC-sensitive processes in the regulation of the HPA
axis, possibly through CORT regeneration and/or feedback communication.
It is clear from studies in mice with varying 1 lp-HSDl activity, that the enzyme plays a
critical role in the amplification of GC signalling in several metabolic and central
processes including body composition, energy homeostasis, blood pressure regulation,
the stress response and behaviour.
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1.5 Development of the HPA axis
1.5.1 Prenatal Ontogeny
Intricate control and regulation of the appropriate GC environment is of vital
importance in maintaining normal health. Dysregulation can have detrimental
consequences and precipitate a broad range of pathophysiology. At no point during an
organism's lifetime is the optimum GC milieu as critical as during development,
including both in utero and during the early postnatal period. The specific actions of
GCs during perinatal life, as indeed in adulthood, are determined by a blend of factors
including the free circulating levels, pre-receptor metabolism and expression of the
intracellular corticosteroid receptors. A complex balance of these components exists
during early life with distinct species-specific ontogenic patterns.
1.5.1.1 Placental Ontogeny
In the baboon, placental 11P-HSD1 expression declined relative to 11P-HSD2 as
gestation progressed, reflecting reduced Cortisol transfer to the fetus as full term
approaches (Pepe et al., 2001). The human placenta displayed increased 11 p-HSD2
activity as pregnancy progressed (Shams et al., 1998) and a similar ratio of type 2 to
type 1 expression at term (Pepe et al., 2001). This suggests that an equivalent placental
GC metabolism may exist in primate species, where fetal Cortisol exposure decreases
towards the end of pregnancy.
1.5.1.1.1 Differences between rodent species
The prenatal regulation of the HPA axis is markedly different in rodents, perhaps not
surprising considering the different developmental stages at birth. Rodents are bom less
mature than primates (Pryce et al., 2002), and the early postnatal period is thought to be
a more critical period of growth in these species. The placental labyrinthe zone is
primarily responsible for fetal hormone transfer (Cross, 2000) and is a major site of
11(3-HSD2 expression in rodents (Brown et al., 1996b; Burton et al., 1996; Thompson et
al., 2002). In both rats and mice, 11P-HSD2 rapidly decreased whilst 11P-HSD1
increased towards term (Brown et al., 1996b; Burton et al., 1996; Thompson et al.,
2002; Speirs et al., 2004), consistent with the progressively increased fetal CORT
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exposure observed in rats during the final trimester (Diaz et al., 1998). The basal zone
is the main site of placental steroid and peptide hormone synthesis, although no
expression of 11(3-HSD2 was detected in this region of the mouse placenta (Thompson
et al., 2002). However, in rats 11[3-HSD2 mRNA expression was detected in the basal
zone, although, in contrast to that seen in the labyrinthe zone, 11P-HSD2 mRNA
increased during gestation, whilst 11P-HSD1 declined towards term (Burton et al.,
1996). In both species, GR expression was stably expressed within both zones
throughout gestation (Waddell et al., 1998; Speirs et al., 2004) suggesting an importance
of local GC action in maintaining placental function. In the rat, maternal GC levels
remained low during pregnancy, and close to term the HPA axis was hyporesponsive to
stress (Neumann et al., 1998), coupled with altered feedforward regulation (Johnstone et
al., 2000). However, in stark contrast mice exhibited a progressive surge of CORT
towards term and became unable to elicit a further elevation following stress exposure
(Douglas et al., 2003; Holmes et al., 2003). The availability of CBG was also
significantly increased, although magnitude of the rise was approximately 10-fold less
indicating that the free CORT levels were significantly elevated towards term (Douglas
et al., 2003). Both species experienced rapid decline of placental 11P-HSD2 expression
from the labyrinthe zone (Brown et al., 1996b; Burton et al., 1996; Thompson et al.,
2002) during the final trimester, suggesting similar regulation of the feto-placental
corticosteroid hormone barrier. These observations indicate that the mouse has a
greater demand for GC to prepare the dam for birth and/or facilitate late fetal
development. This may be important in the consideration of fetal programming across
these species.
1.5.1.2 Fetal ontogeny
A dynamic ontogeny of the HPA axis has also been observed in fetal tissues. The
expression of GR exhibited tissue-specific differences in time-course and abundance.
Although generally increasing during embryonic life, GR mRNA displayed only
temporary expression in certain sites, including the pancreas (Speirs et al., 2004), which
may underlie the critical periods of vunerability to GC excess in different tissues. 11(3-
HSD1 mRNA expression is evident from E15 in various fetal tissues, including the
liver, lung, thymus and brain regions (Speirs et al., 2004). MR expression was observed
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from E13.5 in tissues including the pituitary, heart, muscle and later the gut, kidney,
thymus, discrete areas of lung and several brain regions including hippocampus and
hypothalamus (Brown et al., 1996b; Kretz et al., 2001). 11P-HSD2 expression was
observed in many fetal tissues during early and midgestation, although rapidly
decreased from E13 to E15 when distribution became limited to that observed in adult
mice (Brown et al., 1996b; Condon et al., 1997). A similar distribution of 11P-HSD2,
GR and MR mRNA has been observed early in human fetal life (Condon et al., 1998)
suggesting that similar mechanisms of HPA axis development and regulation of fetal
GC signalling may occur across species.
In the rodent brain, 11P-HSD2 mRNA and activity were dramatically silenced during
the third trimester except in the thalamus and cerebellum (Brown et al., 1996b; Diaz et
al., 1998), regions that have a greater reliance on postnatal maturation (Robson et al.,
1998). In contrast, 11P-HSD1 was below the level of detection before E15.5, but
progressively increased in transcript abundance during late gestation throughout the
brain (Diaz et al., 1998). In the rat, GR mRNA was first detected in discrete regions on
E12.5, but became more widely and robustly expressed during the final week. MR
mRNA was initially seen on E15.5 and similarly developed until term (Diaz et al., 1998;
Speirs et al., 2004). The increased expression of 11P-HSD1, GR and MR combined
with 11P-HSD2 silencing in late gestation will encourage key GC-dependent
maturational events. In particular appreciable expression of these genes is detected in
the hippocampus towards the end of gestation (Diaz et al., 1998). When compared to
the rat, mice display a similar MR ontogeny within the hippocampus. However, in
contrast GR mRNA expression is absent from the antenatal murine hippocampus, the
onset of which is delayed until the few days following birth (Schmidt et al., 2003;
Speirs et al., 2004; Noorlander et al., 2006). Therefore, within this structure GC actions
during fetal life will be exclusively MR-mediated, a potentially important difference
between these rodent species.
1.5.2 Postnatal ontogeny
During the early postnatal period both mice and rats were found to exhibit a stress
hyporesponsive period characterised by very low basal CORT levels and an inability of
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mild stressors to induce an elevation in circulating ACTH and CORT. In the rat this
lasted from about postnatal day (P) 4 to P14 (Levine, 1994; Galeeva et al., 2006), whilst
in the mouse it was observed from just after birth (PI) to P12 (Schmidt et al., 2003).
GR blockade disinhibited the hypoactivity, implicating enhanced GR-mediated negative
feedback in the mouse (Schmidt et al., 2005). During the stress hyporesponsive period,
the level of both free and total corticosterone were found to be maintained at low levels
in the rat (Henning, 1978) and displayed a similar proportional increase around P14,
suggesting that CBG also displayed a similar developmental trajectory during the pre-
weaning period.
The postnatal ontogeny of hippocampal corticosteroid receptors has been studied in
both rats and mice. In the rat a high density ofMR mRNA expression was observed
within all hippocampal subfields at P2 and remained so through the early postnatal
period and into adulthood. GR mRNA expression increased during the first two weeks
before receding to stable levels, as observed in the adult, by weaning (van Eekelen et
al., 1991). In the mouse, hippocampal GR mRNA expression has been found to
increase from its initial appearance following birth, primarily in the CA1 subfield, to
reach adult levels by the end of the second week (Schmidt et al., 2003; Noorlander et
al., 2006). MR displayed a subfield-specific mRNA expression pattern, but generally
decreased during the first week when levels recovered to those observed in the adult by
the third week (Schmidt et al., 2003; Noorlander et al., 2006).
Although subtle differences in postnatal development of the HPA axis are seen, the
major species difference in HPA axis ontogeny between the mouse and rat is apparent in
the final prenatal week. Whilst 11 (3-HSD2 expression is silenced in a similar time-
specific manner in both species, CORT levels in the pregnant mouse multiply towards
term, in contrast to the HPA axis hypoactivity observed in rats. Central GR mRNA
expression is not evident in the prenatal mouse indicating GC actions on the fetal brain
are mediated predominantly, if not solely through the MR. These findings imply that
the optimum developmental GC milieu required for late fetal development in the mouse
is much higher than the rat, although the absence of GR in the brain indicates that it may
be peripheral rather than central maturation that is impacted.
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1.6 Prenatal Programming
1.6.1 The phenomenon in humans
Epidemiological evidence in humans indicated that low birth weight, independent of a
genetic component, was associated with a raised prevalence of cardiovascular disease,
obesity, insulin resistance/type II diabetes mellitus (Barker et al., 1990; 1991; 1993;
Hales et al., 1991) promoting the Barker hypothesis of the fetal origins of adult disease
(Barker, 1992). This phenomenon has also been described as environmental or
developmental plasticity, although we shall henceforth refer to it as programming. In
humans, maternal stress has been found to lower offspring birth weight (Mutale et al.,
1991; Edwards et al., 1994; Oyemade et al., 1994). Antenatal GCs, administered to
promote fetal lung maturation, have been found to induce a similar birth weight
reduction (French et al., 1999; Bloom et al., 2001), implicating these hormones in the
mechanism of growth restriction following prenatal stress (PS). The majority of clinical
studies have been retrospective, they show that PS is associated with dysregulation of
HPA axis function and increased susceptibility towards a range of psychological
disorders including anxiety, depression and schizophrenia (reviewed in Weinstock,
2001; Van den Bergh et al., 2005).
1.6.2 Prenatal manipulation in experimental animals
A substantial body of research has been conducted in experimental animals.
Programming has been investigated in several experimental species including the rat,
mouse, guinea pig, sheep and non-human primate (Nathanielsz, 2006). The prenatal
component of programming has been studied experimentally through maternal
manipulation including stress, exogenous GC administration and dietary alteration and a
common feature of these prenatal treatments has been intrauterine growth restriction
(IUGR) with the consequence of reduced birth weight. GCs are thought to play an
essential role in programming through prenatal manipulations. With regard to this
thesis we shall focus on programming mediated through the altered prenatal
environment, rather than early postnatal life. Additionally we shall limit our discussion
mainly to studies performed in rats and mice, in order to introduce the work conducted
in our investigations. However, we acknowledge that important findings have also
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arisen from studies conducted in other species including the guinea pig, sheep and non-
human primate.
1.6.2.1 Prenatal stress exposure
Prenatal stress (PS) exposure through maternal manipulation has been widely studied.
Many variations in paradigm have been employed including the nature, timing, duration
and frequency of stressors applied during the prenatal period. The consequence of
These stressors have been found to elicit a stress response and consequent elevation of
CORT levels in the pregnant dam, thought to be the primary determinant of prenatal
effects on the developing fetus. The most common stressor used has been maternal
restraint, most often applied for three 45-min periods daily during the final week of
gestation, although studies have also been performed with different timing, daily
frequency and duration. Stressors and administration paradigms that have been studied,
and the primary findings are shown in Table 1.1.
1.6.2.2 Prenatal exogenous GC administration
The synthetic GC dexamethasone (DEX) has been most widely used in studies
exploring prenatal GC programming. DEX rapidly passes into the fetal circulation due
to its poor substrate specificity for the placental 11P-HSD2 enzymatic barrier (Brown et
al., 1993) although it also impacts maternal physiology. The synthetic GC
betamethasone (BET) and CORT have also been administered by several groups. The
route of GC administration and dose has differed depending on laboratory (Table 1.2).
In our laboratory in Edinburgh DEX has been administered at a dose of 0.1 mg/kg/day
during the final trimester through subcutaneous injection, comparing these offspring
with those receiving vehicle (VEH) injections, thus correcting for the influence of
handling and injection stress. Other groups have similarly administered GCs through
injection although doses have varied, whilst CORT pellets and DEX osmotic
minipumps have also been utilised. In contrast, DEX has also been administered
through drinking water (Brabham et al., 2000; Hauser et al., 2006). Thus comparisons
between various GC treatment paradigms are sometimes difficult as route-, dose- and
time-dependent differences may exist.
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Nature of _. . Daily Duration
Species . Timing ' .... .stressor 3 Freq (Mins) Reference(s) Primary Findings
Rat Restraint E14-21 3x 60 Rimondini et al., 2003 t stress-potentiated anxiety
E11-22 3x 45 Morley-Fletcher et al., 2003b t CORT stress response
Laviola et al., 2004 t anxiety-like behaviour
E14-20 3x 45 Frye and Orecki, 2002a; 2002b J, sexual performance
Frye and Wawrzycki, 2003 T depressive-like behaviour
Zimmerberg and Blaskey, 1998 T anxiety-like behaviour
E14-21 3x 45 Maccari et al., 1995 i hippocampal GR/MR mRNA
Koehletal., 1997; 1999 HPA axis phase shift
Vallee et al., 1997; 1999 t anxiety-like behaviour
i cognitive ability
Morley-Fletcher et al., 2003a T depressive-like behaviour
Fumagalli et al., 2004 i cortex/striatum BDNF
Bowman et al., 2004 t anxiety-like behaviour
| cognitive ability
Alterations in central NA and DA systems
Poltyrev and Weinstock, 2004 t anxiety-like behaviour
Louvart et al., 2005
Van den Hove et al., 2005
Zagron and Weinstock, 2006
Barros et al., 2006b
Poltyrev et al., 2005 t anxiolytic drug response
Viltart et al., 2006 dysregulated regional brain activation
E15-20 3x 45 Lemaire et al., 2000; 2006 J. hippocampal neurogenesis
E15-21 3x 45 Igosheva et al., 2004 T stress-induced blood pressure
E15-19 3x 30 Szuran et al., 1991; 1994; 2000 | cognitive ability
E15-22 3x 30 Lehmannet al., 2000 j fear-related cognitive ability
E14-21 2x 60 Rao et al., 1999 sleep disturbance
E17-20 1x 90 Gueetal.,2004 | cognitive ability
Meunier et al., 2004
E10-20 1x 60 Smith et al., 2004 T depressive-like behaviour
t CORT stress response
E15-21 1x 60 Reznikov et al., 2001; 2003; alterations in central NA and DA systems
2004;2005
E18-22 1x 60 Gerardin et al., 2005 | sexual performance
alterations in central NA and DA systems
E15-17 1x 30 or 240 Fujiokaetal., 2001; 2006 T anxiety-like behaviour
E15-19 1x 20 McCormick et al., 1995 T CORT stress response
Variable E14-22 - - Koenig et al., 2005 T schizophrenia-like behaviour
Kinnunen et al., 2003 T CORT stress response
E15-20 - - Murmu et al., 2006 | dendritic arborisation/synaptic loss
Handling E14-21 1x - Cratty et al., 1995 t CRH in amygdala
and injection Ward et al., 2000 t stimulated CRH release in amygdala
White and Birkle, 2001 I function response to 5-HT,A blockade
Griffin, III et al., 2003 t anxiety-like behaviour
Dickerson et al., 2005
Table 1.1 Experimental models of prenatal stress reported in the literature
5-HT = serotonin; BDNF = brain-derived neurotropic factor; CORT = corticosterone; DA =
dopamine; E = embryonic day; GR = glucocorticoid receptor; HPA = hypothalamic pituitary
adrenal; MR = mineralocorticoid receptor; NA = noradrenaline
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„ Nature of . Daily Duration „ , , . .Species stressor Timing (Mins) Reference(s) Pnmary Findings
Crowding E15-21 1x - Hayashi etal., 1998 | cognitive ability with [ synaptic density
and altered hippocampal 5-HT turnover
injection E16-21 1x - Peters, 1982; 1984; 1986a; 4 anxiety-like behaviour
1986b; 1988b; 1990 altered central NA and 5-HT
Injection and E5-birth 1x 15 Dragoetal., 1999 | depressive-like behaviour
forced swim [ fear-related cognitive ability
Noise and E10-18 1x 15 Nishioetal., 2001 I cognitive ability
forced swim
Noise and Whole 3x week - Poltyrevet al., 1996 | anxiety-like behaviour
light Weinstocketal., 1998 | CORT stress response
Whole Random - Fride et al., 1988 4 anxiety-like behaviour
Weinstock et al., 1988; 1992 4 CORT stress response
4 plasma catecholamines
Footshock Whole Every - Estanislau and Morato, 2005; | anxiety-like behaviour
other day 2006 4 stress-potentiated anxiety
J, cognitive ability
Cat E10, E14 XooXCNJ 15 Lordi et al., 1997; 2000 i cognitive ability
presence and E19 Patin et al., 2002; 2005 4 anxiety-like behaviour
[ maternal behaviour
Restraint E14-20 3x 45 Meek etal., 2000; 2001; 2006 J. cognitive ability
| maternal behaviour
i sexual performance
Ishiwata et al., 2005 i cognitive ability
J, hippocampal 5-HT (transient)
j. hippocampal spine densities
Tamuraet al., 2005 I neurogenesis factors
E15-21 3x 30 Sternberg and Ridgway, 2003 | CORT stress response
E12-17 2x 60 Ward and Wainwright, 1988 neurobehavioural deficit
E13-18 2x 30 Kinsley and Svare, 1986; 1988 J, intermale aggression
E8-19 1x 360 Chung etal., 2005 4 CORT stress response
J, hippocampal GR
4 anxiety-like behaviour
Son et al., 2006; 2007 DAergic hyperfunctionality
1 NMDA-mediated synaptic plasticity
E1-birth 1x 180 Alonso et al., 1994; 1997; 2000 4 depressive-like behaviour
DA abnormalities in nucleus accumbens
CUMS E1-birth - - Pardon et al„ 2000 | maternal behaviour
Noise E12+14 1x 24 hrs Pincus-Knackstedt et al., 2006 4 anxiety-like behaviour
4 CRH in PVN
Crowding E12-17 - - Harvey and Chevins, 1984; 1987 J. sexual performance
Crump and Chevins, 1989
Footshock E15-19 1x - Palermo-Neto et al., 2001; 2003 4 anxiety-like behaviour
4 CORT stress response
Table 1.1 (Cont.) Experimental models of prenatal stress reported in the literature
5-HT = serotonin; CORT = corticosterone; CRH = corticotropin-releasing hormone; CUMS =
chronic ultramild stress; DA = dopamine; E = embryonic day; GR = glucocorticoid receptor; PVN
= paraventricular nucleus
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Species GC Timing DailyFreq
Dose Reference(s) Primary Findings
Rat DEX Whole 1x 0.1 mg/kg sc Celsietal., 1998
Ahlbom et al„ 2000
Welberg et at, 2001
Hadoke et at, 2006a
Chen et at, 2004
hypertension (glomerular damage)
t neonatal brain sensitivity to oxidative stress
1 anxiety-like behaviour
t amygdala GR/MR mRNA
hypertension (T vascular tone)
renal abnormalities
E1-10 1x 0.1 mg/kg sc Woods and Weeks, 2005 4 maternal food intake
E15-20
E1-7 1x 0.1 mg/kg sc Nyirenda et at, 1998 hyperglycaemia, hyperinsulinemia
E8-14 4 glucose tolerance
E15-21 T hepatic GR/PEPCK mRNA/activity
E8-birth 1x 0.1 mg/kg ip Emgard et at, 2007 4 cognitive ability
E9+11+13 1x 0.1 mg/kg ip Swolin-Eide et at, 2002 abnormal skeletal growth





E14-19 1x 0.125 mg/kg sc Shoener et at, 2006 T CORT stress response
4 hippocampal MR/f hippocampal 11fl-HSD1 mRNA
E14-21 1x 0.1 mg/kg sc Holson et at, 1995
O'Regan et at, 2004
4 sexual performance
1 hepatic GR/PEPCK mRNA/activity
hypertension (T FtAAS activity)
E15-18 1x 0.2 mg/kg ip Dagan et at, 2006 renal abnormalities
E15-20 1x 0,1 mg/kg sc Levitt et at, 1996 t CORT stress response
hypertension
E15-birth " 2.5 ug/ml
drinking water
Brabham et at, 2000 4 cognitive ability
1 CORT stress response
E15-21 1x 0.1 mg/kg sc Nyirenda et at, 2001; 2006
Welberg et at, 2001
Cleasby et at, 2003a; 2003b
Drake et at, 2005
hyperglycaemia, hyperinsulinemia
J. glucose tolerance
T hepatic GR/PEPCK mRNA/activity
T anxiety-like behaviour
4 hippocampal GR/MR mRNA
4 fat depot weight
intergenerational metabolic programming
E15-21 1x 0.1 mg/kg or 0.2 mg/kg
by osmotic pump
Langdown et at, 2001; 2003;
Sugden et al., 2001
4 cardiac function (altered cardiac protein expression)
F16-birth 1x 0.1 mg/kg im Wan et at, 2005 f neonatal hippocampal 113-HSD1 mRNA
E17-19 1x 0.05 mg/kg
0.2 mg/kg
0.8 mg/kg
Navarro et at., 1989
Carlos et al., 1991
Slotkin et at, 1992; 1996; 2006
Kauffman et at, 1994
Muneoka et al., 1997
Kreider et al., 2005
impaired postnatal lung growth
| neonatal brain sensitivity to oxidative stress
altered central monoaminergic content
4 neonatal cardiac tolerance to hypoxia
monoaminergic disturbances during weaning period
J, cognitive ability
E18+19 1x 0.1 mg/kg sc Oliveira et at, 2006 4 DEX suppression
E20+21 1x 0.4 mg/kg ip Okajima et al., 2001 impaired postnatal lung growth
Rat BET E8-birth 1x 0.1 mg/kg ip Emgard et at, 2007 4 cognitive ability
Rat CORT E14+15 1x 0.8 mg/kg sc Singh et at, 2007 hypertension (4 nephron number)
E14-21 3x 0.7 mg/kg sc Holson et al., 1995 4 sexual performance
E16-birth - 2.4 mg/day pellets Diaz et at, 1995; 1997 t spontaneous activity
altered response to amphetamine and apomorphine
E18+19 1x 25 mg/kg sc Oliveira et al., 2006 4 DEX suppression
Table 1.2 Experimental models of prenatal GC administration reported in the literature
11 |3-HSD1 = 11 p-hydroxysteroid dehydrogenase type 1; BET = betamethasone; CORT =
corticosterone; DEX = dexamethasone; E = embryonic day; GR = glucocorticoid receptor; ip =
intraperitoneal; MR = mineralocorticoid receptor; PEPCK = phosphoenolpyruvate
carboxykinase; sc = subcutaneous
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1.6.3 Effects of Prenatal programming
1.6.3.1 Effects on behaviour
PS and exogenous GC administration in rodent models are known to precipitate several
behavioural abnormalities including anxious-, depressive- and schizophrenic-like
behaviour in tests.
1.6.3.1.1 Anxiety
Several groups have investigated the anxiety-like behaviour in rodent offspring from
different PS paradigms (see Table 1.1). The animal tests employed in the investigation
of anxiety in these rodents include the elevated plus maze (EPM), open field (OF) and
light/dark box (LD). The EPM is comprised of two open and two closed arms on an
elevated platform. The test measures the conflict between the exploratory behaviour
and the aversion to open spaces and has been validated for the measurement of anxiety
levels in the rat (Pellow et al., 1985) and mouse (Lister, 1987). The open field test was
originally described in 1934 (Hall) and since has become one of the most popular
anxiety tests (reviewed in Prut and Belzung, 2003). Animals are assessed in an
inescapable open arena, where the exposed centre presents a more anxiogenic
environment for the rodent and the exploratory activity is measured. The LD test was
initially described as an anxiety test in mice (Crawley and Goodwin, 1980) and has
since been employed to measure emotional behaviour and evaluate anxiolytic drug
efficacy (reviewed in Bourin and Hascoet, 2003). The LD test is based on the conflict
of avoidance of brightly illuminated areas and the innate desire to explore a novel
environment.
PS rat offspring have displayed heightened anxiety-like behaviour when assessed on the
EPM (Fride and Weinstock, 1988; Zimmerberg and Blaskey, 1998; Poltyrev and
Weinstock, 2004; Patin et al., 2005; Zagron and Weinstock, 2006; Barros et al., 2006b;
Estanislau and Morato, 2006), OF (Peters, 1986; Lehmann et al., 2000; Fujioka et al.,
2001; Bowman et al., 2004; Laviola et al., 2004; Van den Hove et al., 2005) or both
(Poltyrev et al., 1996; Vallee et al., 1997; Poltyrev and Weinstock, 2004). Not all
studies found a difference in spontaneous behaviour under basal conditions in these tests
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(Rimondini et al., 2003; Poltyrev et al., 2005). However, PS offspring had an enhanced
anxiety response to acute stress (Rimondini et al., 2003; Estanislau and Morato, 2006)
and heightened sensitivity to an anxiolytic drug treatment (Poltyrev et al., 2005). The
integral role of maternal GCs in the programming effects of PS have been illustrated by
the normalisation of offspring by prior maternal adrenalectomy (Barbazanges et al.,
1996; Zagron and Weinstock, 2006). Additional support for GCs mediating PS-induced
behavioural programming comes from maternal administration studies. Prenatal DEX
administration in rats increased anxiety-like behaviour on the EPM and OF when given
throughout the final trimester (Welberg et al., 2001) or E18 and 19 only (Oliveira et al.,
2006).
Increased anxiety-like behaviour in PS rat offspring has also been detected in fear
conditioning (Griffin et al., 2003), defensive withdrawal (Dickerson et al., 2005) and the
light/dark test, although only following aversive conditioning (Louvart et al., 2005).
The acoustic startle response was unaltered by PS, although offspring displayed a
reduced response to anxiogenic drugs acting via modulation of the serotonergic system
(White and Birkle, 2001).
PS-mediated behavioural programming has been less studied in mice. Increased
anxiety-like behaviour has been programmed by sound stress during E12 and 14
(Pincus-Knackstedt et al., 2006), and footshock stress daily between E15 and 19
(Palermo-Neto et al., 2001). Of particular note in the latter experiment was the
detection of programmed effects despite unaltered birth weight (Palermo-Neto et al.,
2001). Programmed consequences of prenatal GC treatment, in the absence of birth
weight deficits have been also been observed in rats (Ortiz et al., 2001; 2003) and
primates (de Vries et al., unpublished observations), indicating that this may not be
absolute requirement following prenatal GC treatment. Following a severe PS regimen,
mice were not found to display any alteration in behaviour, although exhibited enhanced
anxiety following chronic postnatal stress (Chung et al., 2005). Single dose DEX or
BET on El4 decreased juvenile anxiety, with the BET effects persisting through to
adulthood (Rayburn et al., 1997). Multiple dose BET, however did not result in any
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alteration in anxiety levels (Rayburn et al., 1998), or indeed cognitive ability
(Christensen et al., 2001).
Studies conducted by the Matthews laboratory in Toronto have investigated prenatal GC
programming in guinea-pigs and observed heightened anxiety-like behaviour in the OF
following PS administration (Kapoor and Matthews, 2005), although not BET treatment
(Owen and Matthews, 2007) despite the evidence of altered HPA axis regulation in
response to both regimes (reviewed in Kapoor et al., 2006).
1.6.3.1.2 Depression
Investigators have also studied the depressive-like behaviour of prenatally manipulated
offspring in the forced swim test originally described by Porsolt (1977; 1978). This test
measures the behavioural despair of rodents placed in a inescapable cylinder of water
and decreased immobility interpreted as antidepressant efficacy (reviewed in Cryan et
al., 2005). Several studies revealed an increase in immobility in both rats (Alonso et al.,
1997; Drago et al., 1999; Morley-Fletcher et al., 2003a; Frye and Wawrzycki, 2003;
Smith et al., 2004; O'Mahony et al., 2006) and mice (Alonso et al., 2000), indicative of
behavioural despair and depression-like behaviour. However, others studies have also
found prenatally stressed offspring to display a reduced immobility (Stohr et al., 1998;
Welberg et al., 2001). Whilst reduced immobility time can be interpreted as reduced
depressive-like behaviour, this could alternatively represent an impaired coping strategy
through cognitive deficits (Welberg et al., 2001).
1.6.3.1.3 Cognition
An elegant epidemiological study of the Lothian Birth Cohort reported a positive
correlation between birth weight and cognitive ability at age 11 (Shenkin et al., 2001).
Furthermore, this correlation was still apparent when cognitive ability was assessed at
age 78 (Deary IJ, personal communication). Cognitive function has been assessed
following PS or prenatal GC treatment in rodent species, most commonly in the Morris
Water Maze (Morris, 1984). Programmed deficits in water maze performance,
indicative of memory and/or learning impairment have been observed in rats (Hayashi
et al., 1998; Brabham et al., 2000; Nishio et al., 2001; Meunier et al., 2004; Emgard et
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al., 2007) and mice (Meek et al., 2000). Szuran et al. (1994; 2000) did not observed any
change in cognitive performance when the water was at an ambient temperature (18-
20°C), although when measured in cold water (10-12°C) male PS rat offspring showed a
reduced capacity in the colder, more stress-provoking water compared to control
offspring. However, CORT response was not seen to be significantly different
depending on prenatal treatment or the temperature of the water (Szuran et al., 2000),
indicating other alterations are likely to be responsible.
Several other rodent tests have detected a prenatal treatment-specific effect on cognitive
ability. PS rat offspring had impaired radial arm maze performance (Vallee et al., 1999;
Bowman et al., 2004; Kreider et al., 2005). Furthermore, decreased retention of passive
(Lordi et al., 1997; 2000; Drago et al., 1999; Gue et al., 2004) and active (Lehmann et
al., 2000) avoidance conditioning was observed following PS in rats. Behaviour in the
Y- or T-maze has delivered further evidence of cognitive impairment (Vallee et al.,
1999; Gue et al., 2004; Estanislau and Morato, 2005).
The tests mentioned above assess different aspects of cognitive function (Ehman and
Moser, 2006) and divergent effects have been observed. One study detected water maze
deficits although object recognition was undisturbed (Bowman et al., 2004). Another
found Y- and radial arm maze impairment, despite unaltered water maze performance
throughout the subject's lifetime (Vallee et al., 1997; 1999). This illustrates the
importance of employing multiple tests in the analysis of cognitive phenotype. The PS
effects on cognition and other features, may be dose-dependent and involve a postnatal
component as mild PS improved memory performance on the radial arm maze and
active avoidance paradigms, findings which were prevented by early adoption to a
control dam (Fujioka et al., 2001).
Page 31
PhD Thesis - A genetic approach to prenatal glucocorticoid programming
1.6.3.1.4 Schizophrenia
An altered fetal GC environment has been proposed in the etiology of schizophrenia,
supported by findings from animal models (Koenig, 2006). The psychological disorder
is often associated with cognitive impairment (Friedman et al., 1999; Freedman, 2003),
which was a common observation in the animal models previously described (see
above). Other features seen in schizophrenic patients include deficits in prepulse
inhibition (PPI) (Braff et al., 1992), reduced latent inhibition (LI) (Lubow and Gewirtz,
1995) and dopaminergic hyperactivity (Nieoullon, 2002). Studies have investigated
these schizophrenia-associated phenomena in PS and GC administration models.
Enhanced amphetamine-induced hyperactivity and PPI deficits were observed in
offspring subjected to a variable PS paradigm in the final week (Koenig et al., 2005),
seen without any alteration in anxiety-like behaviour in the OF. The nature of the
prenatal stressor appears to be important in the programming of schizophrenic-like
attentional deficits. Prenatal restraint stress did not yield similar observations on
dopaminergic function and PPI (Koenig et al., 2005). Reduced LI was observed
following final trimester CORT administration or repeated footshock, but not restraint
stress (Shalev and Weiner, 2001). Another study observed no change in LI, whilst PPI
was enhanced following final trimester restraint stress (Lehmann et al., 2000). Prenatal
CORT administration has also been found to programme increased spontaneous activity
and an altered response to amphetamine and apomorphine administration, with
increased and decreased hyperactivity, respectively (Diaz et al., 1995; 1997). Most
recently, prenatal DEX was not found to consistently impact offspring LI and PPI
(Hauser et al., 2006). It thus appears that the specific nature of stress exposure is
important in mediating effects upon schizophrenic-like behaviour.
1.6.3.1.5 Other behaviours
An effect of PS has been observed on the sleep-wake cycle in adult male rats, with a
dramatic increase in paradoxical sleep and other abnormalities (Dugovic et al., 1999;
Rao et al., 1999). A disruption in normal sexual activity has been observed following
PS. Female rats displayed less socio-sexual contact with decreased lordosis and
solicitation behaviour than controls (Frye and Orecki, 2002b), with differences further
accentuated by acute restraint (Frye and Orecki, 2002a). PS also resulted in altered
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estrous cycling within female mice (Harvey and Chevins, 1987). Male rats subject to
PS or DEX exhibited a reduction in sexual performance (Holson et al., 1995) and
abnormal behaviour including a reduced number of ejaculations (Gerardin et al., 2005).
Male mice subjected to prenatal crowding stress displayed impaired intermale
aggression (Kinsley and Svare, 1988), copulatory behaviour (Harvey and Chevins,
1984) and reduced fertility (Crump and Chevins, 1989), coupled with alterations in
sexual partner preference (Meek et al., 2006), indicative of demasculinization of
behaviour. Findings of alterations in sleep patterns and sexual performance have been
observed in depressed patients (Ferguson, 2001; Tsuno et al., 2005) and are consistent
with prenatal programming of depressive-like symptoms.
The findings discussed above provide significant evidence of the crucial role of the
prenatal GC milieu in development and programming of the lifelong behavioural
phenotype. Prenatal stress and GC administration has been found to be associated with
elevated symptoms of anxiety, depression, cognitive deficits, schizophrenia, sleep
disturbance and sexual dysfunction. CORT is well known to modulate behaviour and
the observed behavioural abnormalities may be a related to programming effects upon
the HPA axis.
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1.6.3.2 Effects on the HPA axis
In humans, a negative correlation between adult HPA axis activity and birth weight has
been observed (Phillips et al., 2000; Reynolds et al., 2001; 2005). The HPA axis has
been well-studied in experimental models and evidence of similar prenatal HPA axis
programming is available. Most often a hyperactivity of the axis has been observed
although studies differ in specific abnormalities and gender dichotomy is common.
Increased basal CORT has been observed in female rat offspring following prenatal
restraint stress (Szuran et al., 2000), but the majority of studies have not reported any
difference in either gender (McCormick et al., 1995; Vallee et al., 1996; 1997; 1999;
Reznikov et al., 2001; Smith et al., 2004; Viltart et al., 2006) when examined at the
diurnal nadir. However, a phase shift in the circadian rhymicity was detected with an
earlier and enhanced diurnal peak in both genders following PS in rats (Koehl et al.,
1997; 1999), which was prevented by a postnatal stressor during the first week of life
(Koehl et al., 1997).
PS in rats has been found to programme an altered stress response. Following acute
restraint, female PS offspring had an exaggerated and prolonged elevated of CORT
(McCormick et al., 1995). Several studies have reported no exaggeration in the peak
stress response, but rather a prolonged return to baseline (Vallee et al., 1996; 1997;
1999; Smith et al., 2004; Viltart et al., 2006) which was ameliorated by either
environmental enrichment during adolescence (Morley-Fletcher et al., 2003b) or
chronic tianeptine antidepressant treatment (Morley-Fletcher et al., 2003a). A
decreased habituation to repeated stress was seen in male offspring (Bhatnagar et al.,
2005). In a unique finding, female PS offspring displayed a prolonged stress-response,
whilst males display a more rapid return to baseline than control offspring (Reznikov et
al., 2001). Similarly, Fischer 344 PS male offspring had a reduced peak CORT
response 20 and 60 mins post restraint (Van den Hove et al., 2005), indicating that
similar to behaviour, diverging effects of PS on the HPA axis can occur in different
strains (Stohr et al., 1998).
PS male mice had an exaggerated CORT stress response at weaning, which was
prevented by chronic postnatal selective serotonin reuptake inhibitor (SSRI) treatment
Page 34
PhD Thesis - A genetic approach to prenatal glucocorticoid programming
(Ishiwata et al., 2005). In another study basal CORT was unaltered, although a
prolonged acute stress response was observed in male PS offspring (Chung et al., 2005).
Similar programming effects on the HPA axis in rats have been seen following exposure
to prenatal stressors, other than restraint. Noise and light PS resulted in elevated basal
CORT and exaggerated and prolonged levels following acute stress in adulthood,
together with increased plasma catecholamines and metabolites (Weinstock et al., 1992;
1998). Variable PS, which programmed schizophrenia-like behaviour also resulted in a
prolonged stress response in male rat offspring (Kinnunen et al., 2003). Elevated basal
CORT was observed in mice receiving footshock PS which was highest when the
stressor was inescapable (Palermo-Neto et al., 2001; 2003).
Prenatal GC administration in rats has also exacerbated hyperactivity of the HPA axis.
Some studies observed no difference in basal or stress-induced CORT in the morning in
male prenatal DEX offspring (Nyirenda et al., 2001). However, similar studies did
detect increased basal CORT at this time-point in male (Levitt et al., 1996), but not
female prenatal DEX offspring (O'Regan et al., 2004) although stress levels were
unaltered (Levitt et al., 1996). Prenatal DEX administration through drinking water led
to unaltered basal or peak stress CORT, although the response was prolonged in both
sexes (Brabham et al., 2000). This was abolished by postnatal adoption to a control
mother. However, similar dysregulation was seen in control offspring fostered to a
DEX drinking dam identifying the postnatal period as the critical locus of HPA axis
programming in this study (Brabham et al., 2000). Another study found no difference
of prenatal DEX or CORT administration on nadir and peak basal CORT levels,
although both treatment offspring had reduced DEX suppression (Oliveira et al., 2006).
Elevated basal and stress-induced ACTH and CORT was observed in male offspring
during the rising phase following prenatal DEX injection on E14-19 (Shoener et al.,
2006).
These rodent studies provide evidence of significant CORT hyperactivity in offspring
following PS and prenatal GC administration indicating programming of the HPA axis.
Page 35
PhD Thesis - A genetic approach to prenatal glucocorticoid programming
1.6.3.3 Effects on the brain
1.6.3.3.1 Regulation of the HPA axis
PS and exogenous GC administration have been found to instigate alterations within the
brain including mRNA transcript expression, neurochemistry and function.
Corticosteroid receptors localised to the limbic system and PVN regulate behaviour and
the HPA axis. Adult rats subjected to prenatal restraint stress had a reduction in
hippocampal GR and MR mRNA expression in both sexes (Koehl et al., 1999)
associated with a reduced ability to curtail the CORT response to acute stress (Henry et
al., 1994). Adoption to a non-stressed mother ameliorated both the HPA axis
hyperactivity and decreased central expression of the corticosteroid receptors,
presumably through the increased maternal behaviour expressed by foster mothers
(Maccari et al., 1995). Others have found alterations in GR binding in rat PS offspring,
although only in females (Szuran et al., 2000). Another prenatal restraint paradigm
(E15-19; 20 min/day) found no GR binding differences in the hippocampus, but an
increase in the amygdala and septum with a decrease in the frontal cortex of PS rats
(McCormick et al., 1995) although CRH content in the median eminence was
unchanged (Smythe et al., 1996). Within the amygdala CRH receptor binding, content
and depolarization-induced release were however elevated in offspring following final
trimester saline injection stress (Cratty et al., 1995; Ward et al., 2000). Furthermore,
both a mild stressor and intracerebroventricular (icv) CRH administration caused more
marked acetylcholine (ACh) release in the hippocampus of PS male and female rat
offspring, compared to controls (Day et al., 1998).
Prenatal DEX administration has also been observed to programme alterations in central
HPA axis abnormalities. Male prenatal DEX rats had reduced mRNA expression of
MR and GR within the hippocampus following DEX in the final trimester (Levitt et al.,
1996), whilst administration throughout gestation did not elicit hippocampal changes.
CRH mRNA was elevated following both treatments within the amygdala and PVN,
although only treatment throughout gestation resulted in increased MR and GR mRNA
in the amygdala (Welberg et al., 2001). Shoener et al. (2006) found reduced
hippocampal MR, but not GR mRNA expression, whilst 11(3-HSD1 mRNA was
elevated during adulthood following prenatal DEX treatment. The expression of
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hypothalamic CRH mRNA was upregulated, although GR and AVP were unaltered. An
elevation in hippocampal 11|3-HSD1 mRNA and protein content has also been found on
PI and P7 (Wan et al., 2005). In rats, final trimester DEX administration in drinking
water reduced hippocampal GR and feedback sensitivity, although fostering to a control
dam ameliorated this effect (Brabham et al., 2000).
In mice, restraint PS yielded reductions in GR and MR protein content within the
hippocampus. CRH and GR content within the hypothalamus and amygdala was also
elevated, although only when combined with a postnatal stressor (Chung et al., 2005).
Alterations in the expression of the corticosteroid receptors and CRH within the
hippocampus, amygdala and PVN may underlie the observed CORT elevations
following PS and prenatal GC treatment through increased forward drive and/or reduced
negative feedback on the HPA axis. Additionally, the corticosteroid receptors and CRH
are well-known to regulate behaviour and their modified expression may also be
involved in the behavioural changes seen in prenatal programming models. However,
modifications within other central neurochemical systems will also certainly play a
mediating role too.
1.6.3.3.2 Neurochemistry
GCs and monoamine neurotransmitter systems possess reciprocal modulatory roles
(reviewed in Chaouloff, 2000; Carrasco and Van de Kar, 2003; Van Craenenbroeck et
al., 2005). Serotonergic and noradrenergic inputs to the HPA axis from the raphe
nucleus and locus coeruleus, respectively are shown in Figure 1.1 (page 5). Therefore,
it is expected that PS and prenatal exogenous GCs would have effects upon brain
neurochemistry and neurotransmitter systems. GC effects may be mediated through
activated corticosteroid receptor binding to GREs, such as located in the 5-HTia gene
regulatory region which can inhibit the transcription of this neuronal receptor (Ou et al.,
2001). Studies performed over 15 years ago by Peters in rats, identified PS effects on
the serotonergic and noradrenergic systems. Alterations were observed at P16 (but not
P9 or P23) in 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and
noradrenaline (NA) levels were observed in the cortex and hypothalamus, but only the
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latter had persistent alterations when measured at P60 (Peters, 1982). At P16, a
transient reduction in al, a2 and (3-adrenoreceptor binding was observed in several
brain regions. In adulthood, 5-HT binding was increased in the cortex, and reduced in
the hippocampus, which also displayed reduced 5-HT synthesis from tryptophan
(Peters, 1986). These PS offspring also showed altered behavioural responses to the 5-
HT agonist 5-methoxy-N,N-dimethyltryptamine (5-MeODMT), dependent on a strong
interaction with the postnatal rearing conditions (Peters, 1986; 1988a). Peters (1988b)
identified the critical period for PS on programming of serotonergic dysfunction to be
from P15 until birth, as PS from E3-14 had no observable impact. The central fetal and
neonatal 5-HT environment was investigated in this experiment and found to be
significantly increased in the PS group during this period and up to P10 (Peters, 1990).
Prenatal DEX from E17-19 resulted in transient 5-HT/5-HLAA decrease in the
hippocampus, neocortex, hypothalamus and medulla at P21 (Muneoka et al., 1997).
Another group observed reduced 5-HT and elevated 5-HLAA levels in the hippocampus
at P35 in PS rat offspring, concurrent with a reduction in synaptic density (Hayashi et
al., 1998).
These studies indicate a significant influence of PS and DEX treatment on the
serotonergic system. The underlying mechanism is unclear, although a recent study in
adolescent rats (P23) reported alterations in the 5-HT system following 7-day CORT
pellet implantation (Bush et al., 2003). This manipulation resulted in a flattening of the
diurnal CORT rhythm such that circulating CORT levels throughout the cycle
resembled those of the evening peak. 5-HTJA binding and serotonin turnover (5-
HIAA/5-HT) was reduced by CORT treatment in the cortex at 21 days following the
start of treatment, but not 7 days after (Bush et al., 2003). This report indicates that
exaggerated CORT can impact on the 5-HT system, although the effects may be
delayed, similar to the observations of transient alterations following PS. No alterations
were seen in hippocampal 5-HTia binding in the previous study (Bush et al., 2003),
although another observed significantly reduced 5-HT]A immunobinding in the ventral,
but not dorsal hippocampus following PS, whilst 5-HT2A immunobinding was
unaffected (Van den Hove et al., 2006a). A decreased functional response to 5-HTiA
receptor blockade has also been reported (White and Birkle, 2001). A significant
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increase in pre-synaptic 5-HT transporter was observed in the brainstem and cortex,
where 5-HTia and 5-HT2 (non-specific) expression was also increased in the absence of
any change in 5-HT levels (Slotkin et al., 1996; 2006). The alterations of the
serotonergic system, including neurotransmitter levels, turnover and receptor expression
within the cortex and hippocampus may act to alter behaviour following prenatal
programming. In addition, other neurotransmitter systems have displayed similar
disturbance following PS or prenatal GC exposure, including NA and dopamine (DA).
Brainstem and midbrain noradrenergic and dopaminergic maturation was accelerated
following prenatal DEX in rats from E17-19, although levelled off prematurely (Slotkin
et al., 1992). Reduced DA turnover in the hypothalamus and lower NA content in the
hippocampus was seen at P21 (Muneoka et al., 1997). In adulthood NA, 5-HT and DA
content within the hypothalamus was unaltered, although 5-HT and DA levels were
increased in the striatum of PS offspring (Gerardin et al., 2005). 5-HT and DA turnover
and NA levels displayed alterations in the rat prefrontal cortex, hippocampus and
amygdala following PS (Bowman et al., 2004). Gender-specific differences in
catecholamines within the preoptic area and medial basal hypothalamus of 10 day-old
rats were attenuated as a result of PS or exogenous GC administration, which was
prevented by naltrexone, implicating endogenous opioids in the effect (Reznikov et al.,
2003; 2004; 2005). The alterations in NA and DA content within the hypothalamus of
PS rat offspring persisted through to adulthood, as was the icv NA-induced adrenal
CORT release (Reznikov et al., 2001). DA abnormalities have also been observed in
the nucleus accumbens (Alonso et al., 1994; 1997). Following final trimester prenatal
restraint, D2 and A-methyl-D-aspartic acid (NMDA) receptors were increased in the
dorsal frontal cortex, medial prefrontal cortex, hippocampal CA1 and nucleus
accumbens in adult rats. Similarly, metabotropic group III glutamate receptors were
elevated in the dorsal frontal cortex and medial prefrontal cortex only (Berger et al.,
2002). Several of these alterations could be prevented by cross-fostering (Barros et al.,
2004). Benzodiazepine receptors were reduced in the central amygdala (CeA) and
hippocampus, ameliorated by cross-fostering (Fride et al., 1985; Barros et al., 2006b).
Microarray analysis identified significant changes in genes associated with the NMDA
receptor/postsynaptic density complex and the vesicle exocytosis machinery in
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offspring that received variable PS (Kinnunen et al., 2003). Chronic prenatal restraint in
mice was also found to programme alterations suggestive of hyperfunctionality of the
dopaminergic system (Son et al., 2007) and reduced NMDA receptor-mediated synaptic
plasticity (Son et al., 2006).
The alterations observed in brain neurochemistry are likely to participate in the
behavioural deficits that we have described following prenatal manipulation. For
example, genetically modified mice lacking functional NMDA receptor expression in
the dentate gyrus displayed spatial working memory deficits (Niewoehner et al., 2007).
Furthermore, 5-HTiA receptor deletion has been found to elicit heightened anxiety-like
behaviour (Parks et al., 1998; Ramboz et al., 1998), whilst overexpression was found to
modulate emotionality in the opposite direction (Kusserow et al., 2004).
1.6.3.3.3 Other effects on the brain
A deficit in neurogenesis within the dentate gyrus was detected in adult rats following
PS and found to be associated with reduced hippocampal-dependent spatial learning
(Lemaire et al., 2000), but could be entirely prevented with postnatal pup stimulation,
mimicking maternal behaviour (Lemaire et al., 2006). This PS-induced impairment in
neurogenesis was shown to be GR-mediated. In the same study a milder PS paradigm
produced an opposite enhancement of neurogenesis, which was identified to be MR-
mediated (Fujioka et al., 2006). Tolloid-like 1, a metalloprotease positively involved in
neurogenesis and negatively regulated by GCs, was decreased in the hippocampus of
female PS mice offspring (Tamura et al., 2005). Brain-derived neutrophic factor
(BDNF) was found to be reduced in the cortex and striatum of PS offspring, and
expression was dysregulated following chronic stress during adulthood (Fumagalli et
al., 2004). The sensitivity to oxidative stress in neonates exposed to prenatal DEX
treatment was enhanced throughout the brain (Carlos et al., 1991; Ahlbom et al., 2000).
Hippocampal BDNF and the astroglial-specific neurotrophic factor, S100B were
reduced following PS with a concomitant decrease in brain cell proliferation (Van den
Hove et al., 2006b; 2006c). In adulthood PS induced a long-lasting astroglial reaction
and reduced dendritic arborisation with global synaptic loss (Barros et al., 2006a;
Murmu et al., 2006). PS exhibited a higher number of Fos-immunoreactive neurones in
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the hippocampus and locus coeruleus indicative of increased regional activation.
Following a mild stressor (15-min open arm exposure), control offspring displayed
enhanced Fos expression, whilst PS offspring displayed no further rise in Fos,
suggestive of dysregulated activity in HPA axis feedback sites of PS offspring (Viltart
et al., 2006).
1.6.3.4 Effects on peripheral function
In humans, birth weight has been reported to be negatively correlated with metabolic
abnormalities including hyperglycaemia/type II diabetes, hypertension, heart disease
(Barker et al., 1990; 1991; 1993; Hales et al., 1991), features of the human metabolic
syndrome. These features have been studied in rodent programming models and
findings from these are presented below.
1.6.3.4.1 Body weight maintenance
The vast majority of studies have found PS or exogenous GC treatment to precipitate
IUGR and a reduction in birth weight. Prenatal DEX administration was found to
programme reduced body weight throughout life, associated with reduced fat deposition
(Cleasby et al., 2003a), although most papers report a normalisation of body weight in
adulthood (O'Regan et al., 2004; Drake et al., 2005). Evidence from human studies has
indicated that catch-up growth may play a mechanistic role in low birth weight
susceptibility to adult pathophysiology (Ong, 2006).
1.6.3.4.2 Liver and glucose homeostasis
Prenatal restraint stress induced hyperglycaemia, glucose intolerance and reduced basal
leptin levels in aged rats. Body weight, fat deposition and basal food intake were
unaltered, although food intake was higher in PS offspring following cessation of a 24-
hr fast (Lesage et al., 2004). Another study found increased basal glucose, despite
reduced food intake and body weight in adulthood (Vallee et al., 1996). Prenatal DEX
treatment has been found to programme increased fasting glucose, reactive
hyperglycaemia and hyperinsulinemia, although only when administered in the final
week. This was associated with elevated hepatic GR mRNA and PEPCK
mRNA/activity (Nyirenda et al., 1998; O'Regan et al., 2004). Interestingly, cross-
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fostering after birth did not prevent the glycaemic dysregulation suggesting that
programming occurs independently of the postnatal environment (Nyirenda et al.,
2001). Recently, the hepatocyte nuclear factor 4 alpha (HNF4a) has been suggested to
play a role in the GC-mediated induction of PEPCK, increased gluconeogenesis and
altered glucose homeostasis (Nyirenda et al., 2006). The prenatal DEX-induced rise in
PEPCK and glucose hyperactivity was also seen to be intergenerational (Drake et al.,
2005).
1.6.3.4.3 Blood pressure and cardiac function
Human epidemiology has observed a robust link between low birthweight and
subsequent hypertension in adulthood (Barker et al., 1990). Hypertension was observed
in prenatal DEX offspring (Levitt et al., 1996) which was associated with hyperactivity
of the RAAS in females (O'Regan et al., 2004; Hadoke et al., 2006a). The majority of
studies have assessed blood pressure through direct manipulation causing unavoidable
stress to the subject. A recent study has recorded mean arterial pressure via
radiotelemetry and made intriguing observations. Opposite to that seen previously,
prenatal DEX offspring of both genders displayed resting hypotension. In contrast, an
exaggerated rise in mean arterial pressure during even brief disturbance or restraint
stress was observed. This response was ameliorated by prior reserpine administration
implicating a sympathetic component in the hypertensive mechanism (O'Regan et al.,
unpublished observations). Increased vascular tone to NA, AVP and potassium also
reported (Hadoke et al., 2006a; O'Regan et al., unpublished observations). Basal blood
pressure was unaltered in PS offspring, although markedly increased following restraint
(Igosheva et al., 2004). Heart disease susceptibility has been negatively correlated to
birth weight (Barker, 2002). PS offspring had altered cardiac protein expression,
consistent with impaired function (Langdown et al., 2001; 2003; Sugden et al., 2001),
whilst neonatal cardiac tolerance to hypoxia was lowered (Kauffman et al., 1994).
1.6.3.4.4 Kidney and renal function
Altered renal function has been reported in several models of prenatal programming and
may underlie, at least in part, the hypertension observed. Maternal CORT programmed
hypertension in both sexes which was found with a deficit in nephron number and renal
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angiotensin receptors (Singh et al., 2007). Proximal tubular transport was increased, in
part through stimulated Na+/H+ exchanger activity in prenatal DEX offspring (Dagan et
al., 2007). This region was also found to be more susceptible to toxin-induced
apoptosis (Chen et al., 2004). Hypertension and reduced nephron number was also
observed following twice-daily prenatal DEX treatment on consecutive days, despite no
alteration in birth weight (Ortiz et al., 2001; 2003). PS offspring from another study
displayed glomerular damage and sodium retention along with hypertension (Celsi et
al., 1998).
1.6.3.4.5 Others
A clear role for GCs in promoting lung development and function is known, although in
excessive amounts they can be detrimental resulting in impaired normal postnatal lung
growth (Navarro et al., 1989; Okajima et al., 2001). Immune function has been altered
by prenatal GC manipulation including abnormalities in macrophage number and
function (Palermo-Neto et al., 2001; 2003) and dysregulated cellular and humoural
immune responses (Pincus-Knackstedt et al., 2006). Abnormal skeletal growth
following prenatal DEX supports role for GCs in functional bone development (Swolin-
Eide et al., 2002).
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1.7 Perspectives in prenatal programming
1.7.1 Prenatal component
It is most likely that prenatal GCs elicit their offspring effects by acting at several
different sites. A key component will be mediated through passage of GC across the
2placenta to directly impact on the developing fetus. Binding to corticosteroid receptors
in different tissues will elicit downstream effects on fetal development and maturation,
and GCs are known to regulate the expression of several key growth signals including
insulin-like growth factors (IGFs) and growth hormone. PS was recently found to
reduce fetal rat circulating GH at E21 (Mairesse et al., 2007). Another component of
GC programming of the fetus may be indirect through GC effects on the placenta.
Maternal DEX administration in drinking water was found to inhibit the normal rise in
vascular endothelial growth factor in the placental labyrinthe zone towards the end of
gestation and was associated with decreased placental vascularisation (Hewitt et al.,
2006). Increased apoptosis has also been observed in the placenta following prenatal
DEX or CBX in rats, although only in the basal, and not labyrinthine zone (Waddell et
al., 2000). Maternal DEX also increased endothelin-1 and endothelin receptor
expression in ovine placental arteries (Kutzler et al., 2003). These effects may serve to
restrict the efficiency of the placenta and the transfer of nutrients to the fetus.
The 11P-HSD2 feto-placental 'barrier' has also been identified as a vital target of GC
programming and will be discussed below. PS and prenatal GC adminstration may also
induce alterations in maternal nutritional intake, and thereby fetal nutrient availability.
Reduced food intake and body weight gain has been observed in prenatally manipulated
dams (Kinsley and Svare, 1986; Woods and Weeks, 2005) and these were found to be
highly correlated to neurobehavioural deficits (Ward and Wainwright, 1988). Indeed,
lifelong programmed effects have been observed in response to maternal dietary
manipulation, including nutrient restriction, low protein and high fat diets. Global
maternal undernutrition has been found to downregulate fetal IGF1 leading to IUGR,
reduced offspring birthweight and hypertension (Woodall et al., 1996a; 1996b; 1998).
The programming effects of a low protein diet during gestation have been well studied
and observed to include IUGR, low birth weight, HPA axis dysregulation, renal
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damage, hypertension, glucose intolerance and obesity (Bertram and Hanson, 2001;
Langley-Evans et al., 2005), but also alterations in hippocampal morphology (Cintra et
al., 1997; Granados-Rojas et al., 2002).
1.7.2 Postnatal component
Although insults in the aforementioned studies occur during the prenatal period,
evidence also indicates that a locus of effect may be in the susceptible postnatal period
through altered maternal care. Dams stressed during gestation displayed a reduction in
maternal behaviours including arched back nursing, nesting/grouping and pup retrieval
behaviour (Fride et al., 1985; Pardon et al., 2000; Patin et al., 2002; Smith et al., 2004).
The Meaney group in Montreal has investigated the lifelong effects of variations in
maternal care by studying pups raised by dams with maternal behaviour at disparate
ends of the normal distribution. This has revealed profound consequences of maternal
care on lifelong welfare, potentially involving epigenetic mechanisms (Meaney, 2001;
Meaney and Szyf, 2005). Neonatal programming has been found to elicit lifelong
programmed effects and manipulations studied include neonatal handling and brief
maternal separation, have been found to permanently programme positive consequences
on the offspring, including reduced negative behaviour and improved cognitive ability
(Levine, 2005). These consequences have generally been opposite to those observed in
PS or GC programmed offspring and postulated to be mediated through improved
maternal care during rest periods. Opposite, detrimental effects can be programmed by
longer periods ofmaternal separation which decrease offspring nurture. Studies have
found neonatal handling or brief maternal seperation to prevent the emergence of PS
programmed effects (Wakshlak and Weinstock, 1990; Lemaire et al., 2006), possibly
through normalisation of deficits in maternal behaviour.
Adoption has been seen to improve maternal care in rats (Maccari et al., 1995), although
was not observed to prevent the anxiogenic behaviour induced in PS offspring (Barros
et al., 2006b). Cross-fostering did however have effects upon anxiety-like behaviour
(Barros et al., 2006b), central neurotransmitter regulation (Barros et al., 2004) and HPA
axis activity (Maccari et al., 1995). In these studies the adult phenotype of the offspring
was reliant on the mother's treatment during gestation, rather than the prenatal group of
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the offspringper se. However, other parameters including hypertension, impaired
glucose homeostasis and dopamine-dependent hyperactivity have not been prevented by
cross-fostering (Diaz et al., 1995; Nyirenda et al., 2001; Igosheva et al., 2004). Other
studies found no reversal of programmed deficits by cross-fostering, although
abnormalities could be programmed in control offspring reared by a prenatally DEX-
treated mother (Peters, 1988a; Brabham et al., 2000; Hauser et al., 2006). It is therefore
apparent that in particular circumstances the impaired postnatal rearing environment can
play a dominant or complementary role in 'prenatal' programming. In addition to
altered physical mother-pup interactions, modified hormone levels delivered through the
milk could be implicated in the mechanism of perinatal programming.
1.7.3 Reversibility and prevention
Prenatal GC programmed effects were found to be both preventable and reversible by
pharmacological treatment during fetal (Meunier et al., 2004; Ishiwata et al., 2005) and
in postnatal life (Zimmerberg and Blaskey, 1998; Reznikov et al., 2003; Poltyrev et al.,
2005), respectively.
1.7.4 11P-HSD2: a common mechanistic link?
PS, GC administration and nutritional restriction appear to share similar features in the
programming effects they elicit. A common link between these prenatal manipulations
is the evasion of the protective enzymatic barrier, 11 (3-HSD2. Repeated PS results in
maternal CORT levels that overwhelm the barrier, whilst DEX circumvents GC
inactivation due to poor substrate specificity and has a relatively unrestricted journey
into the fetal circulation (Brown et al., 1993). Studies in rats (Langley-Evans et al.,
1996; Bertram et al., 2001) and sheep (Whorwood et al., 2001) have observed a
downregulation of placental 11(3-HSD2 following maternal nutrient restriction and
recently a similar reduction was also observed following PS in rats (Mairesse et al.,
2007). Furthermore, in humans the enzyme has been found to positively correlate with
birth weight (Stewart et al., 1995; Shams et al., 1998; McTernan et al., 2001). The
lowered barrierwill therefore allow greater passage of GCs across the placenta.
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The 11P-HSD inhibitor carbenoxolone (CBX) has been used to study the impact of
enzyme blockade during gestation. Prenatal CBX treatment was found to programme
similar alterations to those already described with PS or DEX administration, namely
low birth weight, hypertension, glucose intolerance, HPA axis hyperactivity and altered
behaviour (Lindsay et al., 1996; Saegusa et ah, 1999; Welberg et ah, 2000). Increased
basal CORT and a prolonged stress response were observed despite unaltered
hippocampal corticosteroid receptor mRNA expression. GR was upregulated in the
amygdala, and reduced in the PVN where CRH was elevated. Behavioural alterations
suggestive of heightened anxiety were also noted in the EPM and OF (Welberg et ah,
2000). However, CBX is a non-specific inhibitor of the 11(3-HSD type 1 and 2 enzymes
(Stewart et ah, 1990; Jellinck et ah, 1993) and treatment with this pharmacological
agent could have additional effects upon the pregnant dam. Therefore, we have chosen
to investigate mice lacking the 11(3-HSD2 enzyme, a potential model for prenatal GC
programming.
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1.8 Hypotheses and aims
The primary objective of this thesis was to further explore the phenomenon of prenatal
GC programming and investigate the protective role of the 11(3-HSD2 feto-placental
barrier by addressing the following aims:
1.) Studies performed in our laboratory have detected elevated basal plasma CORT
(O'Regan et al., 2004) and unearthed a heightened BP sensitivity to stress in
prenatally DEX-treated rat offspring (O'Regan et al., unpublished observations).
We hypothesise that similar enhanced stress sensitivity may be observed in
anxiety-related behaviour, which could be related to altered patterns of brain
activation. Therefore, we aim to extend previous findings in the prenatal DEX
model through analysis of the diurnal CORT excretion, behavioural sensitivity
to stress and brain activation following stressor exposure.
2.) The importance of the feto-placental 11 [1-HSD2 barrier has been demonstrated
using the non-selective lip-HSD inhibitor, CBX (Lindsay et al., 1996; Welberg
et al., 2000). Similar to prenatally DEX-treated rat offspring (Welberg et al.,
2001), prenatally CBX-treated rat offspring displayed heightened anxiety,
altered plasma CORT and central HPA axis-associated gene expression
(Welberg et al., 2000). Homozygous-bred 11 [1-HSD2 null mutant mice have
been studied and shown to exhibit anxiety-like behaviour (Holmes et al., 2006).
However, variations in maternal nurture and behaviour could account for these
consequences of enzyme deletion. We hypothesise that a key locus of effect in
llp-HSD2 null mutant mice is the overexposure of GCs during the fetal period.
In order to control for mothering influence on the offspring phenotype we aim to
use the unique model of prenatal GC overexposure, the heterozygous-bred lip-
HSD2 knockout mouse, to study the consequence of global 11P-HSD2 enzyme
deletion on the brain, behaviour and HPA axis.
Page 48
PhD Thesis - A genetic approach to prenatal glucocorticoid programming
Prenatal DEX treatment has been found to programme metabolic disturbances
including a lean body phenotype (Cleasby et al., 2003a) and impaired glucose
homeostasis (Nyirenda et al., 1998; 2001; 2006; O'Regan et al., 2004; Drake et
al., 2005). We hypothesise that the heterozygous-bred 11P-HSD2 knockout
mouse will display similar alterations in metabolic profile. Therefore, we aim to
perform initial characterisation of the metabolic phenotype.
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2.1 Materials
Unless otherwise stated, suppliers are located in the United Kingdom and all chemicals
and reagents were purchased from Sigma-Aldrich Company Ltd., Poole, Dorset.
2.1.1 General chemicals
BDH-Merck, Poole, Dorset:
Acetone, Formaldehyde, Glacial Acetic Acid, Hydrochloric Acid, Xylene




Fisher Scientific, Loughborough, Leicester:
Duolite Mixed Resin
Fluka Chemicals Ltd., Gillingham, Dorset:
Acetic Anhydride, Triethanolamine
Hayman Ltd., Witham, Essex:
Ethanol
VWR International, Lutterworth, Leicester:
Paraformaldehyde, SuperFrost Plus Slides
Whatman® International Ltd., Maidstone, Kent:
Whatman 3mm Chromatography Paper, Whatman Filter Paper
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2.1.2 Molecular Biology Reagents
AppliedBiosystems, Warrington, Cheshire:
TaqMan® Gene Expression Assays
Amersham Biosciences, Chalfont, Buckinghamshire:
Anti Rabbit Scintillation Proximity Assay (SPA) reagent, Hybond-N Membrane, NICK
Sephadex G-50 DNA column®, Rediprime® II Random Prime Labeling System
Anachem Ltd., Luton, Bedfordshire:
Rnaid Matrix, Rnaid Wash
BiowhittakerMolecularApplications, Wokingham, Surrey:
SeaKem® LE Agarose
HA. West (X-Ray) Ltd., Edinburgh:
Amfix High Speed Fixer, Kodak Developer D-19
Invitrogen, Paisley, Renfrewshire:
lkb DNA Ladder, Low DNA Mass Ladder, Low Melting Point Agarose, Quant-iT™
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Promega Ltd., Southampton, Hampshire:
Nuclease-free H2O, Nucleotides, Restriction Enzymes (Aval, EcoRI, Hindlll and Xbal),
Reverse Transcription System, RNA Polymerases (T3, T7 and SP6), RNase Inhibitor
(RNasin), RQ1 DNase (RNase-free), Transcription Optimised Buffer (5x), Vectors
(pGem-3, pGem-4)
Qiagen Ltd., Crawley, West Sussex:
HotStarTag DNA Polymerase, QIAquick Gel Extraction Kit, QIAquick PCR
Purification Kit
Roche Diagnostics Ltd., Lewes, East Sussex:
LightCycler® 480 Multiwell Plate 384, LightCycler® 480 Probes Master, Malate
Dehydrogenase, RNase A
Sigma-Aldrich Company Ltd., Poole, Dorset:
Kodak Biomax MR Film, Kodak Biomax MS Film
Stratagene, Amsterdam, The Netherlands:
pBluescript KS Vector
Thermo Fischer Scientific, Salford, Manchester:
Infinity1M Glucose Hexokinase Liquid Stable Reagent
Viagen Biotech Ltd., LosAngeles, Calfornia, USA:
DirectPCR Lysis Reagent (Ear)
ZinsserAnalytic, Maidenhead, Berkshire:
Aquasafe 300 Plus Scintillant
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2.1.3 Radioisotopes
Amersham Biosciences, Chalfont, Buckinghamshire:
[l,2,6,7-3H]-corticosterone (2.8-3.9 TBq/mmol), a32P-dCTP (111 TBq/mmol), 35S-UTP
(30 TBq/mmol)
2.1.4 Animals




SpecialDiet Services (SDS), Witham, Essex:
Rat and Mouse Breeder and Grower (CRM(E)) Chow (62.0% carbohydrate, 18.6%
protein, 3.4% oil)
Rat and Mouse No.l Maintenance (RM1(E)) Chow (66.7% carbohydrate, 14.4%
protein, 2.7% oil)
Rat and Mouse No.3 Breeding (RM3(E)) Chow (55.7% carbohydrate, 22.4% protein,
4.3% oil)
2.1.5 Materials for plasma corticosterone assay
Reagent ofDr. CJKenyon, Edinburgh:
Anti-Corticosterone
2.1.6 Equipment
Amersham Biosciences, Chalfont, Buckinghamshire:
GeneQuant RNA/DNA Calculator, Hypercassette™
Beckman Coulter Ltd., High Wycombe, Buckinghamshire:
Beckman Optima™ TLX Ultracentrifuge, TLA 100.3 rotor
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Bio-Tek Instruments Inc., Winooski, Vermont, USA:
EL 312e Bio-Kinetics Microplate Reader
Carl Zeiss, Welwyn Garden City, Hertfordshire:
Zeiss Stemi 100 Dissection Microscope
Dage Inc., Michigan City, Indiana, USA:
Dage MTI CCD72S Imaging Camera
EppendorfLtd., Histon, Cambridge:
Centrifuge 5415R
Fuji Photo Film Company Ltd., Tokyo, Japan:
Phosphoimager FLA-2000, Phosphoimager screens
Gene Technologies Ltd., Braintree, Essex:
G-storm Thermal Cycler
Heraeus Sepatech GmBH, Osterode, Germany:
Megafuge 3.OR
Hook& Tucker Instruments, Croydon, Surrey:
Rotamixer
Hybaid Ltd., Basingstoke, Hampshire:
Hybaid Omni Slide Wash Module
Ilea, Labortechnik, Staufen, Germany:
Ultra-Turrax T8 Auto-Homogeniser
Interfocus Imaging Ltd., Linton, Cambridgeshire:
Northern Light Illuminator
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Jencons-PLS, East Grinstead, West Sussex:
Techne Dri-Block DB3, Techne Genius Thermal Cycler, Techne Hybridiser HBID,
Techne Hybridisation Bottles
KonicaMinolta, Milton Keynes, Buckinghamshire:
Konica SRX-101 X-ray Developer





Rat Elevated Plus Maze
PerkinElmer, LAS (UK) Ltd., Beaconsfield, Buckinghamshire:
Wallac 1450 Microbeta Plus Liquid Scintillation Counter, Wallac Victor2 1420
MultiLabel Counter
Roche Diagnostics Ltd., Lewes, East Sussex:
Roche Lightcycler® 480 Real-Time PCR System
Sarstedt, Numbrecht, Germany:
Microvette Tubes, EDTA-coated
Shimadzu UKLtd., Milton Keynes, Buckinghamshire:
Shimadzu UV-160A Spectrophotometer
Spectronics Corporation, Westbury, New York, USA:
Spectrolinker XL-1500 UV Crosslinker
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Techniplast UKLtd, Kettering, Northamptonshire:
Mouse Wheel Running Cages, Rat Metabolic Cages
Ugo Basile, Comerio, Italy:
Passive Avoidance Apparatus
UVItec Ltd., Cambridge:




Actimetrics Software, Wilmette, Illinois, USA:
ClockLab™, LimeLight™, WaterMaze™
InterFocus Imaging Ltd., Linton, Cambridgeshire:
MCID Analysis
Raytest Scientific Ltd., Sheffield:
Aida 2.0 Auto Image Data Analyser, Fujifilm Fluorescent Image Analyser FLA-200
Roche Diagnostics Ltd., Lewes, East Sussex:
Lightcyler® 480 Software
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2.1.8 Buffers and Solutions
1.2% Agarose Formaldehyde Denaturing Gel (100ml): 17ml formaldehyde (BDH)
added to 1.2g of agarose, pre-melted in DEPC-H2O (73ml) and 10X MOPS buffer
(10ml)
Box buffer (100ml): 20ml 20xSSC buffer, 50ml deionised formamide made up to
100ml in DEPC-H20
Deionised Formamide: 150ml formamide mixed with 15g mixed bed ion-exchange
resin (Duolite) for at least 1 hr, filtered twice through Whatman filter paper and stored
protected from light using sterile glassware
DEPC-H2O: dH20 mixed with diethylpyrocarbonate (DEPC; 1 drop/ 100ml), shaken
and left for 1-24 hr prior to autoclaving
1MDithiothreitol (DTI): 0.15g was added to 1ml DEPC-H20 and filter sterilised,
stored at -20°C
250mMEDTA (pH 8.0; 100ml): 80ml dH20 was added to 9.3g Na2EDTA.2H20. pH
adjusted with NaOH and volume adjusted to 100ml. Autoclaved before use
Ethanol in Ammonium Acetate:
50% - 11.55g Ammonium Acetate dissolved in 250ml ethanol, made up to 500ml with
dH20
70% - 11.55g Ammonium Acetate dissolved in 350ml ethanol, made up to 500ml with
dH20
90% - 11.55g Ammonium Acetate dissolved in 450ml ethanol, made up to 500ml with
dH20
HEPES/sucrose buffer (pH 7.4): 250mM sucrose, 5mM HEPES and stored at 4°C
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2xHybridisation Buffer: 1.2M NaCl, 20mM Tris-HCl (pH 7.5), 2x Denhardt's
solution, 2mM EDTA (pH 8.0), 0.2mg salmon sperm DNA (llmg/ml), 0.2mg yeast
tRNA (50 mg/ml) and 2g dextran sulphate made up to 10ml in DEPC-H20, stored at -
20°C
LoadingBuffer: 2g Ficoll® 400, lOOmg SDS, 25mg bromophenol blue, 25mg xylene
cyanol dissolved in 10ml 0.1M EDTA
lOxMOPS Buffer (pH 7.0): 42g MOPS, 16.6ml 3M sodium acetate (pH 5.2) and 20ml
0.5M EDTA dissolved in 1L dH20; adjusted to pH 7.0 and autoclaved before use
4% Paraformaldehyde in 0.1MPhosphate Buffer (pH 7.5): 20mM NaH2P04, 80mM
Na2HP04 in 1L DEPC-H20, heated to 80°C prior to addition of 40g paraformaldehyde
using sterile glassware. Stirred for 1 hr to dissolve and stored at 4°C
Phosphate Buffer: 0.2M NaH2P04, 0.6M Na2HP04, 5mM EDTA. Autoclaved before
use
PBS (Phosphate Buffered Saline; pH 7.4): lOmM phosphate buffer with 137mM
NaCl, 2.7mM KC1 in dH20. Autoclaved before use
2x Pre-hybridisation Buffer: 1.2M NaCl, 20mM Tris-HCl (pH 7.5), 2x Denhardt's
solution, 2mM EDTA (pH 8.0), lOmg salmon sperm DNA (llmg/ml), 0.2mg yeast
tRNA (50 mg/ml) made up to 10ml in DEPC-H20, stored at -20°C
RNA Sample Buffer: 50% deionised formamide, 18% formaldehyde, lx MOPS buffer
RNaseA Solution: 25mg RNase A (Roche) dissolved in ImM Tris, 15mM NaCl made
up to 2.5ml with dH20 (lOmg/ml). Heated to 100°C for 15 mins then cooled to room
temperature and stored at -20°C. RNase A (lOmg/ml) added to buffer (3pl/ml)
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Rnase Buffer: 0.5M NaCl, lOmM Tris, ImM EDTA in CIH2O
20x SSC (Saline Sodium Citrate Buffer; pH7.0): 3M NaCl, 0.3M Na citrate in 1L
DEPC-H2O, pH 7.0. Autoclaved before use
5MNaCl: 29.55g added to 100ml DEPC-water
lOx TBE Buffer: 0.9M Tris, 0.9M Boric acid, 20mM EDTA (pH 8.0) in dH20.
Autoclaved before use
lOx TBS (Tris Buffered Saline; pH 7.6): 0.2M Tris, 1.4M NaCl in dfEO
TE Buffer (pH8.0): lOmM Tris-HCl (pH 8.0), ImM EDTA (pH 8.0). Autoclaved
before use
0.1M Triethanolamine (pH 8.0): 13.3ml Triethanolamine (Fluka) dissolved in 800ml
DEPC-water, volume adjust to 1L, using sterile glassware
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2.2 Methods
2.2.1 Animal maintenance
All studies were performed to the highest standards of humane animal care under the
aegis of the United Kingdom Animals (Scientific Procedures) Act, 1986.
2.2.1.1 Rats
Studies employing rats were conducted in the Biological Research Facility (BRF) at the
Western General Hospital (WGH). Female Wistar rats (200-250 g; Charles River) were
maintained under conditions of controlled lighting (lights on 07.00-19.00 h) and
temperature (21-22°C) and allowed ad libitum access to water and chow (CRM(E),
Special Diets Services). After a week of acclimatization, rats were timed mated. A
single virgin female was housed with a sexually-experienced male in breeding cages
until an expelled vaginal plug was noted, designated embryonic day (E) 0. Females
were then housed singly throughout pregnancy until delivery, which occurred on E21-
22. Pregnant females were injected subcutaneously with a solution of lOOpg/kg/day
dexamethasone (DEX) in 0.9% NaCl containing 4% ethanol or with an equivalent
volume of vehicle (VEH) between 09.00 and 11.00 h on E14-21, inclusive. On the day
of birth, pups were weighed, sexed and culled to 8 pups per litter retaining equal
numbers of each sex, where possible. Pups were then weighed weekly until weaning,
which occurred on postnatal day (P) 21. Following weaning, pups were housed in
single-sex, sibling groups of 2-4 and left undisturbed until testing, apart from routine
cage maintenance, which involved a weekly change of cage.
2.2.1.2 Mice
Studies employing mice were conducted in the BRF at the WGH or at Little France
(LF). Where necessary for breeding, C57BL/6J mice were purchased from Harlan.
Mice were maintained under conditions of controlled lighting (lights on 07.00-19.00 h)
and temperature (21-22°C) and allowed ad libitum access to water and food (CRM(E)
under all conditions in the BRF at the WGH; in the BRF at LF: RM3(E) during
breeding and RM1(E) under normal maintenance conditions). The housing
environment of the mice will be mentioned later in relation to individual experiments.
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2.2.1.2.1 Generation of 11P-HSD2 null mutant mouse
A null mutation of the 11J3-HSD2 locus was successfully generated by replacing the
genomic fragment encompassing exons 2-5 with a neomycin resistance cassette through
homologous recombination in mouse 129 embryonic stem cells (Kotelevtsev et ah,
1999). Cells exhibiting homologous recombination were injected into blastocysts,
which ultimately produced chimeras and 11P-HSD2-/- transgenic lines (intercrossed
onto an outbred MF1 background). The targeted 11P-HSD2 allele has now been
backcrossed for more than 10 generations onto the C57BL/6J strain. In homozygous-
breeding experiments male and female 11P-HSD2 null or wild-type mice were pair-
housed in breeding cages with bedding for nest building. In heterozygous-breeding
experiments, male and female 11P-HSD2 heterozygous mice were pair-housed in
breeding cages as above. Following weaning (P21) offspring pups were housed in
single-sex, sibling groups of 2-6 and left undisturbed until testing, apart from routine
cage maintenance.
2.2.1.2.2 Genotyping
Ear notches were taken at time of weaning and tail tips at time of cull for genotyping.
Both were stored at -20°C until DNA extraction. Extraction was performed using two
separate reagent kits: NucleoSpin® Tissue (Macherey-Nagel) or DirectPCR Lysis
Reagent (Viagen Biotech) with proteinase K. Genotyping was performed by
polymerase chain reaction (PCR) using a standard protocol and primers designed by Dr
Janice Paterson. The following primers were used: B2Forw,
AACGGGCTCCAAGTTGAGTC; B2Rev,
GCTTCAGGCGAGGAGAACAGAGGTCACG;NEORev,
CGCTTCCTCGTGCTTTACGGTATCGCCGCTCC (Eurogentec), to target exon 1,
exon 2 and the neomycin resistance cassette, respectively. PCR was performed in a
lOOpl reaction mixture containing: lOpl lOxPCR buffer (Qiagen), 2pl dNTP mix
(Invitrogen), lpl primers (1:10), 0.5pl FIotStarTaq DNA Polymerase (Qiagen), 83.5pi
dF^O and 1 pi DNA (1:5). Thermal cycling conditions comprised an initial denaturation
step at 95°C for 15 mins and 40 annealing and extension cycles of; 95°C for 30 sees,
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55°C for 1 min and 72°C for 1 min followed by a final extension step at 72°C for 10 min
in a Techne Genius thermal cycler (Jencons-PLS).
15pl PCR products were added to 2pl loading buffer and loaded onto a 1% agarose
(Biowhittaker Molecular Applications) gel containing 0.5x TBE and ethidium bromide
(1pi/100ml gel). A lkb DNA ladder (Invitrogen) was run to assess size of the bands
obtained. The gel was run at 100V until adequately separated and the results viewed on
and photographed using the UVIpro gel documentation system (UVItec Ltd.). The
presence of a 700 bp band indicates an 11P-HSD2 null mutant, a 600bp band represents
a wild-type and the presence of both bands indicates an 11 [1-HSD2 heterozygous
genotype. A representative gel picture taken under UV light is shown in Figure 2.1.
Figure 2.1 Picture of 11P-HSD2 genotyping PCR products separated by gel
electrophoresis
+/+ = wild-type, +/- = 11P-HSD2 heterozygous and -/- = 11P-HSD2 null
2.2.2 Behavioural testing
All behavioural tests were conducted between 09.00 and 14.00 h, to coincide with the
nadir of the corticosterone (CORT) circadian rhythm. Subjects were housed in groups
of 2-3 with previous cagemates; no differences were noted in behavioural performance
depending on the order run in the test. The apparatus was cleaned using 90% ethanol
between subjects. Except for passive avoidance, behaviour was monitored by video
camera and captured by a computer tracking programme (LimeLight™, Actimetrics
Software for elevated plus maze and „pen field; WaterMaze™, Actimetrics Software




-/- +/- -/- -/- +/+ +/+ +/+ +/- +/-
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2.2.2.1 Elevated plus maze
The elevated plus maze (EPM) is a common behavioural test that has been used
extensively to investigate the psychological and neurochemical basis of anxiety and in
the discovery of novel anxiolytic agents (Dawson & Tricklebank, 1995). The test has
been validated in both rats (Pellow et al., 1985) and mice (Lister, 1987) and presents a
conflict between the natural exploratory drive and the innate fear of open spaces in
rodents. The EPM consists of two opposing open arms and two arms enclosed by high
walls. The dimensions of the rat (Panlab) and mouse maze (made to order) used are
shown in Table 2.1. The test animal was placed in the central area facing an open arm
and allowed to freely explore the maze for 5 mins, whilst behaviour was recorded. The
following spatiotemporal parameters were determined: the number of entries into the
open and closed arms, time spent on the open arms and distance travelled on the open











Rat 100 10 50 64 Black arms
Grey walls
Polymer
Mouse 90 5 31 100 White arms
White walls
Table 2.1 Dimensions and construction of the rat and mouse elevated plus maze
2.2.2.2 Open field test
The open field (OF) test measures the exploratory and anxiety-like behaviour in a large,
square novel environment. It was originally described in 1934 (Hall) and has since been
comprehensively used in psychopharmacology (reviewed in Prut and Belzung, 2003).
The rat OF box was 100 x 100cm with 50cm high surrounding walls, and was made
from grey-painted wood. The smaller mouse OF box was 60 x 60cm with 30cm
surrounding walls, made from grey polymer. The OF was marked off into 25 equal
squares using the tracking software. The outer rows, adjacent to the walls, are
considered less anxiogenic than the inner squares. The animal was placed in the center
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and allowed to explore freely for 5 mins whilst behaviour was recorded. The following
parameters were determined: the total and inner zone crossings, time spent in the inner
zone and distance travelled in the inner zone and in total.
2.2.2.3 Passive avoidance and modified light/dark test
The passive avoidance (PA) box (length - 39cm; width - 9.5cm; height - 16.5cm; Ugo
Basile) features two chambers of equal sizes, both with gridded flooring. One chamber
is made ofwhite opaque polymer and is brightly lit, whilst the other is made of black
polymer and is not illuminated. The two chambers are separated by a door which can
be automatically opened and closed. On day one, subjects were placed in the light
chamber facing away from the doorway, which was open, and allowed to freely explore
both chambers for 5 mins, whilst recording the time spent in each, the latency to enter
the dark chamber and crossings between the two. These parameters form the basis of
our modified light/dark test of anxiety-like behaviour. On day two, subjects were
placed in the light chamber facing away from the closed door. After 90 sees the door
was opened and upon entering the dark chamber, the door closed and subjects received
an inescapable 0.3mA footshock for 3 sees and were left for a further 5 sees before
being removed. 6 hrs later this was repeated, although no footshock was administered.
The latency to enter the dark chamber during both trials was noted and the increased
latency to enter following footshock represents a measure of fear-related memory.
2.2.2.4 Water maze
Spatial learning and memory was assessed in a water maze test, pioneered by Professor
Richard Morris (Morris, 1984). The water maze consistent of a circular tank (1.8m
diameter, 60cm height) filled to a depth of 35cm with heated water (25 ± 1°C) made
opaquewith 50ml non-toxic latex liquid (Cementone-Beaver). The circular tank was
arbitrarily divided into four quadrants (defined by the software) and a platform, 10cm in
diameter, was submerged 2cm below the surface in the middle of one of these
quadrants. The protocol employed is described in Figure 2.2. On the first two days
mice were tested in the proximally-cued version of the maze where the circular platform
position was indicated by a visible object with curtains drawn around the pool to
exclude extramaze cues. This behavioural task requires the animal to associate the
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object with escape from the water and provides a measure of associative learning. The
training consisted of three trials per day for a total of five days, each trial lasting until
the mouse reached the platform (escape latency) or 60 sees if the mouse had not
previously escaped the water. After each trial the mice were allowed to remain on the
platform for 30 sees. If the subject had not reached the platform during the 60 sees it






Three trials per day Four trials per day nq platform
Day 1 Day 2 Day 1 Day 2 Day 3 Day 4 Day 5 ^
Figure 2.2 Schematic description of water maze protocol
Following two days of rest, the mice were then trained in the spatially-cued water maze
in order to assess the spatial learning and memory. This consisted of four trials per day
for five days, each trial lasting until themouse reached the platform or 120 sees should
the mouse not have previously escaped. After each trial the mice were allowed to
remain on the platform for 30 sees. If the subject had not reached the platform it was
placed on it. Mice were released in the pool from one of four equally spaced start
positions along the perimeter of the pool in a predetermined, pseudorandom order. The
location of the submerged platformwas varied randomly from trial to trial. 90 mins
following the fourth trial on the fifth day a probe test was carried out where the platform
was removed. The time spent in the former platform quadrant and number of crossings
of the former platform location was monitored in a 60 sec test. On all testing days, mice
were returned to drying cages and warmed under a heat lamp between trials (intertrial
interval 30 mins).
2.2.3 Metabolic cage study
Male rats were sibling pair housed in metabolic cages (Techniplast) at five to six weeks
of age and allowed to habituate to the environment for two weeks prior to the start of
collection. The animals were weighed, food and water intake, urine and faeces output
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measured on four consecutive days and urine collected in 25(4,1 6M HC1 and stored at -
20°C until later analysis of CORT concentration.
2.2.4 Wheel running activity
Mice were single housed in wheel running cages (Techniplast) and allowed to habituate
to the environment for one week. Activity was recorded for two weeks and data
averaged over the last week with one wheel rotation equivalent to one count. The
volume of water intake was also monitored to detect any polydipsia present in the 11(3-
HSD2 null mutant mice.
2.2.5 Blood collection, killing and harvesting of tissue
Basal blood samples were obtained in mice by tail nick at 09.00 h, at the diurnal CORT
nadir and collected into EDTA-coated Microvette tubes (Sarstedt). Following 10-min
restraint in a Perspex tube (30mm diameter) mice were culled by decapitation and trunk
blood was collected to provide a peak stress sample. Tubes were later centrifuged
(Eppendorf) at lOOOg for 10 mins at 4°C, and then plasma supernatant was stored at -
20°C. At time of killing, tissues (brain, liver, fat, right adrenal glands, tail tips) were
collected, rapidly frozen on dry ice and stored at -80°C (except tail tips; stored at -
20°C). Left adrenal glands were also collected in formamide, which were cleaned of fat
under a dissecting microscope (Zeiss) and weighed on a semi-microbalance (Mettler).
Rats were decapitated 30 mins following EPM exposure, brains were collected, rapidly
frozen on dry ice and stored at -80°C.
2.2.6 Measurement of hepatic PECPK enzyme activity
2.2.6.1 Protein extraction
Approximately lOOmg liver from freshly killed mice was placed in Eppendorf tubes and
lml ice-cold 250mM sucrose/5mM HEPES buffer pEl 7.4 was added. The samples
were homogenised at 4°C and centrifuged at 13000g for 15 mins at 4°C. The cytosolic
supernatant was removed into ultracentrifuge tubes and spun for 45 mins at 130000g at
4°C (Beckman Coulter). The supernatant was removed and aliquoted, either used for
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quantification of protein concentration or stored at -20°C prior to measurement of
enzyme activity.
2.2.6.2 Measurement of protein concentration
The protein concentration of tissue supematants was determined colorimetrically using
a protein assay kit (Bio-Rad) and bovine serum albumin (BSA) standards (0.05-0.5 mg
protein/ml). Samples were diluted 1:50 and 1:100 in dH20 to give concentrations in the
standard range. 25pi BIO-RAD protein assay reagent A and 200pi Bio-Rad protein
assay reagent B were added to duplicate lOpl aliquots of samples and standards in a 96
well plate. After 15 mins incubation at room temperature, the absorbance in each well
was measured at 750nm (A75o) in a microplate reader. The concentration of protein in
each sample was calculated from the standard curve (A750 vs. mg/ml protein
concentration).
2.2.6.3 PEPCK enzyme activity assay
Within the liver, phosphoenolpyruvate carboxykinase (PEPCK) catalyses the
decarboxylation and phosphorylation of oxaloacetate to form phosphenolpyruvate
during gluconeogenesis. It also catalyses the reverse reaction (incorporation of carbon
dioxide and dephosphorylation, with dGDP as the phosphate acceptor). This assay
measures PEPCK activity by coupling oxaloacetate formation with its reduction by
excess malate dehydrogenase to yield malate, with the equimolar oxidation of NADH.
The rate of the decrease in NADH concentration can be measured
spectrophotometrically and is directly proportional to the gluconeogenic activity of the
PEPCK in a sample (Petrescu et al 1979). lmg protein supernatant, diluted in
HEPES/sucrose buffer (lOmg/ml), was incubated at 30°C (Techne DB-3, Jencons-PLC)
for 3 mins in a reaction mixture containing: 50pi NADH (3.6mg/ml), 40pi
phosphoenolpyruvate (10.4mg/ml), 50pl malate dehydrogenase (1.5iu, Roche
Diagnostics) and made up to 1ml with buffer (50mM HEPES pH 6.5, 50mM sodium
bicarbonate and ImM manganese (II) chloride). The reactions were initiated in a
spectrophotometer (Shimadzu UK Ltd) using 0.15mM dGDP. The drop in absorbance
at 340nm was followed for 3 mins. Reaction mixtures lacking bicarbonate were used as
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negative controls. PEPCK activity was calculated from the rate of decrease in
absorbance during the linear phase of the curve, representative of the breakdown of
NADH.
2.2.7 RNA analysis of hepatic and adipose tissue
Total RNA was extracted from liver using TRIzol® Reagent (Invitrogen) and fat using
RNeasy Lipid Tissue Mini Kit containing QIAzol® Lysis Reagent (Qiagen) - mono-
phasic solutions containing phenol and guanidine isothiocyanate. The reagents maintain
RNA integrity whilst disrupting cells and dissolving cell components.
2.2.7.1 Tissue homogenisation
Whilst still deep frozen, on dry ice, approximately lOOmg tissue was added to 1ml
TRIzol® (liver) or QIAzol® (fat) homogenised using a mechanical homogeniser (Ultra-
Turrax T8, Ika); homogenising intermittently to avoid any sample heating.
2.2.7.2 Extraction of total RNA from liver
Total RNA was extracted with TRIzol® (Invitrogen), using a method derived from that
of Chomczynski & Sacchi (1987). The mixture was allowed to stand for 5 mins at room
temperature to permit the dissociation of nucleoprotein complexes. 300pi of
chloroform per 1ml of TRIzol® was added and the tubes shaken for 15 sees. The
mixture was allowed to stand at room temperature for another 2-3 mins and then left on
ice for 15 mins. Samples were centrifuged at 13000# at 4°C for 15 mins and the upper
aqueous phase was then transferred to another Eppendorf tube. 30pl Rnaid matrix
(Anachem) was added and the mixture vortexed. Tubes were then agitated for 3-5 mins
and spun at 13000# for 1 min to pellet. 500pl Rnaid wash (Anachem) was added and
the pellet resuspended by mixing with a pipette tip and vortexing. The tubes were then
centrifuged at 13000# for 1 min and the wash repeated twice. The resulting pellet was
then resuspended in special DEPC-H2O (lOmM DTT; Rnasin), incubated at 55°C for 12
mins and then spun at 13000# for 1 min at 4°C. Samples were aliquoted, snap frozen
and stored at -80°C.
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2.2.7.3 Extraction of total RNA from fat
Total RNA was extracted from fat using the Lipid Tissue Mini Kit containing QIAzol®
Lysis Reagent (Qiagen) following the protocol. The mixture was allowed to stand for 5
mins at room temperature to permit the dissociation of nucleoprotein complexes. 200pl
of chloroform per 1ml of QIAzol® was added and the tubes shaken for 15 sees. The
mixture was allowed to stand at room temperature for another 2-3 mins before being
centrifuged at 13000g at 4°C for 15 mins and the upper aqueous phase transferred to
another Eppendorf tube. 600pl 70% ethanol was added and tube vortexed vigorously.
700|il sample was pipetted into an RNeasy Mini Spin Column in a 2ml collecting tube
and centrifuged at 9300g for 15 sees at room temperature with the flow-through
discarded. The remainder of the sample was added and the spin repeated. 700pl Buffer
RW1 was added to column and spun as before with the flow-through and collection tube
discarded. The column was transferred to another 2ml collection tube. 500pl Buffer
RPE (with ethanol) was added to the column and spun as before. The flow-through was
discarded before another 500gl Buffer RPE (with ethanol) was added and spun at 9300g
for 2 mins. The column was then placed in new collection tube and spun at 13000g for
1 min at room temperature to dry silica membrane. The column was transferred to a
new 1.5ml collection tube and the RNA was eluted with 30pl nuclease-free H2O
(Promega) spun at 9300g for 1 min. The spin was repeated to elute the remaining RNA.
Samples were then aliquoted, snap frozen and stored at -80°C.
2.2.7.4 Quantification and agarose gel electrophoresis of extracted RNA
2.2.7.4.1 RNA qualification
Agarose gel electrophoresis was used to ensure that the RNA was intact. A 1% agarose
(Biowhittaker Molecular Applications) gel was used containing 0.5x TBE and ethidium
bromide (lpl/lOOml gel) using RNase-free materials. IjjlI of RNA was loaded and
electrophoresis performed in 0.5x TBE. The gel was run at 100V for approximately 1
hr and the results viewed on and picture taken using UVIpro gel documentation system.
The presence of intact 28S, 18S and 5S ribosomal RNA bands indicated that the
preparation was undegraded.
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2.2.7.4.2 RNA quantification
2.2.7.4.2.1 GeneQuant
Prior to Northern blot analysis, RNA extracted from liver was quantified using a
GeneQuant (Amersham Pharmacia) RNA/ DNA Calculator, lpl of resuspended RNA
from each sample was diluted with 99pl DEPC-H2O and its UV absorbance at 260 and
280nm measured. The absorbance at 260nm (A260) and 280nm (A280) were determined
to assess concentration and purity. Only RNA with an A260/A280 of 1.8-2.0 was used.
2.2.7.4.2.2 Quant-iT™ RiboGreen® RNA assay
Prior to use in real-time PCR, RNA extracted from liver and fat was quantified using
Quant-iT™ RiboGreen® RNA Reagent and Kit (Invitrogen). RNA standards were
prepared in the linear range of l-50ug/ml and samples were diluted 1:3000 (liver) and
1:500 (fat) in TE buffer to fall within the standard curve. 5pi standard or sample and
195pi reagent were added to a 96 well plate and incubated for 15 mins at room
temperature. The concentration of each sample was estimated by comparison with the
standard curve.
2.2.7.5 Northern analysis of RNA
2.2.7.5.1 RNA electrophoresis and capillary transfer
All electrophoresis equipment was soaked prior to use in NaOEl for 30 mins and rinsed
in DEPC-H20. Total RNA was separated by electrophoresis on a 1.2% agarose
formaldehyde denaturing gel. A 100ml gel was prepared by melting 1.2g of agarose in
88ml DEPC-H2O, adding 2ml formaldehyde and 10ml of lOx MOPS buffer, and
pouring into a gel mould with appropriately sized combs in place. The gel was allowed
to set and was then pre-run in lx MOPS buffer in a gel tank for 10 mins at 60V. RNA
was prepared for electrophoresis by aliquoting lOpg of RNA, with DEPC-H2O to bring
the total volume to lOpl, then adding deionised formamide (lOpl), formaldehyde (2.5pl)
and lOx MOPS buffer (2.5pi) to give a total volume of 25pi. The sample was mixed
and the RNA denatured by incubating at 65°C for 15 mins. Ethidium bromide was
added to the loading buffer (lpl/50pl loading buffer) and 2pl of this mix added to each
sample of denatured RNA. The RNA was then loaded into the wells on the gel and
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electrophoresed at 60V for 2-3 hrs until the front band of the loading buffer was 3A of
the way down the gel. The gel was soaked in 20x SSC buffer for 15min before blotting
onto a nylon membrane (Hybond N, Amersham Biosciences). A wick ofWhatman
3MM filter paper was placed over an upturned gel mould in a plastic tray containing
20x SSC buffer and the gel was placed on the top. A piece of nylon membrane cut to
the same size as the gel and pre-wetted in 20x SSC was smoothed on top of the gel and
this was covered with 3 layers of 3MM filter paper and approximately 5cm of paper
towels. A plate of glass was placed on the top to secure the apparatus, and a weight
balanced on the top. Capillary transfer was allowed to take place overnight at room
temperature. The next day the membrane was washed in 20x SSC to remove any gel
and the efficiency of transfer was checked by photographing the gel and the membrane
under UV light (X=254nm). The membrane was dried between two sheets of 3MM
filter paper at 80°C for 30 mins, and the RNA cross-linked under UV light (Spectronics
Corporation).
2.2.7.5.2 Hybridisation to 32P-labelled cDNA
The nylon membrane was placed in Hybaid hybridisation bottle containing 10ml 20%
SDS and 20ml phosphate buffer that had been warmed to 55°C (Techne Hybridiser
HBID). To this was added denatured salmon sperm DNA (lOmg/ml; 125pi). The
membrane was prehybridised in a Hybaid hybridisation oven at 55°C for at least 2 hrs.
200pl 32P-labelled cDNA probes (prepared as described below) were added to the
prehybridisation buffer, and the membrane hybridised with the probe overnight at 55°C.
The probe was disposed of and the membrane was washed as follows: three washes in
lx SSC: 0.1% SDS at 55°C for 30 mins, and two washes in 0.3x SSC: 0.1% SDS at
55°C for 30 mins. The membrane was wrapped in parafilm and exposed to a Fujifilm
imaging screen for a variable duration depending on the probe used (see Table 2.2).
The level of hybridized probe was quantified using a Fuji FLA2000 fluorescent image
analyzer. The level of expression of the RNA of interest was then expressed as a ratio
of the signal of the RNA of interest to the signal for eukaryotic ribosomal 18S RNA.
Membranes were also exposed to Kodak Biomax MS film at -70°C for a variable
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duration (see Table 2.2). Membranes were stripped after probing by washing in O.lx
SSC: 0.1% SDS at 67°C for 30 mins - 2 hrs and stored at -20°C before reprobing.
Specific Phosphoimager Autoradiographic
Probe Activity Screen Exposure Film Exposure
(cpm/pl) Time Time
PEPCK 285 K 10 mins 2 hrs
11P-HSD1 210 K 15 mins 4 hrs
18S 54 K 15 sees 1 min
Table 2.2 32P-labelled probes, specific activity and exposure time
32P-labelled probes used for Northern blot analysis (PEPCK - phosphoenolpyruvate
carboxykinase; 11(3-HSD1 -11 (B-hydroxysteroid dehydrogenase type 1; 18S ribosomal RNA),
their specific activity (200pl used of each) and exposure time on phosphoimager screen and
Kodak Biomax MS film
2.2.7.5.3 32P labeling of cDNA
Approximately 25ng ofDNA probe fragment of the target gene was aliquoted into an
Eppendorf tube, diluted to 45pi with DEPC-H2O and denatured at 100°C for 10 mins.
The tube was cooled on ice and briefly centrifuged to bring the contents to the bottom.
Rediprime™ II random prime labelling kit (5pi) and a32P-dCTP (5pi) (both Amersham
Biosciences) were added to give a total reaction volume of 55pi and the reaction
incubated at 37°C for 1 hr. Unincorporated radioactivity was removed by passing the
mixture over a NICK column (Amersham Biosciences). The NICK column was
prepared by washing with 3ml TE before the reaction mixture was applied to the
column. The column was washed with 400pl TE, the elutant discarded and the labelled
DNA eluted from the column with a further 400pl TE. The specific activity of the
probe was measured by mixing 2pl of probe with 1ml of scintillant (Zinsser Analytic)
and counting in a beta-counter (PerkinElmer) for 2 mins. Probes were used if the
specific activity was greater than 50,000cpm/pl and are shown in Table 2.2. The DNA
probe was denatured before use by heating to 100°C for 5 mins followed by snap-
cooling on ice for 5 mins.
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2.2.7.6 Reverse transcriptase PCR
First strand cDNA synthesis was performed using a Reverse Transcription System
(Promega). 500ng RNA (quantified as described above) was added to 0.2ml PCR tube.
Nuclease-free H2O was added to make volume up to lOpl. Samples were denatured at
70°C for 10 mins and kept on ice. 10pl PCR mastermix was prepared with: 4pi MgCl2
(Promega), 2pi reverse transcription buffer, 2pl dNTP mix (Invitrogen), lpl random
primers (Promega), 0.5pl Rnasin (Promega), 0.5pl AMV reverse transcriptase
(Promega) and samples were reverse transcribed under conditions of 42°C for 15 mins,
95°C for 5 mins and 4°C for 5 mins in a G-storm Thermal Cycler (Gene Technologies).
2.2.7.7 Real-time PCR
Real-time PCR exploits the 5'-3' exonuclease activity of Taq DNA Polymerase to
cleave a probe during the PCR reaction. The 7ai7man® probes used in our studies
incorporate 6-carboxyfluorescin (FAM) reporter dye covalently attached at the 5' end
and nonfluorescent quencher (NFQ) at the 3' end of the probe. When the probe is
intact, the proximity of the reporter dye to the quencher dye results in suppression of the
reporter fluorescence. During the PCR reaction, if the target of interest is present the
probe specifically anneals between the forward and reverse primer sites. The 5'-3'
exonuclease activity of Taq DNA Polymerase then cleaves the probe separating the
reporter dye and the quencher dye, which results in increased fluorescence of the
reporter. Accumulation of PCR products is detected directly using the Roche
Lightcycler® 480 Real-Time PCR System, which monitors the increase in fluorescence
of the reporter dye. The cleaved probe fragments are displaced from the target, and
polymerisation of the strand continues. This process occurs in every cycle and does not
interfere with the exponential accumulation of product. The increase in fluorescence
signal is detected only if the target sequence is complimentary to the probe and is
amplified during PCR. Because of these requirements, any non-specific amplification is
not detected.
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cDNA samples Assay mix
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Figure 2.3 Schematic representation of real-time PCR set-up
Data analysis was carried out using Lightcycler 480 Software. Absolute quantification
analysis uses the sample crossing point (Cp) to determine the concentration of target
gene. The Cp value is the cycle at which the fluorescence of the sample rises above the
background fluorescence and corresponds to the maximum of the second derivative of
the curve. The more target gene present in the sample the earlier it will be detected in
the PCR cycles and the lower the Cp. A standard curve is constructed using serial
dilutions of cDNA. Relative target gene mRNA abundance in samples is extrapolated
from the standard curve (Cp value vs. target gene abundance) and expressed in arbitrary
units. Target gene data are then normalised to an endogenous control, TATA-box
binding protein (TBP) or eukaryotic 18S rRNA (18S), and calibrated to the control
group in the study. The details of the real-time PCR assays used in this study are
described in Table 2.3.
cDNA (standards and samples) and assay mastermix were added to 384-well plate and
then centrifuged (Megafuge 3.OR, Heraeus Sepatech) at lOOOg for 2 mins at 4°C to mix.
The PCR was performed in a lOpl reaction mixture containing 5.0pl of LightCycler®
480 Probes Master (Roche Diagnostics), 2.5pl of LightCycler® 480 Probes Master H20,
PCR-grade, 0.5pl TaqM&n" Gene Expression Assay for the target gene (see Table 2.3
(Applied Biosystems) and 2pl of template (1:20 dilution of cDNA synthesised as
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previously described) in a 384-well plate (LightCycler® 480 multiwell plate 384, Roche
Diagnostics). In order to generate a standard curve; an aliquot of cDNA from each
sample was collected and used to form stock cDNA. Serial dilutions (1:4,1:8,1:16,
1:32,1:64,1:128,1:256) of the stock cDNA were included as standard samples on the
plate in a similar manner to test samples. Non-template negative controls were also
constructed by substitution of nuclease-free H20 for cDNA. Each sample was assayed
in triplicate. Thermal cycling conditions comprised an initial denaturation step at 95 °C
for 5 mins and 50 cycles of; 95°C for 10 sees and 60°C for 30 sees.
Target Gene Assay Accession No. Amplicon
Length
GR Mm00433832 _m1 NM_008173.2 68
PEPCK COCOCOo"itooE _m1 NM_011044.1 88
11P-HSD1 ■CMcoCOr-■<frooE2 _m1 NM_008288.1 67
LPL Mm00434764 _m1 NM_008509.1 61
18S Hs99999901_ s1 X03205.1 187
TBP Mm00446973 _m1 NM_013684.2 73
Table 2.3 TaqMan® Gene Expression Assays
Gene expression assays (GR - glucocorticoid receptor; PEPCK- phosphoenolpyruvate
carboxykinase; 11(B-HSD1 - 11 (3-hydroxysteroid dehydrogenase type 1; LPL-lipoprotein lipase;
18S ribosomal RNA; TBP - TATA binding protein) used in real-time PCR quantification of target
gene mRNA expression
2.2.8 35S In Situ hybridisation histochemistry
In situ hybridisation histochemistry allows for the visualisation and quantification of
specific gene transcripts by hybridisation of a 35S-UTP labelled 'antisense' RNA probe
to the mRNA of interest. 35S-UTP labelled 'sense' RNA probes of similar length,
nucleotide content and specific activity were included in experiments in order to assess
the specificity of the hybridisation seen. Only RNase free, sterile solutions and
equipment were used to prevent degradation of target mRNA by exogenous RNases.
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2.2.8.1 Slide preparation
Slides were racked and washed in the following series of solutions; 0.2M HC1 for 3
mins, DEPC-H2O for 3 mins, 2% 3-aminopropyltriethoxysilane (dehydrated by filtering
through NaSO,*) for 10 sees, acetone for 3 mins (twice), and finally DEPC-H2O for 3
mins. Slides were air-dried for 30-60 mins before baking at 50°C (Gallenkamp Fan
Incubator, Weiss-Gallenkamp) for 4-16 hr. Dried slides were wrapped in aluminium
foil and stored for up to 3 months.
2.2.8.2 Tissue section preparation
Whole brains were routinely frozen on dry ice immediately after dissection from the
animal and stored at -80°C until required. Brains were later placed in the cryostat
(Leica) chamber at -20°C and allowed to equilibrate for approximately 30 mins.
Following equilibration, the brains were embedded in Cryo-m-bed embedding
compound (Bright Instruments) and positioned in the correct orientation for sectioning.
14pm thick coronal sections were collected and transferred to the prepared slides, and
stored at -80°C until required.
2.2.8.3 Synthesis of 35S-UTP labelled riboprobes
2.2.8.3.1 Preparation of cDNA templates by PCR
cDNA templates were prepared for various genes of interest, to be used subsequently
for the synthesis of RNA probes for in situ hybridisation analysis, using one of three
methods:
Method 1 - For MR, GR, CRH and AVP, plasmid vectors (pGem3/4; Bluescript KS)
containing the cDNA fragment of interest were linearised using digestion by the
appropriate restriction enzyme (see Table 2.4). The template was then purified using a
QLAquick PCR Purification Kit (Qiagen).
Method 2 - For serum/glucocorticoid-regulated kinase 1 (Sgkl), FK506 binding protein
5 (Fkbp5) and brain-derived neurotrophic factor (BDNF), a standard PCR method was
used to generate cDNA templates. Mouse brain cDNA was used as a template for a
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'floppy' PCR where primers included 5' extensions containing phage polymerase
consensus sites, with antisense and sense primer pairs incorporating T3
(ATTAACCCTCACTAAAGGGA) and T7 (TAATACGACTCACTATAGGG) sites,
respectively (see Table 2.5). Thermal cycling conditions comprised an initial
denaturation step at 95°C for 15 mins and 35 annealing and extension cycles of: 94°C
for 45 sees, a variable annealing temperature (Sgkl 55°C; Fkbp5 50°C; BDNF 48°C) for
30 sees and 72°C for 45 sees followed by a final extension step at 72°C for 10 min in a
G-storm thermal cycler. cDNA was pooled from several PCR reactions for each










Enzyme Polym Enzyme Polym
MR Hindlll SP6 EcoRI T7 pGem4/
EcoRI
2769-3282 514
GR Aval T7 EcoRI SP6 pGem3/
Pst1-EcoRI
1743-2364 622
CRH Xbal T3 Hindlll T7 Bluescript KS/
Pvull-BamHI
1525-2043 519
AVP EcoRI SP6 Hindlll T7 pGem3/
Hindlll-EcoRI
135-575 440
Table 2.4 In situ hybridisation riboprobe synthesis from plasmid vectors containing the
cDNA of interest
Plasmid vectors were linearised with appropriate antisense or sense restriction enzyme and
cDNA was then reverse transcribed with appropriate RNA polymerase to synthesise specific
riboprobe. MR = mineralocorticoid receptor; GR = glucocorticoid receptor; CRH =
corticotrophin-releasing hormone; AVP = arginine vasopressin
Method 3 - For c-fos, rat brain cDNA template was prepared by a nested PCR method.
An initial PCR product was generated using the thermal cycling conditions detailed
above, with an annealing temperature of 50°C, using nested primers. The product was
used as the template for a second PCR reaction using 'floppy' primers. This PCR
product was purified by QIAquick Gel Extraction Kit (Qiagen). Using this second
purification method, the sample was first electrophoresed on a low melting point
agarose gel. The DNA fragment was visualised under UV light, excised from the gel
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using a scalpel, purified from the gel using the QIAquick Gel Extraction Kit and
resuspended in 50pi DEPC-H2O.
Recovery of the DNA fragment was assessed by electrophoresis of lpl of the DNA
solution through an agarose gel with a DNA mass ladder (Invitrogen) to obtain an
approximate concentration of the purified cDNA fragment. Riboprobes cDNA









Primers (5' -> 3')
c-fos X06769 1203-1711 509
F - GCCCACCGAAAGGGCAGC
R - GCTGCACTAGATACAATC
Sgk1 NM_011361 205-868 664
F-CCTATGCATGCAAACACGCTGAAGTTC
R - TCAGGAGCCAGATACTCAGGCGTG
Fkbp5 NM_010220 672-1294 623
F - CTGGAAGGCTGCTGTGG
R - GCCAACACCTTCTCGAAGTCG
BDNF AY57908 843-1362 520
F - TGGCTGACACTTTTGAGC
R - CTTATGAATCGCCTGCC
Table 2.5 cDNA template synthesis for the generation of in situ hybridisation riboprobes
Mouse (Sgk1, Fkbp5 and BDNF) or rat (c-fos) brain cDNA was used to generate cDNA
templates of 509-664 bp in length using specific forward and reverse primers in a PCR. RNA
polymerases were then used to synthesise riboprobes: T3 for antisense and T7 for sense. Sgk1
= serum/glucocorticoid-regulated kinase 1; Fkbp5 = FK506 binding protein 5; BDNF = brain
derived neurotrophic factor; F = forward; R = reverse
2.2.8.4 35S-UTP labelling of cDNA
0.5-lpg of cDNA template was transcribed by incubation at 37°C (or 40°C for SP6
RNA Polymerase) for 60-90 mins in a reaction mixture containing ImM ATP, CTP and
GTP, 4pl 35S-UTP (1.48 MBq/pl; Amersham Biosciences), lOmM DTT (Merck
Biosciences), 0.4pl RNasin (40U/pl; Promega), and lpl appropriate RNA polymerase
(Promega) (see Table 2.4 and 2.5) in a total volume of lOpl lx transcription optimised
buffer (Promega). Following incubation, lpl DNase 1 (RNase-free; Promega) was
added and reactions incubated at 37°C for a further 10-15 mins to degrade the DNA
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template, after which probes were placed on ice for 1-5 mins and purified using NICK
columns, to separate unincorporated radioactivity. The column was prepared by
washing through with 3ml TE buffer (pH 8.0). The probe mixture was then applied to
the column. The column was washed with 400pi TE buffer and the initial elutant
discarded. The radiolabeled probe was then eluted in an additional 400pl TE buffer.
For each probe, the total activity was estimated by counting lpl of probe in 1ml
scintillant fluid in a beta-counter (minimum activity required 2xl05 cpm/pl). Probes
were stored at -20°C until required, for up to 3-4 weeks.
2.2.8.5 Tissue preparation and fixation
Slides were removed from the -80°C freezer and kept on dry ice until the start of the
fixation procedure. Slides were fixed at 4°C in 4% paraformaldehyde in 0.1M
phosphate buffer for 10 mins (to maintain tissue morphology and inhibit endogenous
ribonucleases). Slides were rinsed twice in lx PBS for 5 mins, acetylated in 0.1M
triethanolamine with 0.25% acetic anhydride for 10 mins (to reduce non-specific
binding of the probe to positively charged amino groups in tissues) and rinsed in lx
PBS for 3 mins. Following dehydration through a series of ethanol solutions (70, 80
and 95% ethanol in DEPC-H2O) slides were air-dried for a minimum of 30 mins.
2.2.8.6 Prehybridisation and hybridisation
Following fixation, slides were pre-hybridised with 200pl/slide of 2x pre-hybridisation
buffer diluted 1:1 with deionised formamide, at 50°C for 2 hrs. Dampening two layers
ofWhatman 3MM chromatography paper with box buffer humidified the slide boxes,
preventing tissue sections from drying out. Probes were thawed and added to 2x
hybridisation buffer diluted 1:1 in deionised formamide to give a final probe
concentration of lOxlO6 cpm/ml. Probes were denatured at 75°C for 10 mins and snap-
cooled on ice before addition of lOmM DTT (10pl/ml probe solution). Pre¬
hybridisation buffer was drained from slides and 200pi appropriate probe in
hybridisation buffer was applied to slides. Slides were hybridised in sealed, humidified
boxes at 50°C for approximately 16 hrs.
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2.2.8.7 RNase treatment and washes
Following hybridisation, slides were washed three times in 2x SSC for 5 mins and
carefully wiped dry around the sections with lens tissue. 200pi of RNase A (30pg/ ml in
Rnase buffer, Roche Diagnostics) were applied to each slide and slides were then
incubated at 37°C for 1 hr in humidified boxes (1 layer of Whatman 3MM
chromatography paper dampened with Rnase buffer) to remove unhybridised probe.
Following RNase treatment, slides were washed in 2x SSC at room temperature for 1 hr,
then in O.lx SSC at 60°C for 1 hr, and finally in O.lx SSC heated to 60°C and allowed
to cool to room temperature for the duration of the wash (1 hr). Following the washes,
slides were dehydrated through a series of ethanol solutions containing 0.3M
ammonium acetate (2 mins in each of 50, 70 and 90% ethanol) and air-dried.
2.2.8.8 Visualisation of hybridisation
Slides were exposed to Kodak Biomax-MR film for 1-10 days depending on the specific
activity probe used and abundance of the gene transcript.
2.2.8.9 Image analysis
For image analysis autoradiographic films were scanned on a high resolution flatbed
scanner and any damaged or inadequate sections were excluded. The background was
low with sense section backgrounds having a greyscale level not significantly different
to zero. Digital image analysis was performed using MCID image analysis system
(InterFocus Imaging) by optical densitometry. The appropriate section was selected per
animal, and ten measurements were taken per area (five from each hemisphere), with
the background subtracted. The specific signal was measured in several different
regions specified in the individual chapters.
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2.2.9 Corticosterone radioimmunoassay
500pi urine was treated by ethyl acetate extraction and reconstituted in 200pl borate
buffer and was run undiluted whilst plasma was diluted 1:10 in borate buffer containing
0.5% BSA. Samples were heated to 75-80°C for 30 mins to denature CORT-binding
globulin and dissociate the steroid. 3H-CORT was suspended in borate buffer to give
between 10000 and 15000cpm per 50pi solution on the (3-counter. Rabbit anti-CORT
antibody was added to this mix in a 1:100 dilution. 20pi aliquots of diluted plasma
sample or CORT standards, prepared in the linear range from 0.625-320 ng/ml, were
incubated in duplicate with 50pl 3H-CORT/primary antibody mix in 96 well plates.
50pl scintillation proximity assay beads (SPA; Amersham Biosciences) diluted with
borate buffer was then added to each well, the plates were then sealed, shaken and left
overnight at room temperature to equilibrate. Plates were counted on the beta-counter
and the concentration of CORT in each sample was calculated from a graph of cpm
versus [CORT] standards generated using the Multicalc programme (PerkinElmer).
Intra- and inter-assay coefficients of variation were 9.4 and 9.2% respectively. In this
assay, in comparison with CORT (100%), the cross-reactivities for progesterone,
deoxyCORT and Cortisol are 7.7, 6.5 and 5.3 %, respectively (Kenyon, 1993).
2.2.10 Glucose tolerance test
Adult male mice were fasted overnight (16 hrs) and weighed before and after the fasting
period. Following the fast, subjects were given an intraperitoneal injection of D-glucose
(2mg/g body weight in saline). Blood samples (15-20pl) were taken by tail venesection
into EDTA-coated Microvette tubes at 0 min (just prior to glucose injection) and at 5,
15, 30, 60 and 120 mins following glucose load. Blood samples were centrifuged,
plasma supernatant collected and stored at -20°C until glucose levels were assayed.
2.2.11 Glucose assay
Glucose was determined by an enzymatic method using the Infinity™ Glucose
Hexokinase Liquid Stable Reagent (Thermo Fischer Scientific). Glucose standards (0-
45 nM) were freshly prepared prior to the glucose assay. 1 pi of plasma or glucose
standard was added to 180ul reagent, in duplicate on a 96-well plate. The samples were
Page 82
PhD Thesis - A genetic approach to prenatal glucocorticoid programming
left to incubate at room temperature for 15 mins and then counted at 340nm in a plate
reader. The sample glucose concentration was then calculated from the standard curve.
2.2.12 Statistical analysis
Data are expressed as mean±SEM. Comparisons between groups were analysed by the
most appropriate method including either an unpaired t-test, one and two-way analysis
of variance (ANOVA) or a repeated measures (RM) one-way ANOVA, with Student
Newman-Keuls (SNK) post-hoc testing; p<0.05 was considered significant.
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CHAPTER 3
EFFECT OF PRENATAL DEX
ON THE HPA AXIS, BRAIN AND
ANXIETY-RELATED BEHAVIOUR
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3.1 Introduction
It has previously been reported that prenatal dexamethasone (DEX) treatment during the
final trimester of fetal life resulted in hypothalamic pituitary adrenal (HPA) axis
hyperactivity, hypertension and heightened anxiety-related behaviour in rat offspring
(Levitt et al., 1996; Welberg et al., 2001; O'Regan et al., 2004). Plasma corticosterone
(CORT) was found to be significantly elevated at the diurnal nadir, although in male
DEX offspring only (O'Regan et al., 2004). However, following stress activation a
similar response in DEX and vehicle (VEH) control offspring was seen, suggesting no
stress-induced HPA axis hyperactivity was present (Nyirenda et al., 2001). More
recently, blood pressure (BP) was measured in DEX and VEH offspring by
radiotelemetry, which allows for remote quantification of BP without any necessary
subject manipulation. Findings contradicted the hypertension previously detected by
tail-cuff plethysmography, an undoubtedly stressful method (Levitt et al., 1996), and
observed a resting decrease in BP in DEX offspring (O'Regan et al., unpublished
observations). However, when disturbed and restrained an enhanced rise in BP was
evident in DEX offspring indicating a heightened sensitivity to stress rather than
underlying hypertension (O'Regan et al., unpublished observations). The stress-induced
hypertension was blocked by reserpine, implicating increased sympathetic drive as the
mechanism (O'Regan et al., unpublished observations). Prenatal DEX has also been
found to increase anxiety-related behaviour when measured in the elevated plus maze
(EPM) and open field (OF) and increased sympathetic drive may contribute.
In this chapter we aimed to investigate three aspects of the DEX-programmed rat as
follows:
1.) We wished to explore the basal HPA axis activity in DEX offspring in order to
confirm the previous indication of raised basal function. Therefore, male VEH
and DEX offspring were housed in metabolic cages and following two weeks
habituation we collected urine and subsequently measured CORT excretion.
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We wanted to extend the previous finding of enhanced stress sensitivity in DEX
offspring and see whether this was also apparent in the behavioural response.
The EPM presents a conflict between the natural exploratory drive and the
innate fear of open spaces in rodents and has been extensively used to assess
anxiety-related behaviour (Dawson and Tricklebank, 1995). In order to
exacerbate differences in stress sensitivity VEH and DEX prenatally-treated
offspring were subjected to either 30-min restraint stress or brief handling 24 hrs
prior to testing on the EPM. This fear-potentiation has previously been elicited
by several stressors including restraint, forced swim and inescapable footshock
(Korte and De Boer, 2003). The timing and nature of stress exposure was
selected based on the report that restraint stress exacerbated heightened anxiety-
related behaviour when EPM was conducted 24 hrs, but not 1 or 2 hrs later
(Padovan and Guimaraes, 2000).
The transient expression of the immediate early gene, c-fos, or its encoded
protein, Fos, have been extensively employed as neuroanatomical markers of
activation in various situations including novelty, stressor exposure, hormone
and drug treatment (Cullinan et al., 1995; Kovacs, 1998; Singewald et ah, 2003;
Miyata et ah, 2005) and following EPM exploration (Duncan et ah, 1996; Hinks
et ah, 1996). Furthermore, altered patterns of expression have been detected
following acute restraint or EPM exposure in high and low anxiety behaviour-
bred (Salome et ah, 2004), neonatally-handled (Abraham and Kovacs, 2000;
Park et ah, 2003), prenatally-stressed (Viltart et ah, 2006) and prenatal protein-
restricted (Rosene et ah, 2004) offspring. Therefore, we wished to investigate
regional activation in prenatal VEH and DEX with the use of transient c-fos
mRNA expression following EPM exposure. In particular, we were interested in
the interaction of prenatal treatment with the prior acute stress.
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3.2 Methods
Comprehensive details of methods can be found in chapter 2.
3.2.1 Prenatal treatment
In the biological research facility at the Western General Hospital, Wistar rats were
time-mated and dams injected (sc) between 09.00 and 11.00 h on days 14-21 of
pregnancy with either dexamethasone (DEX, lOOpg/kg/day) or Vehicle (VEH, 0.9%
NaCl-4% Ethanol). On the day of birth, pups were weighed, sexed and culled to 8 pups
per litter keeping equal numbers of each sex, where possible. Pups were then weighed
weekly until weaning, which occurred on postnatal day 21 (P21). After weaning, pups
were housed in single-sex, sibling groups of 2-4 and left undisturbed until testing, apart
from routine cage maintenance. Offspring were only subject to one of the following
procedures.
3.2.2 Metabolic cage
Male rats, aged 5-6 weeks, were pair-housed in metabolic cages and, following two wks
habituation, water/food ingestion and urine/faeces excretion was measured. Urine was
collected and later analysed for CORT concentration.
3.2.3 Behaviour in EPM under basal and stress-potentiated conditions
At 8-9 months of age behavioural studies on the EPM were performed on male and
female prenatally-treated offspring. No more than two offspring from each litter were
used. All manipulations were commenced at 09.00 h. For four days, animals were
brought into the experimental room and handled briefly to habituate them to the
investigator and the testing environment. Following two days rest, the VEH and DEX
subjects were randomly separated into two equal groups, control (CON) and STRESS.
The CON group was handled in the experimental room as previously, whilst the
STRESS group was subjected to restraint in plexiglass tubes for 30 mins on the day
prior to behavioural testing. 24 hrs later, anxiety-related behaviour was assessed on the
EPM during 5-min test, under norma1 Hghting conditions (identical to housing rooms).
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30 mins following the test, subjects were decapitated, brains collected and frozen on dry
ice.
3.2.4 In situ hybridisation histochemistry
Coronal sections (14pm thickness) were taken from frozen male brains at the levels of
the cortex, PVN, hippocampus, amygdala, raphe nucleus and locus coeruleus. In situ
hybridisation was performed using a [35S]-labeled antisense probe prepared from the c-
fos cDNA template. Slides were exposed to Kodak Biomax MR film for four days and
image analysis was performed by optical densitometry.
3.2.5 Statistical analysis
Data are expressed as mean±SEM, p<0.05 considered significant, and comparisons
between groups analysed by most appropriate method: unpaired t-test, one or two-way
analysis of variance (ANOVA), with Student Newman-Keuls (SNK) post-hoc testing.
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3.3 Results
3.3.1 Prenatal treatment effects on maternal weight gain
VEH and DEX treatments were well tolerated and injections were not obviously
uncomfortable for the pregnant dams. Weight gain during the final week of pregnancy
(days 14-21 inclusive) was different between the two groups, with DEX-treated dams
gaining significantly less weight (Table 3.1a; p<0.05).
Maternal weight Litter Male:female Birth Weight
before after gain size ratio group male female
(g) (g) (g) (g) (g) (g)
VEH 348.8±7.3 452.4+14.5 103.6+10.8 11.9±1.4 1.2±0.3 6.5±0.1 6.6±0.1 6.4±0.1
(n=8) (n=95) (n=47) (n=48)
DEX 358.7±9.4 422.3±13.6* 63.6±7.7* 13.6±1.5 1.0±0.2 5.3±0.1** 5.4±0.1** 5.3±0.1**
(n=7) (n=95) (n=46) (n=49)
Table 3.1a Prenatal treatment effect on the dam and birthing parameters
Maternal weight before and after vehicle (VEH) or dexamethasone (DEX) treatment, maternal
weight gain during the last week of pregnancy (days 14-21), litter size, male:female ratio,
and group, male and female offspring birth weight. Results are presented as meamSEM.
*p<0.05; **p<0.0001 compared with VEH group.
3.3.2 Birth and growth parameters in VEH and DEX offspring
DEX treatment had no effect on gestation length (data not shown), litter size (p=0.419)
and male:female ratio (p=0.720) compared to VEH (Table 3.1b). Birth weight was
significantly reduced in both male (p<0.0001) and female (p<0.0001) DEX offspring
compared to VEH, representing an 18.7% and 17.5% reduction, respectively. The
reduction in body weight persisted through to 16-17 weeks. However, at 24-25 weeks
no difference in body weight between prenatal treatment groups was observed in either
male (p=0.438) or female offspring (Table 3.1b; p=0.491), suggesting catch-up growth
had been achieved.
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1 wk 2 wks 3 wks
male female male female male female
(g) (g) (g) (g) (g) (g)
VEH 20.0±0.3 19.5+0.2 40.0±0.6 39.0±0.5 63.4±1.0 61.6+0.8
(n=32) (n=30)
DEX 15.6±0.3** 15.5±0.4** 34.3+0.5** 33.3+0.7** 54.7+0.8** 52.8±1.0**
(n=23) (n=23) (n=27) (n=27)
4-5 wks 13-14 wks 16-17 wks 24-25 wks
male male male male female
(g) (g) (g) (g) (g)
VEH 130.6±4.7 550.4±15.3 574.4±12.0 628.5+11.7 347.4±9.1
LOT—II1—IICOIICOIIc (n=10)
DEX 112.2±7.7* 506.6±15.3* 544.4+17.1* 610.8±21.0 357.3±10.6
(n=8) (n=8) (n=11) (n=11) (n=10)
Table 3.1b Prenatal treatment effect on postnatal growth
Comparison of growth in prenatal vehicle (VEH) and dexamethasone (DEX) treated offspring,
measured during first three weeks, and then periodically, in males and females. Results are
presented as mean±SEM. *p<0.05; **p<0.0001 compared with VEH group, n=number of
animals
3.3.3 Urinary CORT measurements in male VEH and DEX offspring
Following habituation to the metabolic cages, urine was collected daily for four days
and CORT levels measured by RIA. The measured parameters and CORT
concentration did not differ between collection days for either group so they were
averaged. Urinary CORT excretion was significantly elevated in DEX offspring (Table
3.2; p<0.05). However, food/water intake (p=0.235; 0.428) and faeces/urine output
(p=0.213; 0.596) were not significantly different between groups. DEX offspring had a
reduced body weight prior to collection (Table 3.2; p<0.05), although the weight gain
during collection was not different compared to VEH offspring (p=0.775).
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Initial Weight Intake Output CORT
Weight Gain Food Water Faeces Urine Excretion
(9) (9) (g/100g BW) (ml/100g BW) (g/100g BW) (ml/100g BW) (ng/g BW)
VEH 198.5±5.2 9.38±0.36 12.9±0.6 17.2±0.8 5.8±0.2 7.2±0.4 36.6±2.2
DEX 172.9±7.2* 9.59±0.62 13.0±0.6 18.3±1.0 6.1 ±0.2 7.6±0.6 49.7+5.6*
Table 3.2 Daily ingestion and excretion in male VEH and DEX rat offspring
Initial weight, weight gain, daily food/water intake, urine/faeces output and CORT excretion
measured daily during 4-day collection in prenatal vehicle (VEH) and dexamethasone (DEX)
treated offspring. Results are presented as mean±SEM. *p<0.05 compared with VEH group.
n=8 per group.
3.3.4 Anxiety-related behaviour in VEH and DEX offspring
3.3.4.1 Male offspring
Anxiety-related behaviour was measured during 5-min exploration of the EPM.
Statistical analyses were performed by two-way ANOVA with SNKpost-hoc testing,
where appropriate.
There was no overall effect of prenatal treatment on the number of entries into the
closed arms (Figure 3.1a; Fi,2o=1.81, p=0.193), although there was a significant effect of
acute treatment (Fi,20=6.55, p<0.05). Post-hoc testing revealed that closed arm entries
were significantly reduced following prior stress in DEX offspring (DEX/STRESS) as
compared to handled controls (DEX/CON) (p<0.05). There were no differences in open
arm entries between VEH offspring that had been stressed (VEH/STRESS) and handled
controls (VEH/CON) (p=0.442) or between VEH/CON and DEX/CON (p=0.852).
We found no overall effect of prenatal treatment (Figure 3.1a; Fi,2o=0.07, p=0.784),
whilst there was a tendency of acute restraint treatment (F1j2o=2.70, p=0.116) on the
number of entries into the open arm. DEX/STRESS had a similar tendency for reduced
open arm entries as compared to DEX/CON, but this was not significant (p=0.104). No
differences were observed between any other groups.
An overall effect of prenatal treatment (Figure 3.1b; Fi,2o=0.26, p=0.617) on the time
spent on the open arms was absent, although a tendency of overall effect in acute
treatment was observed (Fi>2o=3.12, p=0.092).
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(a) Entries (b) Time spent on open arms








Figure 3.1 Behaviour of male VEH and DEX rat offspring in the elevated plus maze under
normal and stress-potentiated conditions
Effects of prenatal dexamethasone (DEX) or vehicle (VEH) with (STRESS) or without (CON) 30-
min restraint stress 24 hrs prior on (a) number of entries into the open and closed arms, (b) time
spent on open arms and (c) distance travelled on the open arms and in total during a 5-min
EPM test. *p<0.05 vs DEX/CON; n=4-8 per group.
No overall effect was observed in the total distance and that travelled on the open arms
by prenatal treatment (Figure 3.1c; Total: Fj,20=1-18, p=0.291; Open arm: Fi,2o=0.42,
p=0.523). There was an overall effect tendency for acute treatment in the total and open
arm distance travelled (Total: Fi;2o=2.68, p=0.117, Open: Fi;2o=2.81, p=0.109). Post-
hoc testing revealed a tendency for reduced total and open arm distance travelled in
DEX/STRESS compared to DEX/CON (Figure 3.1c; p=0.069; 0.102). No differences
were observed between any other groups.
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3.3.4.2 Female offspring
No significant differences were observed in female behaviour in the EPM. Open arm
and closed arm entries (Figure 3.2a), open duration (Figure 3.2b), total and open arm
distance (Figure 3.2c) were all unchanged by prenatal or acute treatment.
(a) Entries (b) Time spent on open arms




Figure 3.2 Behaviour of female VEH and DEX rat offspring in the elevated plus maze
under normal and stress-potentiated conditions
Effects of prenatal dexamethasone (DEX) or vehicle (VEH) with (STRESS) or without (CON) 30-
min restraint stress 24 hrs prior on (a) number of entries into the open and closed arms, (b) time
spent on open arms and (c) distance travelled on the open arms and in total during a 5-min
EPM test. n=5-8 per group.
3.3.5 Expression of c-fos mRNA following EPM exploration
The transient expression of the c-fos IEG is believed to be proportional to the level of
cellular activation (Cullinan et al., 1995). We therefore measured c-fos mRNA
expression in brains taken 30 mins following EPM exploration in male offspring in
order to assess the regional brain activation elicited by this mild stressor in VEH and
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DEX offspring subjected to prior stress or handled controls. Following [ S] in situ
hybridisation and exposure of slides to film, c-fos mRNA expression was analysed from
a single section for each subject by optical densitometry and quantified in several
regions. These regions include the cingulate and frontal cortex, PVN, hippocampus,
raphe nucleus and locus coeruleus which are all implicated in the stress response.
Statistical analyses were performed by two-way ANOVA with SNKpost-hoc testing,
where appropriate. Expression of c-fos mRNA in the cingulate and frontal cortex is
shown in Figure 3.3.
Figure 3.3 Autoradiograph of c-fos mRNA expression
in male rat brain at the level of the cingulate (CgCx)
and frontal cortex (FrCx)
There was a weak tendency of an overall effect of
prenatal treatment on c-fos mRNA expression in the
cingulate (Figure 3.4; Fi;2i=2.55, p=0.125) and frontal
(Figure 3.4; Fi;2i=2.03, p=0.169) cortex. However, no overall effect of acute treatment



























Cingulate Cortex Frontal Cortex
Figure 3.4 c-fos mRNA expression in cingulate and frontal cortex of male VEH and DEX
rat offspring following EPM exposure
In situ hybridisation using a [^SJ-labeled riboprobe for c-fos mRNA. Coronal sections were
taken from brains obtained 30 mins following 5-min EPM exposure in prenatal vehicle (VEH)
and dexamethasone (DEX) treated offspring with (STRESS) or without (CON) 30-min restraint
stress 24 hrs prior. Expression measured by optical densitometry of autoradiography film. n=4-
8 per group.
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In other regions quantified: hippocampus, raphe nucleus and locus coeruleus c-fos
mRNA expression was evident, although no differences were detected between
treatment groups (Table 3.3). In all other regions of the brain the level of expression








VEH/CON 0.13±0.02 0.13±0.02 0.13±0.02 0.17±0.03 0.09±0.01 0.10±0.01 0.15±0.02
(n=7) (n=8) (n=8)
VEH/STRESS 0.13±0.03 0.13±0.04 0.13±0.03 0.17+0.04 0.11 ±0.02 0.12±0.02 0.12±0.02
(n=7) (n=6) (n=6)
DEX/CON 0.13±0.05 0.13+0.04 0.11 ±0.03 0.17+0.06 0.08±0.01 0.09±0.02 0.15±0.02
(n=4) (n=4) (n=5)
DEX/STRESS 0.14±0.02 0.13±0.03 0.12±0.02 0.14±0.02 0.09±0.03 0.09±0.01 0.16±0.02
(n=5) (n=4) (n=5)
Table 3.3 c-fos mRNA expression in hippocampus, raphe nucleus and locus coeruleus of
male VEH and DEX rat offspring following EPM exposure
Expression measured by optical densitometry (arbitrary units). Sections were cut from brains
obtained 30 mins following 5-min EPM exposure in VEH and DEX prenatally-treated offspring
with (STRESS) or without (CON) 30-min restraint stress 24 hrs prior. Results are presented as
mean±SEM.
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3.4 Discussion
Similar to previous studies, we report a reduced birth weight in offspring following prenatal
DEX treatment in the final trimester (Levitt et al., 1996; Nyirenda et al., 1998; 2001;
Welberg et al., 2001; O'Regan et al., 2004; Drake et al., 2005). We observed increased
urinary CORT excretion, further supporting the previously described finding of elevated
HPA axis activity as a consequence of prenatal DEX exposure (Levitt et al., 1996; O'Regan
et al., 2004). Exploration of the EPM following prior acute stress revealed anxiety-like
behaviour in male DEX offspring compared to handled controls. In contrast, no effect of
prior restraint was noted in VEH offspring. No effect of either prenatal (VEH/DEX) or
postnatal (CON/STRESS) treatment was observed in female offspring. The expression of
c-fos mRNA was quantified throughout the brain, which revealed enhanced induction in the
frontal and cingulate cortex following EPM exposure.
Prenatal DEX administration lead to intrauterine growth restriction (IUGR) and a reduction
of birth weight in both male and female offspring. We observed an 18.7% and 17.5%
reduction in birth weight compared to VEH offspring in males and females, respectively.
Interestingly, a large variation in the proportion of growth restriction induced by final
trimester prenatal DEX treatment has been reported in studies performed in Edinburgh (8.8-
25.1%) (Nyirenda et al., 1998; 2001; Cleasby et al., 2003a; 2003b; O'Regan et al., 2004;
Drake et al., 2005). The difference in birth weight between VEH and DEX offspring in our
study therefore reflects growth restriction in the middle of that range, indicating a robust
effect of prenatal GC treatment. The reduced weight in DEX, compared to VEH, offspring
persisted until approximately 6 months of age. Catch-up growth was therefore achieved in
DEX offspring between 4-6 months. Previous studies have also reported differences in
postnatal growth with full catch-up growth being observed by either 3 weeks (Nyirenda et
al., 1998; O'Regan et al., 2004; Drake et al., 2005), 6 months (Nyirenda et al., 2001) or not
at all (Cleasby et al., 2003a). Evidence from human observations indicates that catch-up
growth may play a mechanistic role in prenatally programmed effects (Ong, 2006),
although the involvement in experimental models is less clear. The discrepant findings
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from almost identical treatment paradigms on both birth weight and postnatal growth are an
indication of the sensitivity of this model to outside environmental influence. This may
include the investigator performing the procedure or the general activity in the housing
conditions.
Previous indications of HPA axis hyperactivity in DEX offspring have been obtained from
the reports of elevated basal CORT at the diurnal nadir (Levitt et al., 1996; O'Regan et al.,
2004). In this study, we detected elevated CORT excretion in DEX compared to VEH
offspring, when averaged over the daily cycle, providing further evidence of enhanced
basal HPA axis activity. It should be noted that Heidbreder et al. (2000) report elevated
circulating CORT in rats reared in grid-floored compared to sawdust-filled cages,
suggesting that housing in the metabolic cages may be a stressful experience per se.
However, Erikkson et al. (2004) reported no increase in CORT excretion when 8 week old
rats were placed in metabolic cages for three days, indicating a stress response is not always
elicited. We observed no difference in CORT excretion during our four collection days in
either prenatal treatment group, indicating that the offspring had habituated to the cages.
Together with the previous report of no difference in the CORT response to acute restraint
between DEX and VEH offspring (Nyirenda et al., 2001) and our finding of increased
urinary CORT excretion over the whole daily cycle in young, immature male DEX
offspring, it suggests that basal HPA axis hyperactivity is present following prenatal DEX
treatment from early adulthood.
Previous studies have detected heightened anxiety-related behaviour on the EPM in male
DEX offspring (Welberg et al., 2001). However, we report a lack of effect of prenatal DEX
treatment on spontaneous anxiety-related behaviour on the EPM. Differences in prenatal
treatment protocols could account for the apparently conflicting results. In the present
study, prenatal treatment only commenced on embryonic day (E) 14 and DEX or VEH was
administered daily until E21. However, Welberg et al. (2001) administered VEH from E0
onwards, and then split treatment groups on E15: continuing to administer VEH to one
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group whilst dispensing DEX to the other, until E21. Indeed when DEX was administered
throughout gestation offspring displayed no difference in EPM behaviour compared to
VEH controls (Welberg, 1999). Saline injectionper se acts as a mild prenatal stressor
when administered in the final trimester and has been found to induce alterations in
behaviour including enhanced conditioned fear (Griffin et al., 2003). Whilst the precise
impact of early VEH (Saline-4% Ethanol) treatment has not been investigated, it is not
impossible that it could elicit wider behavioural differences between VEH and DEX
offspring. However, it is also likely that other uncontrollable, external factors such as
variations in animal technicians, investigators and the general environment in the biological
research facility (BRF) could contribute.
Fear-potentiation induced by a 60-min restraint immediately prior to EPM testing revealed
enhanced anxiety-like behaviour in response to acute stress in PS offspring (Estanislau and
Morato, 2005). The behavioural reaction to acute stress has not previously been studied
following prenatal DEX treatment. Following our acute stress procedure (30-min restraint,
24 hrs prior) no change was seen in EPM exploration in VEH offspring. However, in DEX
offspring, behavioural inhibition was observed in the EPM, including a significant
reduction in closed arm entries and a tendency for reduced open arm entries and distance
travelled in the whole maze and the open arms. Together these findings are suggestive of
heightened stress-sensitivity and state anxiety in DEX offspring. These data support the
previous discovery of an increased hypertensive response to stress in DEX offspring
(O'Regan et al., unpublished observations).
It should be mentioned that the measure of closed arm entries is traditionally thought to
reflect purely motor activity (Femandes et al., 1999). However, several papers have
reported a similar reduction in closed arm entries on the EPM following restraint stress in
naive adult rats (McBlane and Handley, 1994; Netto and Guimaraes, 1996; Padovan and
Guimaraes, 2000), suggesting there is a stress-induced component. FG-7142, an
anxiogenic benzodiazepine inverse agonist, was also found to induce hypoactivity in the
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EPM, independent of sedation. Additionally, a recent factor analysis in male rats found
closed arm entries to reflect a measure of anxiety (Doremus et al., 2006). Therefore, it
appears that measures of general activity may also reflect the anxiety-like behaviour.
The absence of stress-induced behavioural inhibition in VEH offspring appears to
contradict previous literature (reviewed in Korte and De Boer, 2003) reporting an
anxiogenic response to restraint performed 24 hr prior to EPM exposure in treatment naive,
control animals (Guimaraes et al., 1993; McBlane and Handley, 1994; Martijena et al.,
1997; Mendonca and Guimaraes, 1998; Padovan and Guimaraes, 2000). The duration of
restraint does not appear to be responsible for this discrepancy as studies observed
enhanced anxiety-related behaviour 24 hrs after a 15-min (Martijena et al., 1997), 1-hr
(McBlane and Handley, 1994) or 2-hr restraint session (Guimaraes et al., 1993; Mendonca
and Guimaraes, 1998; Padovan and Guimaraes, 2000). However, as stated above it should
be remembered that final trimester prenatal VEH treatment per se is a mild prenatal stressor
(Griffin et al., 2003) and our VEH subjects hence cannot be considered untreated. The
anxiogenic response to 15-min acute restraint stress (24 hrs prior to testing on the EPM)
was prevented by inhibition of CORT synthesis with metyrapone (Calvo et al., 1998),
adrenalectomy and GR or MR antagonism (Calvo and Volosin, 2001), confirming the
involvement of CORT in the restraint-induced fear-potentiation. It is possible therefore,
that the heightened CORT levels in male DEX offspring compared to VEH offspring
contributes to the stress sensitisation observed.
Similar to male offspring, no difference in spontaneous anxiety-like behaviour on the EPM
was recorded in female DEX compared to VEH offspring. However, in contrast to males,
female DEX offspring did not display sensitivity to the prior acute stress exposure. Female
DEX offspring from our laboratory have not previously been assessed on the EPM,
although they were not found to exhibit the impaired glucose homeostasis and elevated
basal CORT measured in male DEX offspring (O'Regan et al., 2004). The unaltered CORT
and normal stress-potentiated anxiety-hke behaviour in female offspring further points
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towards a possible role of heightened CORT in the programmed anxiety. However, BP
alterations have been observed in both genders (O'Regan et al., unpublished observations),
indicating that whilst perhaps less susceptible to prenatal GC programming, some effects
are still apparent in female offspring. Gender differences in behavioural tests are widely
reported (reviewed by Palanza, 2001) and PS has been shown to programme sex-specific
effects on anxiety-related behaviour (Bowman et al., 2004; Richardson et al., 2006) and
response to anxiolytic drug treatment (Poltyrev and Weinstock, 2004).
A caveat should be mentioned in that we did not correct for the phase of the oestrus cycle,
which has previously been shown to affect behaviour in the EPM (Mora et al., 1996; Frye
et al., 2000; Marcondes et al., 2001). However, the variability was relatively small in the
parameters measured during the test suggesting this factor may not explain the lack of
measured anxiety.
The quantification of c-fos mRNA was assessed 30 mins following the start of the 5-min
EPM test, shown to represent the peak of c-fos mRNA induction (Cullinan et al., 1995).
The induction of c-fos mRNA was enhanced in male DEX compared to VEH offspring in
the cingulate and frontal cortex following EPM exposure. Abnormalities in these regions
have been reported in human depression, anxiety and HPA axis regulation. Functional
magnetic resonance imaging (fMRI) studies in patients suffering from anxiety disorders
have revealed increased baseline activity in the cingulate cortex (Osuch et al., 2000) and
increased brain activity in response to anxiety-provoking stimuli in the frontal cortex
(Davidson et al., 1999). Additionally, a negative correlation between anxiety severity and
metabolism has been identified in both regions (Kennedy et al., 2003). Furthermore, the
activity within the anterior cingulate was also seen to be a predictor of treatment response
in major depression (Pizzagalli et al., 2001). A reduced left anterior cingulate volume was
found to be associated with dysregulated HPA axis function in elderly male patients
(Maclullich et al., 2006). In experimental studies, anxiety-modulating and antidepressant
drugs have been found to modulate activity in the rat cingulate cortex when measured by
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both c-fos mRNA or Fos protein expression (Miyata et al., 2005; Salchner et al., 2006) and
oxidative metabolism (Singewald et al., 2003; Gonzalez-Pardo et al., 2006). Furthermore,
the expression of c-fos mRNA differed markedly in high and low anxiety-behaviour bred
(FLAB and LAB) Wistar rats following exploration of the light/dark anxiety test (Kabbaj
and Akil, 2001). When compared LAB, HAB rats showed low expression of c-fos mRNA
in the hippocampus, but high c-fos mRNA levels in the olfactory area, the orbital cortex,
the cingulate cortex, the dorsal striatum and the PVN. Perinatal manipulation has been
found to alter c-fos mRNA induction. Following acute restraint stress prenatal protein
malnourished offspring displayed an enhanced Fos protein induction within the anterior
cingulate (Rosene et al., 2004). Additionally, neonatally-handled offspring displayed a
reduced induction of Fos protein in the cingulate cortex following restraint, but also in the
hippocampus, PVN and amygdala (Abraham and Kovacs, 2000).
The expression of c-fos mRNA following EPM exposure was also detected in the
hippocampus, raphe nucleus and locus coeruleus (key regions in central 5-HT and NA
function), although the induction following EPM exposure was similar in DEX and VEH
offspring. Previous findings indicate that prenatal DEX administration reduced the
hippocampal GR and MR expression in adult offspring (Welberg et al., 2001). We
therefore anticipated altered activation within this structure that is fundamentally involved
in the modulation of HPA axis activity, memory and emotion (de Kloet et al., 2005),
however none was observed. GR and c-fos mRNA have been found to co-localise within
the medial prefrontal cortical neurons (Ostrander et al., 2003). It would be interesting to
observe whether the prenatal DEX-induced alterations in corticosteroid receptor expression
are also apparent in the cortex. We intended to quantify this, although unfortunately were
unable to do so as a result of a freezer failure making stored tissue unusable.
c-fos mRNA expression 30-min following EPM exposure was below the level of detection
in the PVN and amygdala. Previous studies have reported undetectable levels of c-fos
mRNA following EPM exposure (Hinks et al., 1996), although a low level of Fos
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immunoreactivity was observed (Duncan et al., 1996). In contrast, both swim and restraint
stress elicited profound induction within these regions when measured 30 mins following
the onset of the stressor (Cullinan et al., 1995). The release of ACTH and CORT appeared
to correlate with the level of c-fos mRNA expression within the PVN, reflecting the
perceived stressful quality of an experience (Pace et al., 2005). Thus, our employed
stressor of EPM appears to be too mild in nature to elicit induction of c-fos mRNA in the
PVN. It would therefore be interesting to study the c-fos mRNA expression in VEH and
DEX offspring following more severe restraint stress to assess the impact of prenatal
treatment on c-fos mRNA induction within these two regions previously found to express
elevated CRH mRNA in DEX offspring (Welberg et al., 2001).
The enhanced induction of c-fos mRNA expression the cingulate and frontal cortex ofDEX
compared to VEH offspring following EPM exposure was no longer evident when restraint
had been administered 24-hrs prior. Thus the pattern of c-fos mRNA expression appears
disconnected to the anxiety-related behaviour recorded on the EPM per se, although may
signal disparate stress reponsiveness between VEH and DEX offspring. Lesions within the
cingulate cortex in rats have not been found to alter EPM behaviour (Bissiere et al., 2006).
Together with our findings, this suggests that c-fos mRNA expression detected may be a
reflection of the stressful experience of EPM exposure, rather than an indication of regions
involved in generating altered exploration of the maze.
It should be noted that our assessment of regional activation measured c-fos mRNA
expression at a 30-min timepoint, in order to measure the peak induction (Cullinan et al.,
1995). It would be interesting to assess the timecourse of c-fos mRNA induction to
observe whether spatiotemporal differences are apparent following prenatal GC
administration. MRI technology, previously only employed in clinical studies (Sizonenko
et al., 2006), has developed rapidly and can now be applied to rodents. The advantages of
such a technique are several: measurements can be performed throughout the whole brain,
rats can be assessed at different ages during life and the timecourse of regional activation
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can be determined. The application of this technology to prenatal GC-treated offspring has
the potential to rapidly develop and expand our knowledge regarding functional
neuroanatomy as a consequence of altered fetal GC exposure.
In this chapter we have reported a reduction in birth weight, increased CORT excretion,
enhanced sensitivity to stress-induced anxiety behaviour and increased cellular activation
within the cingulate and frontal cortex following EPM exposure in animals exposed
prenatally to increased GCs.
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4.1 Introduction
In the previous chapter we described behavioural studies in rat offspring following prenatal
dexamethasone (DEX) treatment where we observed heightened stress-potentiated anxiety.
Other studies have also reported elevated anxiety-like behaviour in offspring following
prenatal stress (PS) (Vallee et al., 1997; Bowman et al., 2004; Patin et al., 2005; Van den
Hove et al., 2005; Barros et al., 2006b) or DEX administration (Welberg et al., 2001;
Oliveira et al., 2006). In addition, cognitive impairment has also been found in PS and/or
DEX treated offspring using the water maze (Brabham et al., 2000; Meunier et al., 2004)
and passive avoidance (Lordi et al., 1997; 2000; Gue et al., 2004) tests, although no
difference in water maze performance was seen in prenatal DEX offspring in our laboratory
(Welberg, 1999).
The developing fetus is normally protected from GC overexposure in utero through tight
regulation of feto-placental GC transport by the ll(3-hydroxysteroid dehydrogenase type 2
(11(3-HSD2) enzyme (Seckl, 1997). This enzyme acts as a high affinity and high capacity
dehydrogenase which inactivates CORT through conversion to its 11-keto metabolite, 11-
dehydrocorticosterone (11-DHC), at least in rodents (Cortisol to cortisone in humans)
(Draper and Stewart, 2005). During early gestation the enzyme is highly expressed in the
rodent placenta, but also many fetal tissues including the brain (Brown et al., 1996b; Burton
et al., 1996; Waddell et al., 1998). However, from mid-gestation expression rapidly
decreases to minimal levels in the placenta and most tissues, in accordance with a greater
requirement for GC-mediated maturation and development (Diaz et al., 1998). The enzyme
is thought to function as a protective barrier from the maternal GCs, which are much higher
than those in the fetal circulation, thereby opposing the concentration gradient. Placental
11P-HSD2 activity is known to correlate with birthweight in both rats (Benediktsson et al.,
1993) and humans (Stewart et al., 1995; Murphy et al., 2002), illustrating the importance of
the enzyme in regulating the fetal endocrine and growth environment.
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Evasion of the 11P-HSD2 feto-placental barrier appears to be a common feature in different
models of prenatal programming including PS, prenatal GC administration and maternal
dietary manipulation (Seckl, 1997). Stress exposure has been found to elevate CORT
within the pregnant dam, which will 'overpower' the enzymatic barrier to cause GC
overexpose to the developing fetus. DEX is a poor substrate for 11P-HSD2 and does not
undergo the rapid inactivation that occurs with CORT (Brown et al., 1996a). The synthetic
GC therefore passes readily into the fetal circulation where it can mediate effects during
development. The importance of the 11P-HSD2 barrier and consequences of its inhibition
have previously been addressed in our laboratory. Welberg et al. (2000) treated dams with
the lip-HSD inhibitor carbenoxolone (CBX) throughout pregnancy. Prenatal CBX
offspring displayed similar programmed effects to those previously observed in DEX
offspring (Welberg et al., 2001), including reduced birth weight, heightened anxiety-like
behaviour and HPA axis dysregulation. However, previous investigations into GC
programming and the role of 11P-HSD2 have been subject to certain limitations:
1.) Studies involve unavoidable manipulations of the pregnant dam in order to exert
prenatal effects upon the offspring. These manipulations will impact on maternal
physiology including reduced food intake (Kinsley and Svare, 1986; Woods and
Weeks, 2005) which will almost certainly affect fetal nutrient supply.
2.) Several groups have reported a negative influence on the level of maternal
behaviour following gestational stress (Patin et al., 2002; Smith et al., 2004).
Indeed, impaired maternal care per se has been found to programme negative
lifelong outcomes (Liu et al., 1997; Meaney, 2001). Additionally, control offspring
could be programmed in a similar manner to prenatal DEX offspring when cross-
fostered to a DEX-treated mother, indicating the early postnatal period to be a
critical window of sensitivity (Brabham et al., 2000; Hauser et al., 2006).
Additionally, the nutritional and hormonal content of maternal milk could be
different in prenatally-manipulated dams. Thus, the early postnatal period may be
an important period of effect in the mechanism of 'prenatal' programming.
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3.) With regard to prenatal CBX treatment, this inhibitor is relatively non-specific for
the 11 p-HSDs (Stewart et al., 1990; Jellinck et al., 1993), so therefore the maternal
blockade of the type 1 enzyme may also involved in the observed effects.
Additionally, the injection stress may also have an impact on maternal physiology.
Genetic deletion of 11 (3-HSD2 is an ideal tool to further study the role of this enzyme in
protecting the fetus from GC overexposure during development and as a model of prenatal
GC programming in absence of maternal manipulation. Homozygous-bred 11P-HSD2 null
mutant mice have significantly reduced birth weights and males displayed heightened
anxiety-like behaviour on the elevated plus maze (EPM) and open field (OF) (Holmes et
al., 2006a). However, as a consequence of 'illicit' mineralocorticoid receptor (MR)
activation these mice displayed a phenotype of apparent mineralocorticoid excess (AME).
This adult phenotype is comprised of electrolyte imbalance, hypertonic polyuria and
hypertension (Kotelevtsev et al., 1999), factors that may affect nutrient provision both in
utero and during the early postnatal period. In contrast, the 11P-HSD2 heterozygous mice
appear physiologically normal. Therefore, to control for a variation in pre- and postnatal
nutrient supply, offspring were obtained from heterozygous breeding which delivers 11 (3-
HSD2 null mutant, heterozygous and wild-type mice within the same litter. Thus, we are
able to study the direct effect on the fetus of a total and approximately 50% loss of enzyme
activity independent of any maternal manipulation or postulated altered pup rearing.
In this chapter we aimed to investigate the anxiety-related and cognitive behaviour in the
heterozgyous-bred 11[3-HSD2 null mutant mouse, a potential model of prenatal GC
programming. We describe behaviour in three separate validated tests of anxiety: EPM, OF
and light/dark (LD) test; and two different tests of memory: the water maze and passive
avoidance tests. Due to unavoidable circumstances, these studies were performed in two
different biological research facilities (BRFs), the implications ofwhich shall be discussed.
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4.2 Methods
Comprehensive details of methods can be found in chapter 2.
4.2.1 Animal maintenance and behavioural testing
11P-HSD2 heterozygous breeding and behavioural analyses of offspring were conducted in
both the Biological Research Facility (BRF) at the Western General (WGH) and later in the
BRF at Little France (LF). This was necessary due to relocation of the Endocrinology Unit.
Three heterozygous breeding cohorts were generated and studied, the first in the BRF at the
WGH and remainder in the BRF at LF.
4.2.1.1 Cohort one
Breeding and subsequent behavioural analyses were performed in the BRF at the WGH.
Male and female 11P-HSD2 heterozygous mice were pair-housed in breeding cages and left
undisturbed until parturition. Cages were checked daily between 09.00 and 11.00 h for
delivery of litters. On delivery, pups were counted and sexed. Litters were left undisturbed
with the mother (apart from routine cage maintenance) until weaning at postnatal day (P)
21, when they were ear-notched (for identification and genotyping), housed in single-sex
groups of 2-6 and left undisturbed until testing.
One week (wk) prior to behavioural testing male and female offspring were re-housed in
groups of 2-3 with previous cagemates. Commencing at the age of 8-9 wks in males and
11-12 wks in females, subjects were tested weekly on behavioural tasks measuring anxiety¬
like behaviour, in the order of the elevated plus maze (EPM), open field (OF) and light/dark
(LD) tests followed by the passive avoidance (PA) test. Subjects were brought into the
experimental room immediately prior to testing.
A further set of male offspring at 29-31 wks of age were rehoused in pairs with previous
cagemates a wk prior to testing in the water maze. All subjects were brought into
experimental room daily, immediately prior to testing of the first subject.
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4.2.1.2 Cohort two
Breeding and subsequent behavioural analyses were performed in the BRF at LF. Male and
female 11 [3-HSD2 heterozygous mice were pair-housed in breeding cages. Females were
subsequently checked daily for a vaginal plug which was used as evidence of copulation.
Upon identification of a plug the day was recorded and designated embryonic day (E) 0.
Males were removed and females singly housed throughout pregnancy, until delivery which
occurred on days 18-19. Pregnant females were randomly divided into two groups:
Control and Restraint. Dams in the Control group (n=14) were left undisturbed until
parturition, whilst those in the Restraint group (n=8) were subjected to restraint stress
during pregnancy. Restraint was performed in a plexiglass tube daily for 1 hr between
09.00 and 11.00 h from E7 until parturition, in a separate procedure room. Cages were
checked each morning for delivery of litters. Following birth, pups were counted, sexed
and weighed. Pups were tattooed on paws using a coded system to allow for continued
recording of weights in individual offspring, which were weighed at P7, P14 and P21. At
P21 offspring were weaned in single-sex groups of 2-6 and left undisturbed until testing,
apart from routine cage maintenance.
One wk prior to behavioural testing, male and female offspring were divided into groups of
2-3 with previous cagemates and moved to a holding room adjacent to the experimental
room. At 13 wks of age male and female subjects were tested weekly in behavioural tests
commencing with the EPM, followed by the OF and LD test.
4.2.1.3 Cohort three
Breeding and subsequent behavioural analyses were performed in the BRF at LF except
there was no further manipulation of the mice during pregnancy or the pre-weaning period,
thus the protocol was similar to that described for cohort one. One wk prior to behavioural
testing male and female offspring were divided into groups of 2-3 with previous cagemates
and moved to a holding room adjacent to the experimental room. Male and female subjects
at 10-11 wks of age were tested on the EPM.
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4.2.1.4 Genotyping
On weaning ears were notched for identification. DNA was extracted from ear notches and
used for genotyping of 11(3-HSD2 null, heterozygous and wild-type mice by PCR and gel
electrophoresis. The presence of an approximately 700 bp band indicates an ll[i-HSD2
null mutant, an approximately 600bp band represents a wild-type and the presence of both
bands indicates an 11 (3-HSD2 heterozygous genotype. A representative gel picture taken
under UV light is shown on page 63.
4.2.1.5 Diet
Mice in both biological research facilities were allowed food and water ad libitum.
However, the food differed between the two locations. Mice housed in the BRF at WGH
were fed CRM(E) chow whilst breeding and under normal maintenance conditions. In
contrast mice at the BRF at LF were fed RM3(E) during breeding and lactation, and the
RM1(E) under normal maintenance conditions.
4.2.2 Statistical analysis
Data are expressed as mean±SEM. Comparisons between groups and prenatal
manipulations were analysed by the most appropriate method including one- and two-way
analysis of variance (ANOVA), with Student Newman-Keuls (SNK) post-hoc testing.
Repeated measures ANOVAs were used to analyse data obtained in the passive avoidance
and water maze paradigms.
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4.3 Results
4.3.1 Cohort one
Male and female 11(3-HSD2+/+, +/- and -/- mice were tested in several behavioural tests
including EPM, OF and LD in order to measure anxiety-related behaviour. Data were
statistically analysed using a one-way ANOVA with SNKpost-hoc testing. Additionally,
fear-related memory was determined in the PA test following initial exploration of the LD
box. Male mice were also tested in the water maze in order to assess spatial learning and
memory. Behaviour in the PA and water maze tests was analysed using repeated measures
ANOVA with SNKpost-hoc testing.
4.3.1.1 Behaviour of male 11P-HSD2 transgenic mice
4.3.1.1.1 Anxiety-related behaviour in the elevated plus maze
Genotype was found to have an effect on behaviour in the EPM. The entries into the more
anxiogenic open arms were found to differ between genotype (Figure 4.1a; F2,3o=9.73,
p<0.001), with 11 p-HSD2-/- offspring making significantly fewer entries compared to both
+/+ and +/- (pcO.OOl). There was no significant difference of entries into the closed arms
of the maze between genotypes (F2,30=1-88, p=0.170). The time spent on the open arms
was significantly different between genotypes (Figure 4.1b; F2(3o=3.61; p<0.01), with 11(3-
HSD2-/- spending significantly less time on the open arms than +/- (p<0.05), whilst 11P-
HSD2-/- displayed a tendancy compared to +/+ (p=0.065). The distance travelled on both
the open arms (Figure 4.1c; F2>30=5.12; p<0.05) and on the whole maze (F2,3o=6.56, p<0.05)
were dependent on genotype. The 11P-HSD2-/- group travelled less on both the open arms
(p<0.05 vs +/+ and +/-) and the entire maze (p<0.01 vs +/+ and +/-). These findings
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(a) Entries
Open arm Closed arm
(c) Distance travelled
Open arm Total





Figure 4.1 Behaviour of male 11 p-HSD2 transgenic mice in the elevated plus maze
Effects of 11(3-HSD2 genotype (+/+ I, +/-0 and -/- D) on the (a) number of entries made onto the
open and closed arms, (b) time spent on the open arms and (c) distance travelled on the open arms
and the whole maze during a 5-min EPM test. Data are expressed as mean±SEM and analysed by
one-way ANOVA with SNK post-hoc testing; n=8-16 per group. *p<0.05, #p<0.01, +p<0.001.
4.3.1.1.2 Anxiety-related behaviour in the open field test
During 5-min exploration of the OF, we did not detect any statistical differences in assessed
behaviour between genotypes in male mice. Crossings within the more anxiogenic inner
zone of the OF box (Figure 4.2a; F2,27=0.96, p=0.397) and crossings in the whole box
(F2,27=2.28; p=0.122), time spent in the inner zone (Figure 4.2b; F2,28=0.68, p=0.514),
distance travelled in the inner zone (Figure 4.2c; F2,27=0.74, p=0.486) and during the entire
test (F2j27=2.92; p=0.071) were not statistically different between genotypes. The 11(3-
F1SD2-/- mice had a tendency to show increased total crossings and distance travelled as
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compared to +/+ and +/- mice. The 11 (3-HSD2-/- mice do not show elevated anxiety-
related behaviour in this test.




Figure 4.2 Behaviour of male 11P-HSD2 transgenic mice in the open field test
Effects of 11P-HSD2 genotype (+/+ I, +/- S and -/- D) on the (a) number of crossings in the inner
zone and in total, (b) time spent in the inner zone and (c) distance travelled in the inner zone and in
total during a 5-min OF test. Data are expressed as mean±SEM and analysed by one-way ANOVA;
n=7-15 per group.
4.3.1.1.3 Anxiety-related behaviour in the light/dark test and fear-related
memory in the passive avoidance test
Significant behavioural differences between genotypes were detected in the LD anxiety test
in male mice. The number of crossings between the two compartments of the apparatus
were different between groups (Figure 4.3a; F2,23=4.53; p<0.05), with 11P-HSD2-/- mice
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making significantly fewer crossings compared to +/+ and +/- (p<0.05). The time spent in
the more anxiety-provoking light compartment displayed a tendency to be altered by
genotype (Figure 4.3b; F2,24=3.19; p=0.059). The latency to enter the dark compartment
was unaltered between genotypes (F2>24=0.036, p<0.965; +/+: 11,4±1.5; +/-: 11.8±2.1;
10.7±5.3 sees).
(a) Crossings between compartments (b) Time spent in light compartment
(c) Latency to cross into dark compartment
* *
1001
+/+ +/- -/- 11 beta-HSD2
Genotype
Figure 4.3 Behaviour of male 11 (5-HSD2 transgenic mice in the light/dark anxiety test and
conditioned passive avoidance paradigm
Effects of 11 (3-HSD2 genotype (+/+1, +/- 0 and -/- D) on the (a) number of crossings between
the two compartments, (b) time spent in the light compartment during a 5-min free exploration on
Day 1 and (c) latency to cross into the dark compartment before (EH) and six hrs after (I) footshock
on Day 2. Data are expressed as mean±SEM and analysed by one-way ANOVA with SNK post-
hoc testing (a,b) and two-way repeated measures ANOVA with SNK post-hoc testing (c); n=9-15
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The response ofmice to passive avoidance conditioning was analysed by two-way repeated
measures ANOVA. Foot shock increased the latency to enter the dark compartment
(Figure 4.3c; Fi,17=14.72, pcO.OOl) although this was not affected by genotype (Figure
4.3c; F2,17=0.24; p=0.789). Data from the LD test implies heightened anxiety-related
behaviour in male 11P-HSD2-/- mice. In contrast, no change in fear-related memory is
suggested from the PA test.
(a) Latency to escape onto visible platform (b) Distance travelled before escape
+/+ +/- -/- 11 beta-HSD2 +/+ +/. ./. 11beta-HSD2
Genotype Genotype
Figure 4.4 Behaviour of male 11 p-HSD2 transgenic mice in the two-day water maze test with
the visibly-cued platform
Effects of 11P-HSD2 genotype (+/+, +/- and -/-) on the (a) latency to escape the water maze onto
the submerged platform and (b) distance travelled until escape measured in the visible water maze
performed over two days. Data are expressed as mean±SEM and analysed by two-way repeated
measures ANOVA with SNKpost-hoc testing; n=9-10 per group. *p<0.05, #p<0.01, +p<0.001.
4.3.1.1.4 Spatial learning and memory behaviour in the water maze test
Behaviour in the water maze test was studied to assess spatial learning and memory ability
in 11[]-HSD2+/+, +/- and -/- male mice. In the visibly-cued water maze there was a
significant decrease in the time taken to escape onto the platform (Figure 4.4a; F1)24=13.48;
pcO.OOl) and in the distances swum until escape between day one and two (Figure 4.4b;
F1j24=19.24; p<0.001). There was no overall effect of genotype in either escape latency
(F2,24=0.34, p=0.719) or distance travelled (F2j24=0.39, p=0.682). However, 11 [1-HSD2+/+
and +/- displayed a significant reduction in escape latency between days one and two
(Figure 4.4a; +/+: P<0.01; +/- P<0.05), although no reduction was noted in -/- (P=0.283).
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The distance travelled showed a similar pattern, with significant reduction in +/+ (Figure
4.4b; PcO.OOl) and +/- (P<0.05), whilst the distance travelled on day two was not
significantly less than from day one for -/- (P=0.172).
In the spatially-cued water maze (with a hidden platform), as expected, a significant
reduction in escape latency (Figure 4.5a; F4j96=28.28; pcO.OOl) and distance travelled
(Figure 4.5b; F4,94=42.38; p<0.01) were observed during the test. There was no overall
statistical difference between genotypes in escape latency (F2,96=1.83, p=0.182) or distance
travelled (F2>94=0.34, p=0.715). However, whilst 11 (3-HSD2+/+ and +/- displayed a
significant reduction between day one and two (Figure 4.5a; +/+: pcO.OOl; +/-: pcO.Ol) no
decrease was observed in escape latency between days one and two in -/- mice (p=0.142).
Similarly, +/+ and +/- (pcO.OOl) swam a shorter distance on day two compared to one,
whilst the reduction was not statistically significant in the -/- group (p=0.077). The average
overall swim speed was not statistically different between genotypes (Table 4.1a;
F2,96=2.16, p=0.138) and slowed during the test in all groups (pcO.OOl). On days two, three
and five 11 (1-HSD2-/- swam significantly slower than +/+ and +/- (pc0.05). On sequential
days in all groups, the time spent near the walls of the circular tank decreased (F4;96=34.01,
pcO.OOl), whilst the time in quadrant containing the platform increased during the testing
days (F4,96=5.05, pcO.OOl) but did not differ significantly between genotypes (F2,96=0.74,
p=0.486; F2j96=0.24, p=0.792 ). These findings suggest a mild impairment of spatial
learning and/or memory in male 11(3-HSD2-/- mice.
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(a) Latency to escape onto hidden platform




+/- -/- 11 beta-HSD2
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Figure 4.5 Behaviour of male 11P-HSD2 transgenic mice in the five-day spatially-cued water
maze test with a hidden platform
Effects of 11 (B-HSD2 genotype (+/+, +/- and -/-) on the (a) latency to escape the water maze onto
the submerged platform and (b) distance travelled until escape measured in the spatial water maze
repeated over five days. Data are expressed as mean±SEM and analysed by two-way repeated
measures ANOVA with SNKpost-hoc test.; .g; n=8-10 per group. #p<0.01, +p<0.001.
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In the probe test, neither time taken to reach the former platform position (Table 4.1b;
F2,24=1.25; p=0.304), the number of times the former platform position was crossed
(F2,24=0.17, p=0.849) or time spent in the former platform quadrant (F2,24, p=0.25, p=0.783)
were altered by genotype, although there was a significant difference between genotypes
for swim speed (F2,24=7.00, p<0.01), where 11P-HSD2-/- mice swam more slowly than +/+
(P<0.05) and +/- (P<0.01).
Day 1 Day 2 Day 3 Day 4 Day 5
Genotype
(a) Average speed (cm/sec)
+/+ 18.3±0.6 16.0+0.5 14.710.8 13.510.8 14.210.6
+/- 16.9±0.7 17.510.7 15.510.7 15.010.8 14.2+1.1
-/- 17.U1.0 15.010.8* 12.910.8* 14.010.8 12.610.9*
(b) Twalls (%)
+/+ 56.213.3 37.312.6 28.513.6 24.112.3 25.213.7
+/- 49.014.2 39.913.6 32.814.0 31.913.4 27.114.7
-/- 47.4+3.2 31.412.4 27.913.0 25.113.0 20.112.6
(c) Tquad (%)
+/+ 33.814.9 39.512.9 45.9+4.6 41.314.0 53.3H.9
+/- 43.915.1 41.114.7 41.112.9 46.914.6 49.713.0
34.116.5 39.115.7 51.414.3 47.513.3 44.314.8
Table 4.1a Average swim speed, time spent near walls of maze and time spent in platform
quadrant of male 11(3-HSD2 transgenic mice, measured in the five-day spatialiy-cued water
maze test with a hidden platform
Effects of 11P-HSD2 genotype (+/+, +/- and -/-) on the average swim speed, time spent near walls
of maze (Twalls) and time spent in platform quadrant (Tquad) measured in the spatial water maze
repeated over five days. Data are expressed as mean±SEM and analysed by two-way repeated
measures ANOVA with SNK post-hoc testing; n=8-10 per group. *p<0.05 vs +/+ and +/-.
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+/+ 14.5±3.3 3.5+0.5 41.7+3.5 17.3±0.7
+/- 12.1±2.4 3.8+0.6 40.9±3.7 19.2±0.9
21,3±5.8 3.3±0.4 44.9±5.3 15.5±0.9*'#
Table 4.1b Behaviour of male 11(3-HSD2 transgenic mice in the spatially-cued water maze
probe test
Effects of 11P-HSD2 genotype (+/+, +/- and -/-) on the latency to reach former platform position
(Tplatform), number of crossings of former platform position, time spent in former platform quadrant
(Tquad) and average swim speed during 60-sec spatial water maze probe test performed 90 mins
following last water maze exposure. Data are expressed as mean±SEM and analysed by one-way
ANOVA with SNK post-hoc testing; n=9-10 per group. *p<0.05 vs +/-, #p<0.01
4.3.1.2 Behaviour of female 11P-HSD2 transgenic mice
4.3.1.2.1 Anxiety-related behaviour in the elevated plus maze
Alterations in behaviour between genotypes in female offspring were detected on the EPM.
The number of open arm entries were found to be different depending on genotype (Figure
4.6a; F2,21=4.05, p<0.05). A reduction in open arm entries was observed in 11P-HSD2-/-
which was significant when compared to +/- (P<0.05), but not +/+ (p=0.097). However, no
difference was found between the groups on entries into the closed arms (F2,21=0.26,
p=0.772). A tendency for altered open arm duration between genotypes was observed
(Figure 4.6b; F2;2i=3.17, p=0.062). Whilst 11P-HSD2-/- were not different from +/+ mice
(p=0.613), +/- had a tendency to spend longer in the open arms compared to -/- (p=0.062)
and +/+ (p=0.139) mice. No statistically significant difference between genotypes was seen
in open arm (Figure 4.6c; F2,21=1.45, p=0.256) and total distance (F2>2i=1.95, p=0.167)
travelled. The findings point towards increased anxiety behaviour in female 11 (3-HSD2-/-
mice.
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(a) Entries (b) Time spent on open arms
Open arm Closed arm
(c) Distance travelled
Open arm Total
Figure 4.6 Behaviour of female 11P-HSD2 transgenic mice in the elevated plus maze
Effects of 11(3-HSD2 genotype (+/+ H, +/- E3 and D) on the (a) number of entries made onto the
open and closed arms, (b) time spent on the open arms and (c) distance travelled on the open arms
and the whole maze during a 5-min EPM test. Data are expressed as mean±SEM and analysed by
one-way ANOVA with SNK post-hoc testing; n=5-11 per group. *p<0.05.
4.3.1.2.2 Anxiety-related behaviour in the open field test
In the OF anxiety test in female mice, groups displayed no statistical differences in inner
zone (Figure 4.7a; F2,2i=l-73, p=0.201) or total crossings (F2j2i=0.35, p=0.70l), inner
duration (Figure 4.7b; F2,21=1.75, p=0.198), inner zone (Figure 4.7c; F2,2i=l -43, p=0.261)
or total crossings (F2,2i=0.26, p=0.772) during the 5-min exploration of the apparatus.
Therefore, no indication of altered anxiety was seen in the OF behavioural test.
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Figure 4.7 Behaviour of female 11 (3-HSD2 transgenic mice in the open field test
Effects of 11 (3-HSD2 genotype (+/+ I, +/-0 and -/- D) on the (a) number of crossings in the inner
zone and in total, (b) time spent in the inner zone and (c) distance travelled in the inner zone and in
total during a 5-min OF test. Data are expressed as mean±SEM and analysed by one-way ANOVA;
n=5-11 per group.
4.3.1.2.3 Anxiety-related behaviour in the light/dark test and fear-related
memory in the passive avoidance test
Female mice of each 11|3-ITSD2 genotype did not differ in crossings between
compartments (Figure 4.8a; F2j8=0.62, p=0.538) or time spent in the light compartment
(Figure 4.8b; F2,i8=0.53, p=0.600) during the LD anxiety test. The latency to enter the dark
compartment was also unaltered by genotype (F2>i8=0.16, p=0.850; +/+: 11,9±1.6; +/-:
14.2+2.7; -/-: 12.8±3.0 sees). As analysed by two-way repeated measures ANOVA with
SNK post-hoc testing there was an increased latency to enter the dark compartment post-
shock compared to pre-shock (Figure 4.8c; Fi,is=21.90, p<0.001), although this was
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significant in the +/- and -/- groups only (p<0.01). The latency to cross into the dark
compartment pre-shock did not differ between genotypes, although testing following shock
administration revealed a reduced latency in +/+ mice compared to both +/- and -/-
(p<0.05). These results do not support an alteration of anxiety or fear-related memory in
11 (3-HSD2-/- female mice.
(a) Crossings between compartments (b) Time spent in light compartment




Figure 4.8 Behaviour of female 11P-HSD2 transgenic mice in the light/dark anxiety test and
conditioned passive avoidance paradigm
Effects of 11P-HSD2 genotype (+/+ H. +/- E2 and -/- D) on the (a) number of crossings between
the two compartments, (b) time spent in the light compartment during a 5-min free exploration on
Day 1 and (c) latency to cross into the dark compartment before (D) and six hrs after (I) footshock
on Day 2. Data are expressed as mean+SEM and analysed by one-way ANOVA (a,b) and two-way
repeated measures ANOVA with SNK post-hoc testing (c); n=5-11 per group for (a,b); n=4-8 per
group for (c) with n=4 for +/+. +p<0.01, #p<0.001.
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4.3.2 Cohort two
4.3.2.1 Birth weight and early postnatal growth in 11P-HSD2 transgenic mice
The length of gestation, litter size and male:female ratio were unaltered by prenatal
manipulation (data not shown). Birth and early postnatal weights were analysed by two-
way ANOVA. There was no effect of gender so therefore males and females were grouped
for statistical analysis. Birth weight was significantly different depending on genotype






























































Table 4.2 Birth and pre-weaning weights in 110-HSD2 transgenic offspring subjected to
prenatal restraint or unmanipulated controls
Birth and early postnatal weights in 11 (3-HSD2 offspring (+/+, +/- and -/-) subjected to prenatal
restraint or unmanipulated controls. Data are expressed as mean±SEM and analysed by two-way
ANOVA with SNKpost-hoc testing; n=20-34 for control offspring; n=7-24 for restraint offspring.
*p<0.05 vs +/+ and +/-, +p<0.001 vs +/+ and +/-, xp<0.05 vs +/+, ap<0.05 vs Control
11P-HSD2-/- offspring bom to control dams were significantly lighter than both +/+ and
+/- offspring (p<0.001, SNKpost-hoc test). Following prenatal restraint stress 11 [3-HSD2-
/- mice remained significantly lighter than +/+ (p<0.05), although not +/- offspring
(p=0.138). Additionally, the 11 (3-HSD2+/- mice tended to be lighter than +/+ offspring
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(p=0.062). Prenatal restraint significantly reduced 11 (3-HSD2+/- offspring birth weight
compared with offspring of the same genotype born to unstressed control dams (p<0.001).
4.3.2.2 Body weight at postnatal day 7
There was an overall effect of genotype (Table 4.2; F2,ii2=5.02, p<0.01) and treatment
(Fi,112=19.09, p<0.001) on body weight at P7. Offspring from control dams,
11P-HSD2-/- mice tended to be lighter than +/- (p=0.068) although no different from +/+
(p=0.836). +/- were significantly heavier than +/+ mice (p<0.05). 11 (3-HSD2-/- offspring
from restraint dams were significantly lighter than +/+ and +/- offspring (p<0.05).
Comparing across prenatal manipulation, 11P-HSD2-/- and +/-, although not +/+ offspring
(p=0.420) from dams receiving restraint were significantly lighter than offspring from
control, unmanipulated dams (p<0.001)
4.3.2.3 Body weight at postnatal day 14
There was no significant overall effect of genotype on body weight at P14 (Table 4.2;
F2(ii2=0.71, p=0.496), although there was a significant treatment effect (Fi,i i2~34.75,
p<0.001). Offspring of all genotypes subjected to prenatal restraint were significantly
lighter than those from unstressed control dams (+/-: p<0.001; +/+ and p<0.01).
4.3.2.4 Body weight at postnatal day 21
No significant overall effect of genotype was observed on body weight at P21 (Table 4.2;
F2,iii=2.01, p=0.139), although there was a significant effect of restraint (F 1.111 29.20,
p<0.001). Offspring of all genotypes bom to mothers receiving restraint were significantly
lighter than offspring from control dams (+/-: pcO.OOl; +/+: p<0.01; p<0.05).
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4.3.2.5 Behaviour of male 11P-HSD2 transgenic mice
In contrast to results obtained in cohort one, no change in behaviour was observed in male
11P-HSD2-/- mice in the EPM, OF or LD anxiety tests. Results obtained in male mice on
the EPM are shown in Table 4.3a,b.
11p-HSD2 Prenatal Entries Distance (au) Open
Genotype Manipulation Open Closed Open Total Duration
(sees)
+/+ 17.5±2.5 21.4+2.7 169132 10281104 57.218.1
+/- CONTROL 12.2±2.2 20.1+2.3 162156 9301109 53.6117.4
-/- 16.4+3.2 18.5±1.1 203+42 958183 74.8114.1
+/+ 15.3±3.1 20.6+3.1 187143 1076175 58.6111.2
RESTRAINT
+/- 14.9±2.3 18.5±1.6 208133 964187 88.2+17.8
Table 4.3a Behaviour in the elevated plus maze of male 11P-HSD2 transgenic mice subjected
to prenatal restraint or unmanipulated controls
Effects of 11P-HSD2 genotype (+/+, +/- and -/-) and prenatal manipulation on the number of entries
made onto the open and closed arms, distance travelled on the open arms and the whole maze,
and time spent on the open arms during a 5-min EPM test. Data are expressed as mean±SEM and
analysed by two-way ANOVA; n=7-8 per group, au = arbitrary units
EPM Measure 11 p-HSD2 Genotype Prenatal Manipulation
Open arm entries F2,35=0.56, p=0.575 F, ,35=0.00, p=0.975
Closed arm entries F2,35=0.85, p=0.437 F,,35=0.37, p=0.548
Open duration F2i35=1 .08, p=0.351 Fi,35=1.51, p=0.228
Open distance Fa,35=0.31, p=0.739 F1,35=0.61, p=0.439
Total distance F2,35=0.70, p=0.505 F1,35=0.20, p=0.655
Table 4.3b Statistical analysis of elevated plus maze behaviour shown in Table 4.3a as
analysed by two-way ANOVA with SNK post-hoc testing
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Behaviour in the OF was unaltered by either 11(3-HSD2 genotype or prenatal manipulation
and is shown in Table 4.4a,b.
11p-HSD2 Prenatal Crossings Inner Zone
Genotype Manipulation Inner Total Duration
Zone (sees)
+/+ 51.0±11.2 468±36 21.6±4.9
+/- CONTROL 57.9±15.2 523±30 23.5±5.0
-/- 66.9±10.5 496±19 33.2±4.3
+/+ 45.7±15.7 557±37 17.7±6.5
RESTRAINT
+/- 75.4±13.0 518±18 32.7±4.2
Table 4.4a Behaviour in the open field test of male 11p-HSD2 transgenic mice subjected to
prenatal restraint or unmanipulated controls
Effects of 11P-HSD2 genotype (+/+, +/- and -/-) and prenatal manipulation on the number of
crossings in the inner zone and in total, and time spent in the inner zone during a 5-min OF test.
Data are expressed as mean±SEM and analysed by two-way ANOVA; n=7-8 per group.
OF Measure 11P-HSD2 Genotype Prenatal Manipulation
Inner zone crossings F2,35:=0.27, p=0.767 F1,35==0.05, p=0.822
Total crossings F2,35==0.06, p=0.943 F1,35==1.86, p=0.181
Inner zone duration F2,35==2.87, p=0.070 F1,35==0.32, p=0.576
Table 4.4b Statistical analysis of open field behaviour shown in Table 4.4a as analysed by
two-way ANOVA with SNKpost-hoc testing
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Furthermore, no change in LD behaviour was observed, shown in Table 4.5a,b.
11P-HSD2 Prenatal Latency Crossings Time in
Genotype Manipulation (sees) Light
(sees)
+/+ 11.8±3.1 14.9±1.7 86.0+1.6
+/- CONTROL 9.7H.5 17.0+2.3 95.3±10.3
10.2±1.4 19.0+1.4 102.0±11.9
+/+ 14.2±2.8 14.8±2.3 102.8±19.7
RESTRAINT
+/- 10.0±3.0 16.0±1.6 101.4±16.2
Table 4.5a Behaviour in the light/dark anxiety test of male 11P-HSD2 transgenic mice
subjected to prenatal restraint or unmanipulated controls
Effects of 11P-HSD2 genotype (+/+, +/- and -/-) and prenatal manipulation on the latency to cross
into the dark compartment, number of crossings between the two compartments and time spent in
the light compartment. Data are expressed as mean±SEM and analysed by two-way ANOVA; n=7-
8 per group.
LD Measure 11P-HSD2 Genotype Prenatal Manipulation
Latency to cross F2,29==0.73, p=0.489 F1,29==0.29, p=0.592
Crossings F2,29==1.37, p=0.271 F1,29==0.08, p=0.785
Time in light F2,29==0.28, p=0.761 F1,29==0.69, CO5oIIQ.
Table 4.5b Statistical analysis of light/dark behaviour shown in Table 4.5a as analysed by
two-way ANOVA with SNK post-hoc testing
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4.3.2.6 Behaviour of female 11p-HSD2 transgenic mice
Similar to males no behavioural differences were seen between genotypes and prenatal
treatment groups in the EPM (Table 4.6a,b), OF (Table 4.7a,b) or LD (Table 4.8a,b)
anxiety tests.
11P-HSD2 Prenatal Entries Distance (au) Open
Genotype Manipulation Open Closed Open Total Duration
(sees)
+/+ 14.8±1.4 19.9+1.1 122±34 921±77 42.4±8.1
+/- CONTROL 12.3±1.3 18.9±1.4 103±21 878+83 36.7±6.5
14.3±1.5 20.8+1.5 168±27 994±61 60.9+9.1
+/- RESTRAINT 13.8±2.6 18.5±2.4 127±29 858±77 43.2±8.8
Table 4.6a Behaviour in the elevated plus maze of female 11p-HSD2 transgenic mice
subjected to prenatal restraint or unmanipulated controls
Effects of 11P-HSD2 genotype (+/+, +/- and -/-) and prenatal manipulation on the number of entries
made onto the open and closed arms, distance travelled on the open arms and the whole maze,
and time spent on the open arms during a 5-min EPM test. Data are expressed as mean±SEM and
analysed by two-way ANOVA; n=8 per group.
EPM Measure 11P-HSD2 Genotype Prenatal Manipulation
Open arm entries F2,28=0.55, p=0.584 F1,28=0.35, p=0.558
Closed arm entries F2,28=0.32, p=0.728 F1,28=0.03, p=0.874
Open duration F2,28=2.40, p=0.109 F1,28=0.32, p=0.557
Open distance F2,28=1.45, p=0.252 F1,28=0.37, p=0.551
Total distance F2,28=0.62, p=0.547 F1,28=0.03, p=0.855
Table 4.6b Statistical analysis of elevated plus maze behaviour shown in Table 4.6a as
analysed by two-way ANOVA with SNK post-hoc testing
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11P-HSD2 Prenatal Crossings Inner Zone
Genotype Manipulation Inner Total Duration
Zone (sees)
+/+ 40.3+9.0 519±34 17.8±4.6
+/- CONTROL 42.4±11.3 490±37 19.7±4.3
-/- 50.4±14.3 418±32 22.9±6.3
+/- RESTRAINT 46.9+8.2 413±23 21.4±4.4
Table 4.7a Behaviour in the open field test of female 11P-HSD2 transgenic mice subjected to
prenatal restraint or unmanipulated controls
Effects of 11(3-HSD2 genotype (+/+, +/- and -/-) and prenatal manipulation on the number of
crossings in the inner zone and in total, and time spent in the inner zone during a 5-min OF test.
Data are expressed as mean±SEM and analysed by two-way ANOVA; n=8 per group
OF Measure 11 (3-HSD2 Genotype Prenatal Manipulation
Inner zone crossings F2,28:=0.24, p=0.791 F1,28==0.08, p=0.774
Total crossings F2,28==2.69, p=0.085 F1,28==2.93, "OIIo oCD00
Inner zone duration F2,28==0.27, p=0.767 F1,28==0.05, p=0.822
Table 4.7b Statistical analysis of open field behaviour shown in Table 4.7a as analysed by
two-way ANOVA with SNKpost-hoc testing
11P-HSD2 Prenatal Latency Crossings Time in
Genotype Manipulation (sees) Light
(sees)
+/+ 15.8+2.1 11.4±1.4 58.4±7.2
+/- CONTROL 19.2±3.7 10.5±2.5 61.3±7.5
14.5±2.9 14.1 ±1.4 68.5±6.4
+/- RESTRAINT 16.0+2.1 12.1±2.5 54.9+9.5
Table 4.8a Behaviour in the
light/dark anxiety test of
female 11P-HSD2 transgenic
mice subjected to prenatal
restraint or unmanipulated
controls
Effects of 11 (3-HSD2 genotype
(+/+, +/- and -/-) and prenatal
manipulation on the latency to
cross into the dark
compartment, number of
crossings between the two
compartments and time spent
in the light compartment. Data are expressed as mean±SEM and analysed by two-way ANOVA;
n=8 per group.
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LD Measure 11P-HSD2 Genotype Prenatal Manipulation
Latency to cross F2,26:=0.73, p=0.489 F1,26==0.65, p=0.651
Crossings F2,26==0.90, p=0.419 F1,26==0.31, p=0.582
Time in light F2,26==0.47, p=0.632 F1,26==0.31, p=0.581
Table 4.8b Statistical analysis of open field behaviour shown in Table 4.8a as analysed by
two-way ANOVA with SNK post-hoc testing
4.3.3 Cohort three
To test whether increased handling of mice postnatally (cohort two) reversed the phenotype
observed in cohort one, the anxiety-related behaviour of unmanipulated 11 (3-HSD2
transgenic mice was analysed.
4.3.3.1 Behaviour of male 11P-HSD2 transgenic mice
In the EPM anxiety test, there was no statistical difference of genotype in the measured
parameters. Open entries (Table 4.9; F2)29=0.13; p=0.880), closed entries (F2)29=1.20,
p=0.315), open duration (F2,29=0.91, p=0.414), distance travelled on open arms (F2,29=0.68,
p=0.515) and entire maze (F2i29=0.05, p=0.955) were not different between genotypes.
11 |3-HSD2 Entries Distance (au) Open
Genotype Open Closed Open Total Duration
(sees)
+/+ 12.8±1.9 18.7±1.2 120±34 901±87 40.7±10.5
+/- !3.7±1.7 23.2+1.8 124±33 882±50 45.9±10.9
-/- 14.2±2.3 20.2±3.4 175±40 868±85 62.9H3.2
Table 4.9 Behaviour of male 11P-HSD2 transgenic mice in the elevated plus maze
Effects of 11(3-HSD2 genotype (+/+, +/- and -/-) on the number of entries made onto the open and
closed arms, distance travelled on the open arms and the whole maze, and time spent on the open
arms during a 5-min EPM test. Data are expressed as mean±SEM and analysed by one-way
ANOVA; n=9-13 per group, au = arbitrary units
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4.3.3.2 Behaviour of female 11P-HSD2 transgenic mice
In the EPM anxiety test performed on female offspring, closed arm entries displayed an
overall effect of genotype (4.10; F2,22=4.39; p<0.05) with 11 [3-HSD2-/- group making
significantly fewer closed entries than +/+ and +/- groups (P<0.05). No overall effect of
genotype was observed on open entries (F2,22=0.07, p=0.931), open duration (F2,22=0.52,
p=0.603), distance travelled on the open arms (F2,22=0.49, 0.618) or entire maze (F2,22=0.33,
p=0.719).
11P-HSD2 Entries Distance (au) Open
Genotype Open Closed Open Total Duration
(sees)
+/+ 16.6±4.4 22.4+1.7 99+37 957±82 35.0±10.6
+/- 15.1±2.3 21,9±1.1 149±29 944+58 47.8±7.2
15.0+3.0 16.0±2.1* 147±58 870±86 49.9+16.7
Table 4.10 Behaviour of female 11(3-HSD2 transgenic mice in the elevated plus maze
Effects of 11P-HSD2 genotype (+/+, +/- and -/-) on the number of entries made onto the open and
closed arms, distance travelled on the open arms and the whole maze, and time spent on the open
arms during a 5-min EPM test. Data are expressed as mean±SEM and analysed by one-way
ANOVA with SNKpost-hoc testing; n=6-12 per group. *p<0.05 vs +/+ and +/-. AU = arbitrary units
These results indicate that the early postnatal handling of pups is not responsible for the
loss of heightened anxiety-like phenotype previous observed in 11P-HSD2-/- mice.
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4.4 Discussion
In this chapter we describe work carried out in the behavioural assessment of mice bred
through 11P-HSD2 heterozygous parents, thus generating 11 (3-HSD2 null, heterozygous
and wild-type offspring whilst controlling for any influence of altered pre- or post-natal
maternal nurture. We have shown that 11 (3-HSD2 null mutant mice from heterozygous
mothers display behavioural alterations in anxiety and spatial learning and memory tests.
In brief, male 11 (3-HSD2 knockout mice displayed heightened anxiety-like behaviour in the
EPM and LD test, although not the OF test. Female 11 p-HSD2 knockout mice displayed
anxiety-like behaviour in the EPM only. The results also suggest that there may be a slight
deficit in the spatial learning and memory ability ofmale 11P-HSD2 null mice in the water
maze test. However, 11 (3-HSD2 null mice of both genders did not display alterations in
fear-related memory when assessed in the passive avoidance test.
It has been previously reported that PS or GC administration programs lifelong alterations
in offspring behaviour including heightened anxiety (Vallee et al., 1997; Welberg et al.,
2001; Van den Hove et al., 2005; Oliveira et al., 2006) and cognitive impairment (Lordi et
al., 1997; 2000; Brabham et al., 2000). The presence of the 11P-HSD2 enzyme in the
placenta is thought to be a critical regulator of GC matemal-fetal transfer, acting to restrict
the free passage of CORT into the fetal circulation (Seckl, 1997). 11P-HSD2 null deletion
results in similar effects to prenatal programming including low birth weight and anxiety-
related behaviour in the EPM and OF in male mice (Holmes et al., 2006a). However, these
mice also display symptoms of AME, including hypertension, electrolyte imbalance and
hypotonic polyuria (Kotelevtsev et al., 1999). This may severely impair both the prenatal
nutrient supply and postnatal pup rearing behaviour of the 11P-HSD2 null mother, effects
that may be involved in the observed programmed phenotype. In contrast, 11P-HSD2
heterozygous mice appear 'normal' and do not display signs of AME. Therefore, the
heterozygous mothers are not thought to have deficits in maternal nurture.
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4.4.1 Anxiety-related behaviour
11 [3-HSD2 null male mice from our studies displayed a similar increase in anxiety-like
behaviour in the EPM reported in 11 p-HSD2 null male mice bred through homozygous
matings (Holmes et al., 2006a). However, in contrast to that reported in homozygous-bred
11P-HSD2 knockouts (Holmes et al., 2006a), male mice in our studies did not exhibit
anxiety-like behaviour on the OF. This may indicate a reduced severity of programmed
anxiety in the heterozygous-bred 11P-HSD2 null mice compared to their homozygous-bred
equals. Thus, it is possible that the altered maternal physiology, as a consequence of AME
(Kotelevtsev et al., 1999) and also enhanced anxiety (Holmes et al., 2006a), may contribute
to the severity of the anxious phenotype of the offspring. This altered physiology may
compromise nutrient provision during fetal and early postnatal life and/or maternal
nurturing behaviour. Alternatively, the lack of any measurable difference in the OF may
reflect the insensitivity of the test for assessing affective function in mice.
Female 11P-HSD2 null mice had not previously been examined in anxiety tests. In contrast
to males, our studies do not present concrete evidence for programmed anxiety behaviour in
female offspring, however it should be highlighted that group sizes were small for female
behavioural studies. Due to the relatively high biological variability traditionally noted in
anxiety testing, any subtle alteration in anxiety-related behaviours may be masked. More
studies should be performed obtaining evidence to confirm or deny an anxiety-like
phenotype in female 11P-HSD2 null mice. Nevertheless, we can confirm that anxiety-like
behaviour in heterozygous-bred 11P-HSD2 null mice is more apparent in males than
females. As discussed in the previous chapter, gender differences on both anxiety tests and
sensitivity to prenatal programmed alterations in behaviour are not uncommon.
4.4.2 Learning and memory behaviour
In this study we evaluated the behaviour of heterozygous-bred male 11P-HSD2 null,
heterozygous and wild-type mice in the water maze and passive avoidance tests, to assess
cognitive learning and memory. Performance in the water maze has previously indicated
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impairment of spatial memory in PS offspring (Szuran et al., 1994; 2000; Aleksandrov et
al., 2001; Zagron and Weinstock, 2006; Yang et al., 2007) and following prenatal DEX
(Brabham et al., 2000). However no significant difference in water maze exploration was
reported in offspring prenatally-treated with either CBX or DEX throughout gestation
(Welberg, 1999). The water maze test involves placing the subject into a circular pool of
water containing a submerged platform. During the first two days of the test, the platform
was cued with the addition of a visual object allowing mice to find the submerged platform
and associate the platform with escape from the maze. The following five days the
platform is hidden, although extramaze cues are present to allow acquisition and memory of
platform location.
In both the cued and hidden platform parts of the test 11[3-HSD2 null mice displayed
reduced improvement in escape latency and distance travelled between the first two days,
compared to other groups. This finding suggests these offspring possess a mild impairment
in spatial associative learning and memory, at least in this paradigm. 11 (3-HSD2
heterozygous and wild-type mice displayed a significant reduction in escape latency and
distance travelled between the first two days in both the cued and hidden platform sections
of the test, a finding indicative of significant associative and spatial learning in these mice
(Morris, 1984). However, this reduction in escape latency and distance swum was not
found to be significant in 11 [1-HSD2 null mice, which suggests this group may possess
associative and spatial learning impairments.
The average swim speed was found to be reduced in the 11 (3-HSD2 null mice. This finding
could be indicative of an altered search and escape strategy of these mice in the maze or
alternatively, be explained by a motor impairment in mutant offspring. 1 lp-HSD2 mutant
mice have been reported to display reduced cerebellar size during the early postnatal period
which was associated with delayed developmental landmarks (Holmes et al., 2006b).
Although we have not examined the cerebellum in adult 11 (1-HSD2 mutant mice,
developmental abnormalities in this critical structure mediating motor coordination
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(Swinny et al., 2005) could be reflected in deficits in adulthood. Data from wheel running
activity indicated that male 11(3-HSD2 null mice are spontaneously hypoactive over a 24-hr
period (Chapter 6). However, we did not measure acute motor function in our 11|3-HSD2
null mice, although will be important to do so in the future. Several tests have been
validated for this purpose including the rotarod test (Fujimoto et al., 2004). We observed a
reduction in measures that reflect general locomotor activity in the EPM (number of closed
arm entries and total distance travelled) and LD (crossings between compartments) anxiety
tests. However, these factors are also dependent upon by anxiety levels in the mice, which
we believe to be heightened. Indeed, in the OF test, where locomotor activity is thought to
have a large influence on behaviour (Prut and Belzung, 2003), no difference was detected
between genotypes. The behaviour described above in our anxiety tests does not support a
role for motor impairment in the observed effects. The water maze procedure has been
shown to be extremely stressful (Sandi et al., 1997; Engelmann et al., 2006) and it is
possible that the reduced swim speed may suggest a heightened anxiety response. The time
spent near the walls of the maze (thigmotaxis) has been proposed to be a measure of
anxiety in the water maze (Simon et al., 1994). However, despite evidence of heightened
anxiety-like behaviour on the EPM and LD test we saw no alteration of thigmotaxis in lip-
HSD2 null mice. Together, the strongest evidence suggests that the reduced swim speed is
due to a less proactive approach in escaping the water.
Fear-related memory was assessed in the passive avoidance test in both male and female
11P-HSD2 null mice. This test involves the conditioned pairing of entry into the less
anxiogenic dark compartment of the LD box with a footshock. The association is
subsequently tested and normally expressed as an increased post-shock latency compared to
pre-shock latency to cross into the dark compartment. We observed no significant
difference between male 11 (3-HSD2 genotypes in the magnitude of avoidance conditioning,
implying that memory consolidation of the aversive experience was unimpaired in 11(3-
HSD2 null mutants. A peculiar observation in female mice subjected to the passive
avoidance apparatus was noted. Whilst, 11 (3-HSD2 heterozygous and null mice displayed
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significant avoidance conditioning, this was not evident in wild-type offspring. The reason
for this is unclear, although as previously mentioned the sample size in our female studies
was small and in particular the wild-type group (n=4). We were unable to repeat this test
due to restricted numbers of mice available.
Additionally, care should be taken in attributing the altered behaviour in the 11 (3-HSD2 null
mutant to cognitive impairments. These mice also display heightened anxiety which may
confound the interpretation of behaviour in the water maze.
4.4.3 Behaviour of 11 (3-HSD2 heterozygous mice
In our different murine tests we saw no differences in anxiety-like and cognitive behaviour
in 11P-HSD2 heterozygous mice of either gender. Several possible explanations exist:
1.) The approximate 50% activity of the enzyme within placenta (Kotelevtsev et al.,
1999), and presumably the developing brain regions, provides sufficient regulation
of feto-placental CORT transfer to prevent fetal overexposure to maternal CORT
and subsequent programmed effects observed in the null offspring.
2.) 11P-HSD2 heterozygous mice lack the symptoms of AME (hypotonic polyuria,
hypertension, electrolyte imbalance) observed in null mice (Kotelevtsev et al.,
1999) suggesting that this may underlie the heightened anxiety-like behaviour and
cognitive impairment observed.
3.) The tests employed were not sensitive enough to detect small differences in anxiety-
related behaviour.
The placental expression of 11P-HSD2 in the mouse declines rapidly around E15-16
(Brown et al., 1996a). Additionally, there is a marked surge in maternal CORT during the
last week and dams become incapable of mounting a further increase following 10-min
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stress exposure (Douglas et al., 2003; Holmes et al., 2003). We therefore decided to
commence daily restraint during the more susceptible mid-gestational period, during which
stress can elicit a response (Holmes et al., 2003) and when 11|3-HSD2 is normally highly
expressed (Brown et al., 1996b). We hypothesised that increased levels of CORT
generated by maternal restraint stress would breach the more fragile feto-placental barrier
in 11P-HSD2 heterozygous offspring. To test this, we subjected pregnant l l[i-HSD2
heterozygous dams to restraint stress (E7-19,1 hr daily) and compared offspring to those
born to unmanipulated dams. 11 |3-HSD2 null mice were lighter at birth, irrespective of
prenatal treatment. No difference in birthweight was observed in wild-type or 11 (3-HSD2
null mice when compared to prenatally-unmanipulated offspring of the same genotype.
However, an effect of prenatal restraint was seen in 11 (3-HSD2 heterozygous offspring who
were lighter than those bom to unmanipulated control dams. This susceptibility to
increased maternal CORT may reflect a breach of the weakened defensive barrier in this
genotype, whilst a lack of effect on birth weight following prenatal restraint in wild-type
indicates a more robust protection in these mice. Additionally, the absence of a further
reduction in birth weight in 11 (3-HSD2 null mice following prenatal restraint points towards
a ceiling effect ofmaternal CORT action on growth restriction in utero.
The prenatal restraint procedure performed in our studies (1 hr/day; E7-19) was less severe
than has been employed in mice by other groups (Sternberg and Ridgway, 2003; Chung et
al., 2005; Son et al., 2006) and did not cause growth restriction in the wild-type fetus.
However, when combined with the susceptibility of heterozygous offspring to CORT
overexposure, the prenatal stressor yielded a reduction in birth weight. Despite similar
birth weights ofwild-type and 11 [1-HSD2 null mice following prenatal stress compared to
unstressed controls, offspring of all genotypes born and reared by a restraint-stressed dam
were found to be lighter at weaning. This suggests the presence of a deficient postnatal
environment in these offspring. PS has been reported to alter maternal behavioural in rats
(Patin et al., 2002; Smith et al., 2004) and mice (Meek et al., 2001), including the
impairment of nursing behaviour. In our studies we did not monitor maternal behaviour,
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although PS may have altered both the physical care and/or the nutrient provision to
offspring. The effect on body weight was not permanent as a reduction was no longer
evident at the testing age of 13 wks.
In our studies heterozygous-bred 11(3-HSD2 null mutant mice displayed a normalisation of
the reduced body weight at birth by P14, indicating rapid catch-up growth had occurred.
Homozygous-bred 11P-HSD2 knockout mice had a similar magnitude of birth weight
reduction to that observed in heterozygous-bred mutants. However, homozygous-bred 11P-
HSD2 knockout mice still displayed a marked, approximately 20%, reduction in body
weight into midlife (Holmes et al., 2006a). Whilst a similar impairment of 11P-HSD2 null
fetal growth was observed independent ofmaternal genotype (11P-HSD2 null or
heterozygous), the key difference in the effects on offspring growth seems to lie in the
postnatal period. The putative deficit in postnatal rearing of offspring thus appears additive
to the prenatal GC environment and may contribute to the more visible anxious phenotype
observed in homozygous- compared to heterozygous-bred 11P-HSD2 null male offspring.
Catch-up growth has previously been thought to have a mechanistic involvement in
programmed phenotype, through the metabolic tax placed on offspring during the rapid
growth phase (Ong, 2006). However, this does not appear to be involved in the
programming of anxiety-related behaviour which was apparent with or without catch-up
growth in offspring.
It was highly disappointing when we were unable to detect any difference in behaviour in
the anxiety tests between any 11(3-HSD2 genotype or prenatal treatment when studies were
conducted in the BRF at LF. Genotypes were confirmed twice and 11J3-HSD2 null mutant
mice displayed symptoms of AME, including polyuria and polydipsia. The absence of
heightened anxiety-like behaviour in 11 (3-HSD2 null mice, a result confirmed by several
investigators, contradicts the findings from studies conducted in cohort one, bred and
studied in the BRF at the WGH. The reasons for this are uncertain, although a number of
possible explanations exist:
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1.) The procedures at LF required handling of pups and dam during early postnatal life
during paw-marking and weighing;
2.) The nutritional content of the ad libitum fed diet was altered;
3.) The experimental and adjacent holding rooms were different;
4.) The general environment of the BRF and animal technicians were unavoidably
distinct.
Handling of neonatal offspring daily is known to positively influence adult stress reactivity,
emotional behaviour and cognitive performance in both rats (Fernandez-Teruel et al., 1997)
and mice (Zaharia et al., 1996; Anisman et al., 1998; Parfitt et al., 2004). Additionally,
handling has been observed to attenuate negative effects programmed through prenatal
stress exposure in both species (Wakshlak and Weinstock, 1990; Meaney et al., 1991;
Vallee et al., 1997; Sternberg and Ridgway, 2003), presumably mediated through an
increase in mother-infant interactions (Liu et al., 1997; Francis et al., 1999). In view of
this, we conducted behavioural assessment on offspring bom and reared in the BRF at the
LF, but under similar, undisturbed conditions previously employed in the BRF at the WGH.
However, the results showed no differences between genotype groups in their behavioural
phenotype which excludes postnatal handling as the sole candidate for an absence of
measurable anxiety-related behaviour in 11 (3-HSD2 null mice bred and assessed in the BRF
atLF.
The content of the diet fed to mice differed between the two biological research facilities.
Dams and offspring were fed the CRM(E) diet at the WGH, which is comprised of: 62.0%
carbohydrate, 18.6% protein and 3.4% oil. However, at LF dams were fed the RM3(E) diet
during breeding and lactation, which is comprised of: 55.7% carbohydrate, 22.4% protein
and 4.3% oil. In the BRF at LF, offspring were maintained on the RM1(E) diet which
contained 66.7% carbohydrate, 14.4% protein and 2.7% oil. There is ample evidence that
maternal diet during the perinatal period is capable of programming offspring adult
physiology and behaviour (Buckley et al., 2005). Both high and low protein maternal diets
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during pregnancy and lactation have been reported to programme negative consequences on
the metabolic phenotype of offspring including: reduced birth weight, HPA axis
dysregulation, renal damage, hypertension, glucose intolerance and obesity (Langley-
Evans et al., 1996; Bertram and Hanson, 2001; Daenzer et al., 2002; Thone-Reineke et al.,
2006). In addition, changes in hippocampal morphology have been observed (Cintra et al.,
1997; Granados-Rojas et al., 2002). Daenzer et al. (2002) compared a 40% protein (high)
diet with a 20% protein (normal) diet and observed decreased energy expenditure and
increased adiposity in the high prenatal protein diet-fed group. Langley-Evans et al. (1996)
compared a 9% (low) protein diet to a 18% (normal) protein diet, and detected hypertension
in offspring that had received the prenatal low protein diet. These studies have compared
offspring receiving markedly different protein concentrations in their diet. However, they
illustrate that variation in prenatal protein can have a significant impact upon offspring and
an effect of the different maternal protein diets (18.6% at the WGH; 22.4% at LF) on the
offspring phenotype is not impossible. Additionally, the influence of weaning onto a
different diet at LF (protein 14.4%) may play a role in an altered anxiety phenotype in
adulthood. However, protein concentration is not the only difference in composition
between these diets, but also the levels of carbohydrate and fat. It was recently shown that
the intake of a diet high in omega-3 fatty acids pre- and post-weaning reversed the
hypertension observed following prenatal DEX treatment (Wyrwoll et al., 2006). The
potential impact of the altered nutrition during both breeding and later adult life in our
studies is unknown, and whilst this may be a factor in the prevention of our previously
observed adult phenotype of anxiety-like behaviour this is merely speculation. It would be
of interest to explore a possible dietary involvement in heightened anxiety, although in
future studies experimental animals will be given the CRM(E) diet, previously used in the
BRF at the WGH, where both DEX-programmed rats and 11(3-HSD2 null mice had showed
changes in anxiety-related behaviour.
The experimental rooms were obviously different between research facilities, but the
testing apparatus was identical. We took care to setup conditions as similar as possible,
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including two uplift lamps providing a dim lighting. Lighting levels have been shown to
significantly affect the exploratory behaviour anxiety tests (Griebel et al., 1993; Rodgers
and Dalvi, 1997; Garcia et al., 2005) and the lighting was kept dim to provide a low anxiety
baseline in our animals, thereby providing for a large window in which to measure any
heightened anxiety.
An elaborate study was performed involving a series of behavioural tests, including the
EPM and OF, on six mouse strains in three separate animal facilities (Crabbe et al., 1999).
Care was taken to standardise testing apparatus, protocols and other environmental
variables. The findings showed that not only did the strains differ in behavioural
performance, but measurable anxiety-like behaviour in 5-HTiB knockout mice was present
only in one of the three test sites. Emotionality appears to be highly sensitive to variations
between different research facilities and laboratories (Wahlsten et al., 2003). Therefore,
differences in the individual animal technicians involved and the general environment,
including noise levels and the size of the holding rooms are amongst variables that could
have an influence on the measured anxiety-like behaviour in 11J3-HSD2 null mice.
As discussed above, several factors may influence the presentation of an anxious phenotype
in the 11 (3-HSD2 null mice offspring. Whilst postnatal handling has been excluded as the
lone variable, mice in the future will be returned to the single diet during pregnancy,
lactation and in adulthood used in the BRF at the WGH. Further investigation is underway
to identify the underlying variables responsible for the absence of measurable anxiety we
report here. However, such studies are beyond the scope of this thesis due to time
constraints. Due to the problems showing anxiety in 11P-HSD2 null mutant mice the
experiment conducted to determine whether prenatal stress could tip the heterozygous mice
into a null phenotype was not able to produce any useable behavioural data. However, the
weight differences did suggest that the 11P-HSD2 heterozygous mice displayed increased
susceptibility to PS-induced growth restriction.
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We have shown that heterozygous-bred 11 [3-HSD2 null mice display low birth weight,
heightened anxiety and mild cognitive impairment compared to wild-type and 11 [3-HSD2
heterozygous mice. This phenotype was more apparent in males, although appears to be
sensitive to housing conditions and was not found to be robust across biological research
facilities. 11P-HSD2 null mice therefore display characteristics of prenatal GC
programming similar to those observed with prenatal DEX treatment (Welberg et al., 2001)
and prenatal 11 (3-HSD2 enzyme inhibition with CBX (Welberg et al., 2000). We observed
these deficits in behaviour due to the direct effect of 11[3-HSD2 enzyme loss independent
of any alteration in maternal physiology or nurture, indicating that altered fetal and pup
nutrition and maternal care is not a necessity for the programming of adult behavioural
deficits. However, there is still the slight posibility that an 11P-HSD2 heterozygous dam
could treat lighter (ie 11 p-HSD2 null) offspring differently; the 11P-HSD2 null pup may
not be able to get the same level of care and nipple access for feeding compared to heavier,
more developed littermates. Additionally, 11P-HSD2 null mice also display symptoms of
AME (hypotonic polyuria, electrolyte imbalance and hypertension) and a contribution of
these factors to altered behaviour cannot be ruled out. Furthermore, 11P-HSD2 knockout
mice will have dramatically altered GC metabolism and breakdown throughout life,
potentially altering kinetics of GC/receptor interactions. This model of prenatal GC
programming has significant advantages over other models which involve maternal
manipulation, although limitations exist which preclude the attribution of GC programming
as the sole explanation of observed phenotype. As will be further discussed in chapter 7,
tissue-specific 11P-HSD2 mutations will be crucial in the separation of individual
components capable of mediating the behavioural phenotype in adulthood.
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CHAPTER 5




PhD Thesis - A genetic approach to prenatal glucocorticoid programming
5.1 Introduction
In the previous chapter we observed heightened anxiety-like behaviour and cognitive
impairments in ll(3-hydroxsteroid dehydrogenase type 2 (11(3-HSD2) null mice, thought to
be a result of prenatal glucocorticoid (GC) overexposure. Programmed effects have also
been observed on the hypothalamic-pituitary-adrenal (HPA) axis function throughout life in
previous models. Prenatal overexposure to GCs due to maternal stress, exogenous GC
administration or 11 (3-HSD2 inhibition lead to hypothalamic-pituitary adrenal (HPA) axis
alterations characterised by heightened basal, exaggerated and/or prolonged response to
stress (Levitt ct al., 1996; Wcinstock et al., 1998; Vallee et al., 1999; O'Regan et al., 2004).
Altered circulating corticosterone (CORT) levels have been found in combination with the
altered expression of corticosteroid receptors and corticotrophin-releasing hormone (CRH)
within the hippocampus, amygdala and paraventricular nucleus (PVN) of the hypothalamus
(Welberg et al., 2000; 2001). Studies have shown that circulating CORT levels modulate a
wide variety of behaviours in rodents, including those related to anxiety (Korte, 2001) and
cognition (McEwen and Sapolsky, 1995). Additionally, genetic modulation of receptor
expression within the brain has been found to modulate GC-mediated effects on behaviour
(Steckler et al., 1999; Tronche et al., 1999; Gass et al., 2001; Wei et al., 2004; Berger et al.,
2006). The observed HPA axis hyperactivity in prenatal dexamethasone (DEX)-treated
offspring was postulated to play a role in the anxious behaviour (Welberg et al., 2001). We
therefore wished to investigate the HPA axis and central expression of corticosteroid
receptors and CRH in 11 (3-HSD2 null mutant mice to observe whether similar mechanisms
may underlie our observed phenotype of heightened anxiety-like behaviour and memory
impairments.
In addition we looked at three candidate genes involved in GC action and regulation of
anxiety: Serum/glucocorticoid-regulated kinase 1 (Sgkl), FK506 binding protein 51
(Fkbp5) and Brain-derived neurotrophic factor (BDNF). Sgkl mRNA expression was
found to be responsive to GCs and stress exposure in various cell lines and in the brain
(Naray-Fejes-Toth et al., 2000; Leong et al., 2003; Koya et al., 2005; Murata et al., 2005).
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This kinase has also been implicated in the regulation of ion channels through modulation
of cell surface expression (reviewed in Lang et al., 2003). Sgkl mRNA expression has
been detected in the rat (van Gemert et al., 2006) and murine hippocampus (Murata et al.,
2005), from the late embryonic stage (Lee et al., 2001). Sgkl mRNA expression could
therefore mediate GC-induced effects on cell survival and neuronal excitability within the
hippocampus.
Fkbp5 is an immunophilin, which acts as a co-chaperone of heat shock protein 90 (hsp90),
forming part of the machinery governing nuclear translocation of GR. Fkbp5 is induced by
GR activation and can act to negatively modulate steroid hormone signalling (Cheung and
Smith, 2000). The relative expression of Fkbp5 is thought to be a cause of GC resistance
observed in new world primates (Scammell et al., 2001). Single nucleotide polymorphisms
(SNPs) in the human Fkbp5 gene have been detected and were found to result in altered
recurrence of depressive episodes and response to antidepressant treatment (Binder et al.,
2004). These studies suggest that this downstream target of GR activation could mediate
GC effects upon behaviour and the HPA axis. Whilst hippocampal expression of other
FK506 binding proteins have been reported in the mouse (Kato et al., 2000; Nielsen et al.,
2004), no previous literature regarding hippocampal Fkbp5 mRNA expression in any
species is available.
BDNF has a well-established role in the CNS regulating survival, growth and
differentiation of neurones during development, being expressed in mice from embryonic
day (E) 15 and peaking during second postnatal week (Ivanova and Beyer, 2001). The
neutrophic factor is also expressed in adulthood, where it may function to modulate
neuroprotection and synaptic plasticity (Castren, 2004; Marini et al., 2004). Expression
within the murine brain is relatively ubiquitous, with the highest level observed within the
hippocampus and cortex (Hofer et al., 1990). In the hippocampus, GCs have been shown to
modulate the BDNFmRNA expression although not in all subfields. Activation ofMR and
GR may have opposing effects upon mRNA expression of BDNF (Chao and McEwen,
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1994; Chao et al., 1998). BDNF is thought to play a key role in learning and memory
(Yamada et al., 2002) as well as anxiety; in mice, anxiety-like behaviour on the EPM were
correlated to hippocampal BDNF levels (Yee et al., 2006) and a genetic variant
polymorphism in mice has yielded heightened anxiety (Chen et al., 2006). Reduced mRNA
expression levels of BDNF were detected within the prefrontal cortex and striatum of adult
rats subject to prenatal restraint stress (Fumagalli et al., 2004), although no alterations were
seen in the hippocampus in either mRNA (Fumagalli et al., 2004) or protein (Koo et al.,
2003) expression. In contrast, transiently reduced BDNF mRNA was observed at postnatal
day (P) 5 in the neonatal rat hippocampus following prenatal restraint (Van den Hove et al.,
2006c). From studies mentioned above it appears that Sgkl, Fkbp5 and BDNF are
downstream targets of GC action and are therefore candidate genes for mediating the
consequence of heightened HPA axis function. We therefore decided to explore the
expression of these gene transcripts in addition to those of GR, MR, CRH and AVP in 11(3-
HSD2 null mutants to observe whether they may be dysregulated as a consequence of
prenatal GC programming.
In addition to the state of HPA axis-associated genes during adulthood, we wished to study
the postnatal ontogeny in ll[i-HSD2 null mutant mice. The pre-weaning period is a time of
significant growth and maturation of the limbic system and exhibits heightened sensitivity
to programmed effects. Rat offspring prenatally treated with carbenoxolone (CBX)
displayed increased hippocampal mRNA expression ofMR at one week of age, significant
only in the CA2 subfield. A trend towards increased GR was also evident, although only in
the CA1 (Welberg, 1999). The altered corticosteroid receptor expression was resolved by
adulthood when no changes within the hippocampus were evident (Welberg et al., 2000).
We therefore studied the postnatal ontogeny of corticosteroid receptor mRNA expression
weekly until weaning. In addition we explored the expression of the GC-induced
transcripts (Sgkl, Fkbp5, and BDNF) during this period. Due to experimental limitations
this was performed in mice bred through homozygous matings, the significance of which
will be discussed later.
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5.2 Methods
Comprehensive details of methods can be found in chapter 2. Except where specified,
breeding and studies were performed in the BRF at the WGH.
5.2.1 Study of HPA axis in 11 (3-HSD2 transgenic mice
5.2.1.1 Heterozygous-bred adult offspring
Male and female 11 |3-HSD2 heterozygous mice were pair-housed in breeding cages and left
undisturbed until parturition. Cages were checked daily between 09.00 and 11.00 h for
delivery of litters. Following delivery, pups were counted and sexed. Litters were then left
undisturbed with the dam until weaning at postnatal day (P) 21, when they were ear-
notched (for identification and genotyping), housed in single-sex groups of 2-6 and left
undisturbed until testing, apart from routine cage maintenance.
At the age of 15-16 weeks blood was collected between 09.00 and 10.00 h by tail nick to
obtain an unstressed basal sample at the diumal nadir. Two weeks later mice were
restrained in plexiglass tubes for 10 min before decapitation and collection of trunk blood
to obtain a peak stress sample. Tubes were centrifuged and plasma supernatant was stored
at -20°C, until the measurement of CORT by radioimmunoassay. Brains were removed
from males, rapidly frozen on dry ice and kept at -80°C until sectioned on the cryostat.
Adrenals were removed from males, stored in formamide, later cleaned of fat by
microdissection and weighed on a semi-microbalance.
At the age of 11-12 weeks, the left adrenals from male and female mice from cohort two
bred in the BRF at LF (see Chapter 4, page 109) were removed, cleaned and weighed as
above.
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5.2.1.2 Homozygous-bred pre-weaning offspring
Male and female 11 (3-HSD2 homozygous or wild-type mice were pair-housed in breeding
cages and left undisturbed until parturition. Cages were checked daily between 09.00 and
11.00 h for delivery of litters. Following delivery, pups were counted and sexed. No more
than three pups per litter were removed at one week (P7), two weeks (P14) or three weeks
(P21) of age and decapitated. Brains were removed, rapidly frozen on dry ice and stored at
-80°C.
5.2.2 In Situ Hybridisation histochemistry
Coronal cryosections (14pm thickness) from adult male and mixed-gender pre-weaning
brains were cut at the level of the paraventricular nucleus (PVN) and hippocampus, which
both included amygdala regions (approx. bregma -0.70 to -1.90 mm). Sections were thaw-
mounted onto prepared slides and stored at -80°C until further use. In situ hybridisation
was performed on these sections using the antisense riboprobe for the transcript of interest
shown in Table 5.1 (see also Chapter 2). Antisense riboprobes for GR, MR, CRH and AVP
have previously been validated and used in our laboratory (Holmes et al., 2006; Welberg et
al., 2000; 2001). Antisense riboprobes for Sgkl, Fkbp5 and BDNF had not previously been
validated or used in our laboratory. The cDNA templates were sequenced and found to
match the desired sequence.
Equivalent sense probes were included as controls. Previous studies and initial experiments
indicated that Sgkl and MR mRNA expression in the PVN is below our threshold for
quantification and hippocampal CRH mRNA expression is very low. Therefore, in situ
hybridisation was not performed for these gene transcripts in those regions.
The level ofmRNA expression was quantified by optical densitometry of autoradiographs
from sections containing the specific regions of interest. Individual expression was
calculated from a mean of 5-10 measurements for each region, taken from both sides of the
brain.
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Table 5.1 In situ hybridisation with riboprobes performed in adult and pre-weaning brain
sections
Experiments performed in paraventricular nucleus (PVN) and hippocampus with riboprobes for
glucocorticoid receptor (GR), mineralocorticoid receptor (MR), corticotrophin-releasing hormone
(CRH), arginine vasopressin (AVP), serum/glucocorticoid-regulated kinase (Sgk1), FK-506 binding
protein 5 (Fkbp5) and brain-derived neurotrophic factor (BDNF) mRNA.
5.2.3 Corticosterone radioimmunoassay
Plasma was diluted 1:10 in borate buffer containing 0.5% BSA and denatured at 75-80°C
for 30 mins. 20pl of 1:10 plasma or CORT standards were incubated with 50pl 3H-
CORT/primary antibody mix. SPA beads (50pl) were then added and left overnight to
equilibrate, following which plates were counted on a beta-counter. Sample CORT
concentration was calculated from the Multicalc-prepared graph of cpm versus [CORT].
5.2.4 Statistical analysis
Data are expressed as mean±SEM. In studies on heterozygous-bred adult offspring,
comparisons between genotype were analysed by one-way analysis of variance (ANOVA),
with Student Newman-Keuls (SNK) post-hoc testing. In studies on homozygous-bred pre-
weaning offspring, comparisons in each region, or hippocampal subfield, between genotype
and age were analysed by two-way ANOVA, with SNKpost-hoc testing. Where
expression was only detected at a single age an unpaired t-test was performed.
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5.3 Results
Offspring from litters of less than five were excluded from further analysis. Due to the
semi-quantitative nature of in situ hybridisation, the direct comparison of expression levels
between individual gene transcripts is not possible.
5.3.1 Heterozygous-bred adult male 11P-HSD2 transgenic mice
5.3.1.1 Brain mRNA expression of genes involved in the regulation of GC
action and HPA axis activity
Representative in situ hybridisation autoradiograph pictures are shown in Figure 5.1.
GR MR CRH AVP
Sgk1 Fkbp5 BDNF
Figure 5.1 Autoradiograph pictures following GR, MR, CRH, AVP, Sgk1, Fkbp5 and BDNF in
situ hybridisation at the level of the PVN and hippocampus (HC) in adult male mouse brain
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Hippocampal mRNA expression ofGR (Figure 5.2a), MR (Figure 5.2b), Sgkl, Fkbp5 and
BDNF (Table 5.2) did not display any significant differences within any subfield between
genotypes in adult male mice.





Figure 5.2 Hippocampal GR and MR mRNA expression in adult male 11 (B-HSD2 transgenic
mice
Effect of 11(B-HSD2 genotype (+/+ H, +/- E3, -/- D) on the hippocampal mRNA expression of the (a)
glucocorticoid receptor (GR) and (b) mineralocorticoid receptor (MR). Expression levels were
measured by optical densitometry of in situ hybridisation autoradiographs. Data are expressed as
mean±SEM in arbitrary units (AU) and analysed by one-way ANOVA for each subfield; n=7-15 per
group.
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11P-HSD2 Optical Density (All)
Genotype CA1 CA2 CA3 DG
(a) Sgkl mRNA
+/+ 0.23±0.02 0.44+0.01 0.54+0.02 0.45±0.03
+/- 0.22±0.01 0.43±0.02 0.51 ±0.02 0.43±0.02
0.25+0.03 0.47±0.02 0.53±0.03 0.44±0.03
(b) Fkbp5 mRNA
+/+ 0.31 ±0.04 0.72±0.03 0.31 ±0.04 0.62±0.04
+/- 0.28±0.02 0.74+0.02 0.31 ±0.02 0.58±0.03
0.34±0.03 0.74±0.03 0.32±0.02 0.62±0.02
(c) BDNF mRNA
+/+ 0.26±0.02 0.25+0.03 0.41 ±0.02 0.48±0.03
+/- 0.24±0.03 0.26±0.02 0.41 ±0.03 0.42±0.02
0.23±0.02 0.25±0.02 0.40±0.03 0.40±0.02
Table 5.2 Hippocampal mRNA expression of Sgk1, Fkbp5 and BDNF in adult male 11(3-HSD2
transgenic mice
Effect of 11 (3-HSD2 genotype (+/+, +/-, -/-) on the hippocampal mRNA expression of the (a)
serum/glucocorticoid-regulated kinase (Sgk1), (b) FK506 binding protein 5 (Fkbp5) and (c) brain
derived neurotrophic factor (BDNF). Expression levels were measured by optical densitometry of in
situ hybridisation autoradiographs. Data are expressed as mean±SEM in arbitrary units (AU) and
analysed by one-way ANOVAfor each subfield; (a) n=6-13, (b) n=7-16 and (c) n=7-15 per group.
Furthermore, PVN mRNA expression of GR, CRH, Fkbp5, BDNF and AVP (Table 5.3)
was unaltered by genotype. CRH, Sgkl, Fkbp5 and BDNF mRNA expression within the
amygdala regions was also unchanged by genotype (Table 5.4). Sgkl mRNA expression
was only observed in the central amygdala (CeA), whilst Fkbp5 and BDNF mRNAs were
only expressed in the medial amygdala (MeA) and basolateral amygdala (B1A). The
expression ofMR and GR mRNA was below our threshold for quantification and therefore
was not measured.
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11P-HSD2 mRNA Optical Density (AU)
Genotype (a) GR (b) CRH (c) Fkbp5 (d) BDNF (e) AVP
+/+ 0.60±0.03 0.47±0.04 0.21 ±0.02 0.21 ±0.03 0.61 ±0.06
+/- 0.56±0.03 0.43±0.03 0.20±0.02 0.25±0.01 0.56±0.03
-/- 0.62±0.03 0.39±0.04 0.19±0.02 0.21 ±0.02 0.62±0.03
Table 5.3 PVN mRNA expression of CRH, AVP, GR, Fkbp5 and BDNF in adult male 110-HSD2
transgenic mice
Effect of 11(3-HSD2 genotype (+/+, +/-, -/-) on the mRNA expression in the paraventricular nucleus
(PVN) of the hypothalamus of (a) glucocorticoid receptor (GR), (b) corticotropin-releasing hormone
(CRH), (c) FK506 binding protein 5 (Fkbp5), (d) brain derived neurotrophic factor (BDNF) and (e)
arginine vasopressin. Expression levels were measured by optical densitometry of in situ
hybridisation autoradiographs. Data are expressed as mean±SEM in arbitrary units (AU) and
analysed by one-way ANOVA; (a) n=4-10, (b,d) n=7-16, (c) n=6-16 and (e) n=6-13 per group.
11P-HSD2 Optical Density (AU)
Genotype CeA MeA BIA
(a) CRH mRNA
+/+ 0.18±0.01 below below
+/- 0.17±0.01 quantification quantification
-/- 0.18±0.02 threshold threshold
(b) Sgk1 mRNA
+/+ 0.27±0.03 below below
+/- 0.22±0.01 quantification quantification
-/- 0.26±0.01 threshold threshold
(c) Fkbp5 mRNA
+/+ below 0.26±0.03 0.25±0.03
+/- quantification 0.28±0.02 0.23±0.01
-/- threshold 0.23±0.03 0.25±0.01
(d) BDNF mRNA
+/+ below 0.29±0.05 0.37±0.02
+/- quantification 0.27±0.02 0.36±0.02
-/- threshold 0.28±0.02 0.37±0.04
Table 5.4 Amygdala mRNA
expression of Sgk1, Fkbp5
and BDNF in adult male 11(3-
HSD2 transgenic mice
Effect of 11P-HSD2 genotype
(+/+, +/-, -/-) on the mRNA
expression in the central (CeA),
medial (MeA) and basolateral




kinase (Sgk1), (c) FK506
binding protein 5 (Fkbp5) and
(d) brain derived neurotrophic
factor (BDNF). Expression
levels were measured by optical
densitometry of in situ
hybridisation autoradiographs.
Data are expressed as
mean±SEM in arbitrary units
(AU) and analysed by one-way
ANOVA for each subfield; (a)
n=7-16, (b) n=5-7 (MeA)/n=7-13
(BIA) and (c) n=4-11 (MeA)/n=6-
13 (BIA) per group.
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5.3.1.2 HPA axis
Plasma CORT was not altered by genotype under either basal or stress conditions in adult
male (Figure 5.3a) or female (Figure 5.3b) mice. Relative left adrenal weight was
significantly different between genotype (Figure 5.4; F2,3o=4.40, p<0.05), being reduced in
male 11(3-HSD2-/- compared to +/+ and +/- offspring (p<0.05). However, no difference
was found between genotype in right adrenal weight (F2,27=0.24, p=0.788).

















Basal Stress Basal Stress
Figure 5.3 Plasma corticosterone under basal and stress conditions in adult male and female
11P-HSD2 transgenic mice
Effect of 11(3-HSD2 genotype (+/+ I, +/- E2, -/- dl) on basal plasma corticosterone and following
10-minute restraint (stress) in (a) male and (b) female adult mice. Data are expressed as
mean±SEM in mg/ml and analysed by one-way ANOVA; (a) n=7-15 (basal)/n=8-14 (stress) and (b)
n=5-8 (basal)/n=6-7 (stress) per group.
Figure 5.4 Adrenal gland weight in adult male
11 p-HSD2 transgenic mice
Effect of 11P-HSD2 genotype (+/+ ■ +/- E3, -/- □)
on left and right adrenal gland weight relative to
body weight (BW). Data are expressed as
mean±SEM in mg/100g BW and analysed by one¬
way ANOVA with SNK post-hoc testing; n=8-16
(left)/n=7-14 (right) per group. *p<0.05
Left Right
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Due to the unexpected behavioural results in male and female 11(3-HSD2 transgenic mice
bred and maintained in the BRF at LF from cohort two (see chapter 4), we analysed adrenal
glands from this cohort to check whether alterations in this aspect of their phenotype were
also apparent. Male left adrenals were significantly different between genotype (Table 5.5;
F2,24=5.89, p<0.01), being significantly lighter in 11P-HSD2-/- compared to +/+ (p<0.01)
and +/- offspring (p<0.05) consistent with the observations made in the 15-16 wk old mice
(Figure 5.4). In contrast to males, there was no significant difference in adrenal weight
between genotype in female mice (F2,22=0.89, p=0.427).





Table 5.5 Left adrenal gland weight in adult male and female 11P-HSD2 transgenic mice
Effect of 11 (B-HSD2 genotype (+/+, +/-, -/-) on left adrenal gland weight relative to body weight
(BW). Data are expressed as mean±SEM in mg/100g BW and analysed by one-way ANOVA with
SNK post-hoc testing; n=7-10 per group. *p<0.05 vs +/-, #p<0.01 vs +/+
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5.3.2 Homozygous-bred 11P-HSD2 null pre-weaning offspring
5.3.2.1 Hippocampal mRNA expression
Representative autoradiograph pictures following GR and MR in situ hybridisation in pre-
weaning mice brains at the level of the hippocampus are shown in Figure 5.5.
GR
MR
Figure 5.5 Autoradiograph pictures following GR and MR in situ hybridisation at the level of
the hippocampus in pre-weaning mice
There was an age-dependent increase in GR mRNA expression throughout the pre-weaning
period irrespective of genotype. 11 (3-HSD2-/- displayed significant alterations in
hippocampal GR mRNA expression during early postnatal period (Figure 5.6). At P14
significant differences between -/- and +/+ mice in GR mRNA expression were seen in all
subfields, with -/- mice displaying elevated expression (CA1: p<0.01; CA2/CA3/DG:
p<0.05). Expression at P7 was only detected in CA1 region and was not different between
genotype. No significant difference in GR mRNA expression was observed in any subfield
at P21.
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Figure 5.6 Hippocampal GR mRNA expression during pre-weaning period in 11|J-HSD2 null
mice
Effect of 11 (3-HSD2 genotype (+/+ H, -/- D) on glucocorticoid receptor (GR) mRNA expression in
the (a) CA1, (b) CA2, (c) CA3 and (d) dentate gyrus (DG) hippocampal subfields. Expression levels
were measured in one-week (P7), two-week (P14) and three-week (P21) old mice by optical
densitometry of in situ hybridisation autoradiographs. Data are expressed as mean±SEM in
arbitrary units (AU) and analysed by two-way ANOVA with SNK post-hoc testing for each subfield;
n=5-10 per group. *p<0.05, p<0.01 vs +/+
Hippocampal MR mRNA expression was different in 11 (3-HSD2-/- during early postnatal
period (Figure 5.7). MR mRNA expression was elevated at P7 in the CA2 subfield only
(Figure 5.7b; p<0.05), whilst at P14 it was significantly elevated in both the CA2 and DG
(p<0.05), whilst displaying a tendency in the CA1 subfield (p=0.080). No differences were
seen in any hippocampal subfield at P21.
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(a) CA1 (b) CA2
*
Age Age
Figure 5.7 Hippocampal MR mRNA expression during pre-weaning period in 11P-HSD2 null
mice
Effect of 11 [3-HSD2 genotype (+/+ H, -/- D) on mineralocorticoid receptor (GR) mRNA expression
in the (a) CA1, (b) CA2, (c) CA3 and (d) dentate gyrus (DG) hippocampal subfields. Expression
levels were measured in one-week (P7), two-week (P14) and three-week (P21) old mice by optical
densitometry of in situ hybridisation autoradiographs. Data are expressed as mean±SEM in
arbitrary units (All) and analysed by two-way ANOVA with SNK post-hoc testing for each subfield;
n=5-10 per group. *p<0.05
Representative autoradiograph pictures following in situ hybridisation for Sgkl, Fkbp5 and
BDNF mRNAs at the level of the murine hippocampus in the pre-weaning period are
shown in Figure 5.8. Sgkl mRNA expression was unaltered at P7 compared to 11 p-
HSD2+/+ offspring. However, a strong trend toward increased Sgkl mRNA in 11 p-HSD2-
/- vs +/+ offspring at P14 was observed in the CA2 (Table 5.6; p=0.084), CA3 (p=0.083)
and DG (p=0.068) subfields. At P21 Sgkl mRNA expression was significantly elevated in
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Table 5.6 Hippocampal Sgk1
mRNA expression during pre-
weaning period in 11p-HSD2
null mice
Effect of 11P-HSD2 genotype (+/+
and -/-) on Serum/Glucocorticoid-
regulated kinase (Sgk1) mRNA
expression in the (a) CA1, (b)
CA2, (c) CA3 and (d) dentate
gyrus (DG) hippocampal subfields.
Expression levels were measured
in one-week (P7), two-week (P14)
and three-week (P21) old mice by
optical densitometry of in situ
hybridisation autoradiographs.
Data are expressed as
mean±SEM in arbitrary units and
analysed by two-way ANOVA with
SNK post-hoc testing for each
subfield; n=6-10 per group.
*p<0.05
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Fkbp5 mRNA was elevated in 11P-HSD2-/- compared to +/+ at P14 significantly in the
CA2 (Table 5.7; p<0.05) and a tendency noted in the CA1 (p=0.072). At P21 a significant
increase in Fkbp5 mRNA was observed in the CA1 of 11J3-HSD2-/-, whilst within the CA2
(p=0.058) and DG (p=0.056) expression approached significance. No change in expression





































Table 5.7 Hippocampal Fkbp5 mRNA expression during pre-weaning period in 11P-HSD2 null
mice
Effect of 11 p-HSD2 genotype (+/+ and -/-) on FK506 binding protein 5 (Fkbp5) mRNA expression in
the (a) CA1, (b) CA2, (c) CA3 and (d) dentate gyrus (DG) hippocampal subfields. Expression levels
were measured in one-week (P7), two-week (P14) and three-week (P21) old mice by optical
densitometry of in situ hybridisation autoradiographs. Data are expressed as mean±SEM in
arbitrary units and analysed by two-way ANOVA with SNKpost-hoc testing for each subfield; n=3-9
per group. *p<0.05, #p<0.01 vs +/+
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BDNF mRNA expression was also altered by genotype, being significantly elevated within
the CA2 and DG subfields in 11P-HSD2-/- mice at P14 (Table 5.8; p<0.05). Expression







































Table 5.8 Hippocampal BDNF mRNA expression during pre-weaning period in 11P-HSD2 null
mice
Effect of 11P-HSD2 genotype (+/+ and -/-) on brain derived neurotrophic factor (BDNF) mRNA
expression in the (a) CA1, (b) CA2, (c) CA3 and (d) dentate gyrus (DG) hippocampal subfields.
Expression levels were measured in one-week (P7), two-week (P14) and three-week (P21) old mice
by optical densitometry of in situ hybridisation autoradiographs. Data are expressed as mean±SEM
in arbitrary units and analysed by two-way ANOVA with SNK post-hoc testing for each subfield;
n=4-7 per group. *p<0.05
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5.3.2.2 PVN and amygdala mRNA expression
Representative in situ hybridisation autoradiograph pictures at the level of the PVN are
shown in Figure 5.9.
Fkbp5
GR mRNA expression was significantly increased in 11 [1-HSD2-/- compared to +/+ mice at
all measured ages: P7, P14 and P21 (Table 5.9; p<0.05). No significant difference at any
age was observed in the expression of CRH, Fkbp5 or BDNF mRNA within the PVN
between genotypes.
Figure 5.9 Autoradiograph pictures following GR, CRH, Fkbp5
hybridisation at the level of the PVN in pre-weaning mice
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11 (3-HSD2 Optical Density (AU)
Genotype P7 P14 P21
(a) GR mRNA
+/+ 0.62+0.03 0.53±0.04 0.49±0.03
0.76±0.05* 0.64±0.04* 0.61+0.02*
(b) CRH mRNA
+/+ 1.32±0.13 0.76±0.05 0.60±0.06
1.27±0.15 0.67+0.06 0.45±0.03
(c) Fkbp5 mRNA below
+/+ quantification 0.31 ±0.02 0.34±0.05
threshold 0.36±0.05 0.28±0.03
(d) BDNF mRNA
+/+ 0.29±0.04 0.27±0.02 0.30±0.02
0.32±0.07 0.29±0.04 0.27+0.02
Table 5.9 PVN mRNA expression of GR, CRH, Fkbp5 and BDNF during pre-weaning period in
11P-HSD2 null mice
Effect of 11p-HSD2 genotype (+/+ and -/-) on the mRNA expression in the paraventricular nucleus
(PVN) of the hypothalamus of (a) glucocorticoid receptor (GR), (b) corticotropin-releasing hormone
(CRH), (c) FK506 binding protein 5 (Fkbp5) and (d) brain derived neurotrophic factor (BDNF).
Expression levels were measured in one-week (P7), two-week (P14) and three-week (P21) old mice
by optical densitometry of in situ hybridisation autoradiographs. Data are expressed as mean±SEM
in arbitrary units and analysed by two-way ANOVA with SNK post-hoc testing; (a) n=5-10, (b) n=4-
10, (c) n=3-10 and (d) n=4-8 per group. *p<0.05
Expression of CRH, Sgkl, Fkbp5 and BDNF mRNA within the amygdala was quantified
and no differences were observed between 11 (3-HSD2 genotypes in any of the regions
(Table 5.10 CeA; Table 5.11 MeA and Table 5.12 B1A) at any age (P7, P14 and P21). As
observed in adult mice, the expression ofMR and GR mRNA was below our threshold for
quantification and was therefore not measured.
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11P-HSD2 Optical Density (AU)
Genotype P7 P14 P21
(a) CRH mRNA below 0.45±0.03 0.34±0.02
+/+ quantification 0.53±0.08 0.36±0.02
threshold
(b) Sgk1 mRNA below
+/+ quantification 0.20±0.02 0.25±0.02
-/- threshold 0.24+0.02 0.30±0.03
(c) Fkbp5 mRNA below
+/+ quantification 0.28±0.04 0.27±0.02
-/- threshold 0.27+0.03 0.29±0.02
Table 5.10 CeA mRNA expression of Sgk1, Fkbp5 and BDNF during pre-weaning period in
11p-HSD2 null mice
Effect of 11(3-HSD2 genotype (+/+ and -/-) on the mRNA expression in the central amygdala (CeA)
of (a) corticotropin-releasing hormone (CRH), serum/glucocorticoid-regulated kinase (Sgk1) and (c)
FK506 binding protein 5 (Fkbp5). Expression levels were measured in one-week (P7), two-week
(P14) and three-week (P21) old mice by optical densitometry of in situ hybridisation
autoradiographs. Data are expressed as mean±SEM in arbitrary units and analysed by two-way
ANOVA; (a) n=5-10, (b) n=3-7 and (c) n=4-7 per group.
11P-HSD2 Optical Density (AU)
Genotype P7 P14 P21
BDNF mRNA
+/+ 0.45±0.05 0.48±0.04 0.53±0.03
0.52±0.01 0.55+0.05 0.47±0.05
Table 5.11 MeA mRNA expression of Fkbp5 and BDNF during pre-weaning period in 11 p-
HSD2 null mice
Effect of 11(3-FISD2 genotype (+/+ and -/-) on the mRNA expression in the medial amygdala (MeA)
of brain derived neurotrophic factor (BDNF). Expression levels were measured in one-week (P7),
two-week (P14) and three-week (P21) old mice by optical densitometry of in situ hybridisation
autoradiographs. Data are expressed as mean±SEM in arbitrary units and analysed by two-way
ANOVA; n=4-10 per group.
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11 |3-HSD2 Optical Density (AU)
Genotype P7 P14 P21
(a) Fkbp5 mRNA below below
+/+ 0.37±0.02 quantification quantification
0.39±0.03 threshold threshold
(b) BDNF mRNA
+/+ 0.32+0.01 0.32±0.03 0.39±0.01
-/- 0.27±0.04 0.38±0.02 0.33±0.03
Table 5.12 BIA mRNA expression of Fkbp5 and BDNF during pre-weaning period in 11(3-
HSD2 null mice
Effect of 11 p-HSD2 genotype (+/+ and -/-) on the mRNA expression in the basolateral amygdala
(BIA) of (a) FK506 binding protein 5 (Fkbp5) and (b) brain derived neurotrophic factor (BDNF).
Expression levels were measured in one-week (P7), two-week (P14) and three-week (P21) old mice
by optical densitometry of in situ hybridisation autoradiographs. Data are expressed as mean±SEM
in arbitrary units and analysed by (a) unpaired t-test or (b) two-way ANOVA; (a) n=5 and (b) n=4-9
per group.
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5.4 Discussion
Results described in the previous chapter point to heightened anxiety-related behaviour and
learning impairments in adult 11 (3-HSD2 null mice, indicative of lifelong programming
through overexposure to maternal GCs during fetal life. In addition to behavioural
alterations, studies in rat offspring subjected to prenatal stress (PS), DEX or CBX show
evidence of HPA axis hyperactivity characterised by enhanced CORT levels under basal
conditions and an exaggerated or a prolonged response to aversive situations (Levitt et al.,
1996; Weinstock et al., 1998; Vallee et al., 1999; Welberg et al., 2000; ORegan et al.,
2004). Altered central expression of HPA axis-associated transcripts in key GC feedback
sites, including the hippocampus, is thought to underlie this dysregulation, including
reduced expression of the corticosteroid receptors within the hippocampus (Henry et al.,
1994; Levitt et al., 1996; Koehl et al., 1999; Welberg et al., 2001). This reduction in
receptors will impair negative feedback regulation of the HPA axis and influence
emotionality and cognitive ability in the offspring. Enhanced forward drive on the HPA
axis through elevated CRH in the PVN and amygdala has also been reported (Welberg et
al., 2000; 2001) and may further contribute to the hyperactivity. We therefore investigated
the HPA axis and expression of HPA axis-associated genes, candidates for the altered
behaviour observed in the 11P-HSD2 null mutants.
In contrast to the HPA axis hyperactivity described above, plasma CORT levels were not
altered under basal or peak stress conditions in heterozygous-bred 11 (3-HSD2 null mice.
Furthermore, in adulthood there were no differences in the limbic expression of the
corticosteroid receptors or our other measured transcripts: CRH, AVP, Sgkl, Fkbp5 and
BDNF. It should be noted that a similar absence of altered HPA axis parameters has been
made in our laboratory in adult homozygous-bred 11 (3-HSD2 null mutants (Holmes et al.,
2006a). Thus, the putative altered maternal nurture provided by 11 p-HSD2 null mothers is
discounted from a role in programming the HPA axis. It is worth mentioning that we did
not assess the extended stress response and recovery to baseline. However, the unaltered
limbic expression of the corticosteroid receptors in adult 11 |3-HSD2 null mice makes
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alterations unlikely. Although GC programming of the HPA axis has been well
documented in rats, there have been fewer studies conducted in mice. Following a severe
PS paradigm (6-hr daily restraint; E8 until delivery), adult male ICR mice displayed normal
plasma CORT and adrenal weights (Chung et al., 2005). However, GR receptor density
within the limbic system was reduced and application of a postnatal chronic stressor
exacerbated abnormalities in HPA axis regulation and heightened anxiety (Chung et al.,
2005). A less severe prenatal stressor in Balb/c mice resulted in heightened anxiety and
decreased CRH mRNA within PVN of female offspring (Pincus-Knackstedt et al., 2006).
Unfortunately circulating CORT levels or corticosteroid receptor expression were not
measured and/or reported. Significant differences between rats and mice exist in the
regulation of CORT in the pregnant dam and the pre- and postnatal ontogeny of
corticosteroid receptors. Whilst the maternal CORT levels remain low throughout
pregnancy in the rat (Johnstone et al., 2000), pregnant mice experience a profound surge of
CORT towards term (Douglas et al., 2003; Holmes et al., 2003). In both species,
hippocampal MR mRNA expression was identified from around E15 onwards (Diaz et al.,
1998). However, in the murine hippocampus mRNA expression of GR was not detected
until the first few days of postnatal life (Schmidt et al., 2003; Speirs et al., 2004;
Noorlander et al., 2006), whilst GR is detected from midgestation onwards in the fetal rat
(Diaz et al., 1998). These differences may decrease murine susceptibility to prenatal GC
programming of the HPA axis and this should be kept in mind when comparing effects
between species.
In male 11 (3-HSD2 null mutants, we observed significant hypotrophy of the adrenal gland,
suggestive of HPA axis dysregulation. Reduced adrenal weight is indicative of decreased
activity of the HPA axis, although no change in circulating CORT was detected. Several
explanations could account for this observed HPA axis profile. Firstly, loss of 11(3-HSD2
results in apparent mineralocorticoid excess (AME), characterised by hypertension,
electrolyte imbalance and hypotonic polyuria, which could function to reset the HPA axis
in these mice. However, how this could occur is unknown. Secondly, mice may be less
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susceptible to programming of the HPA axis in general, as discussed above, or our
background strain (C57BL/6) may be more resistant to HPA axis dysregulation, as has been
observed in 11(3-HSD1 null mice (Carter et al., unpublished observations). Thirdly, loss of
the enzyme removes a key clearance pathway of CORT. Therefore a lower rate of
synthesis is required to maintain normal circulating levels. One would expect a smaller
adrenal gland to be reflected in reduced CORT response to acute stress, although we
observed similar stress levels to wild-type mice. Perhaps prenatally programmed HPA axis
hyperactivity is actually present in 11 [3-HSD2 null mice, as normal circulating CORT levels
are seen when a hypoactivity would be anticipated. The observation of programmed
behavioural alterations in the 11 (3-HSD2 null mice, independently of HPA axis
hyperactivity, does indicate that elevated adult GCs are not the primary determinant of the
anxiety phenotype. Interestingly, hypotrophy was only observed in the left adrenal gland.
Although not well studied, adrenal asymmetry has been noted by other investigators
(Droste et al., 2003; Perel'muter and Paderov, 2004). However, the reason for a selective
weight reduction on the left hand side is unknown. Left adrenal glands from 11P-HSD2
mutant females did not display significant hypotrophy, although were approximately twice
the size ofmales, a finding that correlates well with the roughly two-fold higher levels of
basal circulating CORT in female compared to male mice that we observed and has been
reported in the literature (Grad and Khalid, 1968). The apparent reduced sensitivity to 11 p-
HSD2 deletion in female mice is consistent with observations made on anxiety-like
behaviour.
We examined the HPA axis and associated gene expression profile during the first three
weeks of postnatal life. This represents a highly sensitive period in development, during
which events can determine lifelong programmed effects (Meaney, 2001; Levine, 2005).
Similar to adulthood, no alterations in circulating CORT under basal or stress conditions
were observed at two weeks of age (Holmes et al., 2006a), although we uncovered
significant changes in HPA axis-associated gene expression within the limbic system. The
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postnatal ontogeny of the corticosteroid receptors and CRH was found to be in general
agreement with previous studies in mice (Schmidt et al., 2003; Noorlander et al., 2006).
We detected MR mRNA expression in all hippocampal subfields at P7, the abundance of
which increased towards P21. However, 11P-HSD2 null mice displayed a significantly
altered developmental trajectory ofMR mRNA expression compared to wild-type mice.
The MR transcript was significantly elevated at P7 although only in the CA2 subfield. At
P14, increased expression of MR mRNA was seen in all but the CA3 subfield. We
observed GR mRNA expression at P7 although only in the CA1 subfield. Similar to MR,
11P-HSD2 null mice had an altered trajectory of GR ontogeny during the pre-weaning
period. Transient elevations in all hippocampal subfields were detected at P14 in 11(3-
HSD2 null mutants, whilst no changes were seen at P7 or P21 compared to wild-types.
Hippocampal elevations in GR mRNA have been observed previously following neonatal
handling of rat offspring. This increase was detected as early as P7 (Meaney and Aitken,
1985) and has been found to persist throughout adulthood (Meaney et al., 1992). Enhanced
GR within the hippocampus has been postulated to play a mechanistic role in the 'positive'
consequences of neonatal handling, which include a less reactive HPA axis, reduced
anxiety-like behaviour and prevention of age-related spatial memory impairment (Meaney
et al., 1989; Vallee et al., 1997). In contrast to the lifelong hippocampal modification of
GR mRNA expression following neonatal handling (which were opposite to those seen
following prenatal DEX), the alterations observed in the 11(3-HSD2 mutant mice were
transient and not apparent in adulthood. Prenatal CBX was also found to transiently elevate
hippocampal MR and GR in rat offspring at P7, although other pre-weaning ages were not
studied (Welberg, 1999). The explanation for, or indeed the downstream effects of, the
altered developmental trajectory are unclear.
The transient elevation in GR and MR is indicative of enhanced GC action in the
hippocampus during this period. The neonatal cerebellum has previously been studied in
llp-HSD2 null mice. An altered cerebellar growth trajectory was observed during the pre-
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weaning period in combination with a delay in developmental landmarks. Additionally,
11P-HSD2 null mutants were found to exhibit enhanced growth restriction following
neonatal CORT treatment (Holmes et al., 2006b). In contrast to the cerebellum which
displayed appreciable postnatal 11P-HSD2 mRNA expression (Roland et al., 1995b;
Robson et al., 1998), hippocampal expression was found to be restricted to fetal life (Brown
et al., 1996b; Diaz et al., 1998). Therefore, the hippocampal elevation of MR and GR
mRNA is unlikely represent a direct intracellular effect of enzyme loss. Several possible
explanations exist; it may be a result of prenatal GC overexposure and/or deficient pre- and
postnatal nurture by the 11|3-HSD2 null mother. Alternatively, the removal of CORT
breakdown and distorted GC metabolism may be responsible. The hippocampus is a region
that also exhibits considerable postnatal maturation (Leinekugel, 2003). Intricately
involved in this maturation is CORT, identified as an important regulator of neurogenesis
and neural development both in adulthood (Cameron and Gould, 1994), but also early
postnatal life (Gould et al., 1991).
Corticosteroid receptors have been shown to have contrasting effects on neurogenesis in the
hippocampus: whilst MR activation enhanced, GR activation inhibited neurogenesis in vivo
(Fischer et al., 2002; Avital et al., 2006) and in vitro (Yu et al., 2004). This makes the
relative balance of GR and MR an important functional determinant of CORT signalling,
particularly within the hippocampus (de Kloet et al., 1998; Meijer and de Kloet, 1998).
Fujioka et al. (2006) recently reported opposite effects of a mild or severe PS on
neurogenesis. Severe PS caused a GR-mediated inhibition, whilst mild PS resulted in a
MR-mediated enhancement of neurogenesis in the dentate gyrus of two week old rat
offspring indicating a profound impact of prenatal manipulation on the postnatal
hippocampus.
The net effect of the transient upregulation of both corticosteroid receptors in 11(3-HSD2
null mice is uncertain. We did not assess the hippocampal morphometry or proliferation
during the pre-weaning period in 11(3-HSD2 null mice although this will be important in
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identifying the functional consequences. The elevation of GR mRNA expression during
the second and third week of postnatal life suggests that neurogenesis and the development
of neuronal processes may have been inhibited. However, during this period MR was also
increased in 11 [3-HSD2 null offspring which could cancel out the GR-mediated effect on
neuronal maturation within the hippocampus. Elevations in the hippocampal transcripts of
Sgkl, Fkbp5 and BDNF were also detected in 11(3-HSD2 knockouts at P14. Sgkl and
Fkbp5 mRNA expression remained elevated at P21. The upregulation of these GC-
inducible genes at these time-points provides support for elevated hippocampal GC
signalling in llfi-HSD2 null mutants during the pre-weaning period. Whether these genes
are involved in the downstream effects of the transient elevations in GC signalling is
unknown. Whole brain Fkbp5 and Sgkl mRNA were found to be elevated in methyl-CpG
binding protein (Mecp2) null mice (Nuber et al., 2005). These mice displayed heightened
anxiety despite unaltered circulating CORT (a similar scenario to that observed in the lip-
HSD2 null mutant). The potential contribution of these GC-inducible genes to the
development of altered behaviour was postulated (Nuber et al., 2005).
Sgkl is involved in regulating cell surface expression of ion channels (Lang et al., 2003)
and is a key target of both MR and GR (Bhargava and Pearce, 2004). Therefore, the
transient upregulation may be a consequence of activation of either corticosteroid receptor
and could act to modulate neuronal excitability. Fkbp5 is induced by GR activation and
may feed back to suppress steroid hormone signalling (Cheung and Smith, 2000). Fkbp5
may therefore be involved in dampening the induction of GR, although we can only
speculate that it could be responsible for quenching the transient elevation we observed in
11P-HSD2 null mice. The question arises whether the transcriptional elevation we
observed in the pre-weaning period occurs as a direct result of the prenatal GC effects (and
possible downstream mediating effects on adult anxiety and cognitive behaviour) or as
compensation for them. BDNF is known to positively influence growth and differentiation
of neurones during development, being expressed in mice from E15 and peaking during
second postnatal week (Ivanova and Beyer, 2001). Transiently reduced hippocampal
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BDNF mRNA was observed at postnatal day (P) 5 in the neonatal rat hippocampus
following prenatal restraint (Van den Hove et al., 2006c). BDNF mRNA expression has
been found to be upregulated following aldosterone-mediated MR activation, and
downregulated following GR activation (Chao et al., 1998). Therefore, our observation of
elevated BDNF mRNA suggests a possible MR-mediated compensatory effect.
GCs and monoamine transmitter systems are known to exhibit reciprocal modulation
(reviewed in Chaouloff, 2000). It was beyond the scope of this thesis to study monoamine
systems in the 11(3-HSD2 null mutants, although alterations have been documented
following PS and DEX exposure and which could play a role in observed behavioural
phenotype (Takahashi, 1998). PS in mice elicited a transient decrease in intrahippocampal
5-HT levels, observed at P21 and 42 but not at P7 or 63 (Ishiwata et al., 2005).
Intriguingly, SSRI administration in the first three weeks normalised both the reduced 5-HT
levels and decreased spine densities within the CA3 subfield observed at postnatal day 21,
and prevented learning disability in the water maze seen during adulthood (Ishiwata et al.,
2005). Administration between week 4 and 6 did not correct the aforementioned prenatally
programmed deficits. These studies complement findings we have made in 11(3-HSD2 null
mutants and highlight the importance of the early postnatal development and alterations in
predetermining later behavioural effects.
Prenatal DEX and CBX treatment has previously been found to elicit alterations in
expression of HPA axis-associated genes within the PVN and amygdala (Welberg et al.,
2000; 2001). Throughout the first three weeks of life we observed a significant rise in GR
mRNA coupled with a slight, although non-significant, decrease in CRH mRNA expression
in the PVN at P21 in llfS-HSD2 null mutants. However, the levels of Fkbp5 and BDNF
mRNA expression were not affected, whilst Sgkl expression, similar to in adulthood, was
below our threshold of quantification. The amygdala is a key mediator of anxiety which is
positively influenced by stress and corticosteroids (Schulkin et al., 1994), possibly through
enhanced expression of CRH (Makino et al., 1994; Hsu et al., 1998). Prenatal DEX
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treatment lead to increased CRH mRNA in the amygdala (Welberg et al., 2001).
Furthermore, elevated CRH content of the amygdala has been observed in the rat (Cratty et
al., 1995) and mouse (Chung et al., 2005) following PS. Expression within the amygdala
regions in both the adult and early postnatal period was quantified, where possible.
However, we did not measure any alteration in transcript levels within these regions in the
11(3-HSD2 null mutant mice. Our results do not indicate any positive drive to the HPA axis
as a consequence of 11 (3-HSD2 deletion.
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In summary we observed transient elevations of corticosteroid receptors and GC-inducible
transcripts in 11(3-HSD2 null mutants during the early postnatal period. We postulate that
elevated GC signalling during this critical developmental stage may inhibit neurogenesis
and maturation of neuronal processes, later reflected in altered anxiety-related and
cognitive behaviour in adulthood. Fetal GC overexposure may have programmed the
altered developmental trajectory of the limbic system, particularly the hippocampus rather
than hardwiring it prenatally. The offspring used to study the postnatal maturation of the
limbic system were bred through homozygous matings. Therefore, maternal care and
nutrition provided by the 11 [3-HSD2 mutant mother could play a significant part in the
observed deficits, in addition to the excess GC milieu during fetal life. It would be
interesting to follow-up our studies in offspring bred through heterozygous matings to
identify the relative contribution of altered maternal nurture to our observations. A
significant limitation of using 11P-HSD2 null mice with global enzyme deletion is that the
effects of enzyme deficiency during fetal life cannot be dissociated from the obvious AME
in these mice. This is especially pertinent in the study of the HPA axis where removal of
the CORT inactivation pathway may mask any prenatally determined effects. This removal
will prevent the accumulation of 11 (5-HSD1 substrate, 11-dehydrocorticosterone (11-DHC)
and prevent the normal intracellular CORT regeneration and amplification of signalling,
thus generating a state of 11(3-HSD1 pseudo-inhibition and local CORT hypoactivity. The
consequence of this will be discussed further in Chapter 7. Tissue-specific mutations will
allow for the investigation of perinatally programmed effects, independent of additional
deletion of the enzyme during adulthood. This will be a crucial step in confirming the
locus of GC actions responsible for our observed findings.
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6.1 Introduction
Although the main emphasis of this thesis is on the HPA axis, brain and behaviour we
made observations during the course of our studies on a metabolic phenotype of llp-HSD2
null mice, which may be relevant to the programmed phenotype. However, the results
presented in this chapter really express a 'snapshot', demonstrating the importance of this
model for future work. Prenatal dexamethasone (DEX) administration has previously been
reported to programme hypertension, hyperglycaemia and impaired glucose tolerance in
adult offspring (Nyirenda et al., 1998; 2001; 2006; O'Regan et al., 2004; Drake et al.,
2005). The impaired glycaemic control is thought to be mediated through elevated GC
signalling within the liver by heightened basal circulating plasma corticosterone (CORT)
levels and/or enhanced hepatic glucocorticoid receptor (GR) mRNA expression (Nyirenda
et al., 1998; 2001). Induction of the GC-regulated rate-limiting enzyme of
gluconeogenesis, phosphoenolpyruvate carboxykinase (PEPCK) is thought to underlie this
(Nyirenda et al., 1998; 2001; O'Regan et al., 2004; Drake et al., 2005) as glucose uptake
into the muscle or adipose tissue was found to be unaffected by prenatal DEX treatment
(Cleasby et al., 2003a). Altered body composition was identified in DEX-treated offspring
which displayed a 'lean' phenotype of reduced epididymal fat depot weight at 7-8 months
of age (Cleasby et al., 2003a). Elevated GR mRNA expression was observed in this depot,
although not in subcutaneous fat. Lipoprotein lipase (LPL) mRNA is known to be
positively regulated by GCs and insulin (Fried et al., 1993; Oliver and Rogers, 1993).
However, LPL mRNA expression was reduced in prenatal DEX epididymal fat (Cleasby et
al., 2003a), suggesting this effect may be a secondary to elevated CORT and adipose GR,
perhaps as a consequence of insulin resistance (Nyirenda et al., 1998). LPL overexpression
has been seen to drive lipid accumulation in adipose depots (reviewed in Montague and
O'Rahilly, 2000). Therefore, the reduction in LPL mRNA could contribute to the decreased
adiposity through reduced fatty acid uptake from plasma.
11 p-hydroxysteroid dehydrogenase type 1(11 (3-HSD1) mRNA expression within the body
is widespread. The highest transcript and activity levels have been observed in the liver,
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although abundant expression has also been seen in the brain and adipose tissue (Monder
and Lakshmi, 1990; Rajan et al., 1995). Through the local regeneration of CORT, 11(3-
HSD1 plays a key role in the amplification of GC signalling within these tissues. Obese
humans and several rodent models ofmonogenic obesity have displayed elevated 11(3-
HSD1 mRNA expression and enzyme activity within adipose tissue (Livingstone et al.,
2000a; 2000b; Rask et al., 2001; 2002; Lindsay et al., 2003). The generation and study of
transgenic mice has been invaluable in exploring the role of the enzyme in metabolic
balance. 11 [3-HSD1 null mutant mice displayed a 'cardioprotective' metabolic profile,
characterised by increased hepatic and adipose insulin sensitivity, glucose tolerance, a
favourable lipoprotein profile and resistance to increased weight gain following a high fat
diet, even despite hyperphagia (Morton et al., 2001; 2004a). Although 11 (3-HSD1 mutant
mice had adrenal hyperplasia and elevated circulating levels of CORT, they resisted
hyperglycaemia upon high-fat diet (HFD) or stress challenge (Kotelevtsev et al., 1997).
Adipocyte-specific overexpression of 11 [3-HSD1 in transgenic mice resulted in a modest
increase in GC regeneration but with marked metabolic changes. These mice displayed
hypertension (Masuzaki et al., 2003), central obesity, glucose intolerance and insulin-
resistant diabetes (Masuzaki et al., 2001). These findings recapitulate those observed in the
clinical 'metabolic syndrome' supporting the involvement of excess GC signalling in the
disorder. Whilst circulating CORT levels were normal, those in the portal blood were
elevated approximately three-fold (Masuzaki et al., 2001) suggesting the locus of effect
may include the liver in addition to adipose tissue. The involvement of increased intra¬
hepatic GC levels was explored through the generation and subsequent investigation of
liver-specific 11P-HSD1 overexpressing transgenic mice. These mice were not found to
exhibit obesity, but displayed more subtle alterations ofmetabolism including
hypertension, insulin resistance, fatty liver and dyslipidemia (Paterson et al., 2004).
However, no elevation in hepatic PEPCK mRNA was observed indicating that there was no
major activation of the gluconeogenic pathway, despite elevated intrahepatic GC
regeneration (Paterson et al., 2004). More recently, a transgenic mouse with adipocyte-
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specific expression of the human 11 [3-HSD2 gene was created, resulting in appreciable
CORT inactivation in fat depots where normal endogenous levels of the enzyme are
minimal (Kershaw et al., 2005). These mice displayed a similar phenotype to the 1113-
HSD1 deficient mouse (Morton et al., 2004a), resisting weight gain on a HFD and
displaying reduced fat mass, improved glucose tolerance and insulin sensitivity although
food intake was decreased (Kershaw et al., 2005), in contrast to the hyperphagia observed
as a result of 11(3-HSD1 deficiency (Morton et al., 2001). This discrepancy was later
explained by alterations in the hypothalamic appetite and energy expenditure pathways in
lip-HSDl null mutant mice (Densmore et al., 2006). Findings from studies investigating
11 (3-HSD transgenic mice have been consistent with a positive correlation between
intracellular CORT and detrimental metabolic consequence, including obesity and the
dysregulation of glycaemic control.
11(3-HSD2 null mutant mice could display alterations in their metabolic phenotype, similar
to either prenatal DEX-treated offspring or in 11(3-HSD1 null mutant mice, as a
consequence of prenatal GC overexposure and adult lip-HSDl pseudo-inhibition (lip-
HSD2 null mice lack 11-dehydrocorticosterone (11-DHC), the substrate for lip-HSDl).
Also, they have altered GC kinetics which may affect GC regulation ofmetabolism.
Therefore, we aimed to study the metabolic profile resulting from global 11P-HSD2
deletion. Although we were not able to obtain a comprehensive picture of this metabolic
profile within 11P-HSD2 null mutants we have analysed the regional fat distribution,
spontaneous voluntary activity, glucose tolerance and the expression of several GC-
regulated genes within the liver and epididymal adipose tissue.
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6.2 Methods
Comprehensive details of methods can be found in chapter 2.
6.2.1 Heterozygous-bred 11P-HSD2 null animal maintenance
Mice were bred and maintained in the biological research facility (BRF) at the Western
General Hospital (WGH). Male and female 11J3-HSD2 heterozygous mice were pair-
housed in breeding cages and left undisturbed until parturition. Cages were checked daily
between 09.00 and 11.00 h for delivery of litters. Following delivery, pups were counted
and sexed. Litters were then left undisturbed until weaning at postnatal day (P) 21, ear-
notched (for identification and genotyping), housed in single-sex groups of 2-6 and left
undisturbed until testing in the water maze (see Chapter 4), apart from routine cage
maintenance. Following testing at an approximate age of 8 months, mice were culled and
tissue (fat: epididymal, subcutaneous, mesenteric; liver) was dissected and rapidly frozen
on dry ice. A small section of liver was collected in HEPES/sucrose buffer and kept on ice,
until the sample was homogenised and protein extracted (see below). Prior to storage at -
80°C fat samples were weighed.
Male and female mice from which fat samples were obtained at 3 months of age were 11(3-
HSD2 heterozygous-bred and maintained in the BRF at Little France (LF). These mice had
previously been subjected to a battery of behavioural testing (see Chapter 4; cohort three).
Male mice studied for their spontaneous activity at 4 months and dynamic glucose response
at 6 months of age had also been subject to a variety of behavioural tests (see Chapter 4;
cohort two).
6.2.2 Wheel running
Adult male mice were single housed in wheel running cages and allowed to habituate to the
novel environment for a week. Activity was recorded for one week and data averaged for
this period.
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6.2.3 Glucose tolerance test
Adult male mice were fasted overnight (16 hrs) and weighed before and after the fasting
period. Following the fast, subjects were given an intraperitoneal injection of D-glucose
(2mg/g body weight in saline). Blood samples (15-20pl) were taken by tail venesection
into EDTA-coated Microvette tubes at 0 min (just prior to glucose injection) and at 5,15,
30, 60 and 120 mins following glucose load. Blood samples were centrifuged (lOOOg for
10 mins at 4°C), plasma supernatant collected and stored at -20°C until glucose levels were
assayed.
6.2.4 Hepatic PEPCK enzyme activity
Hepatic tissue was homogenised in HEPES/sucrose buffer and protein was extracted
following centrifugation. Protein concentration was assayed using a Bio-Rad protein assay
kit and lmg protein was used in each reaction. The reaction mixture was incubated for 3
min at 30°C prior to measurement of absorbance at 340 nm in the spectrophotometer. The
absorbance drop reflects the breakdown of NADH and is proportional to PEPCK enzyme
activity.
6.2.5 Real-time PCR and northern analysis
RNA was extracted from liver and adipose samples by two different methods, appropriate
to the properties of the individual tissues. RNA was quantified by GeneQuant prior to
Northern analysis and Quant-iT for real-time PCR. Liver and adipose RNA samples were
run by real-time PCR using probes for the following mRNA: PEPCK, GR, 11P-HSD1 and
lipoprotein lipase (LPL). Gene expression was corrected for RNA loading using a probe
for TATA binding protein (TBP) as an internal control.
Probes for PEPCK and llbeta-HSDl were radiolabelled with 32P and used to quantify the
hepatic expression by Northern analysis. Gene expression was corrected for RNA loading
using a probe for ribosomal 18S RNA as an internal control. Expression data are presented
in arbitrary units relative to control (11P-HSD2+/+ = 1.0).
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6.2.6 Glucose assay
Glucose was determined by an enzymatic method using the Infinity Glucose Hexokinase
Liquid Stable Reagent.
6.2.7 Statistical analysis
Data are expressed as mean±SEM. Comparisons between genotype were analysed by
unpaired t-test, one-way analysis of variance (ANOVA) or two-way repeated measures
ANOVA, with Student Newman-Keuls (SNK)post-hoc testing, where appropriate.
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6.3 Results
6.3.1 Adipose depot weight
The weight of each individual fat depot was compared between 11|3-HSD2 genotypes by
one-way ANOVA with SNK post-hoc testing.
(a) 3 month old males (b) 3 month old females
Epi SubQ Mes Epi SubQ Mes
Fat Depot Fat Depot




Figure 6.1 Adipose depot weights in adult 11P-HSD2 transgenic mice
Effect of 11(3-HSD2 genotype (+/+ H, +/- S3, -/- D) on the epididymal (Epi) (or perigonadal in
females), subcutaneous (SubQ) and mesenteric (Mes) adipose depot weights in (a) 3 month old
males, (b) 3 month old females and (c) 8 month old males. Data are expressed as meantSEM in
mg relative to body weight (g) and analysed by one-way ANOVA with Student Newman-Keuls
(SNK) post-hoc testing; (a) n=9-12, (b) n=6-11 and (c) n=8-10 per group. +p<0.001, #p<0.01,
*p<0.05
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The weight of the epididymal (or perigonadal in females) fat depot was found to be
significantly altered by genotype in both male (Figure 6.1a; F2,28=8.40, p<0.001) and
female (Figure 6.1b; F2,23=3.66, p<0.05) three month old mice. 11[3-HSD2-/- mice of both
genders had a significantly smaller epididymal or perigonadal fat depot weight compared to
+/+ and +/- (male: p<0.01; female: p<0.05). However, no difference was observed between
genotypes in the weight of the subcutaneous or mesenteric adipose depots at three months
in either males or females. In contrast, in male mice at eight months of age, all three depots
were found to be different according to genotype (Figure 6.1c; epididymal: F2,24=10.24,
p<0.001; subcutaneous: F2;24=5.61, p<0.01; mesenteric: F2>24=4.69, p<0.05). Thus, the fat
depot weight, relative to body weight, was reduced in 11 (3-HSD2-/- mice compared to both
+/+ and +/- in the epididymal (p<0.001), subcutaneous (+/+: p<0.01; +/-: p<0.05) and
mesenteric depots (p<0.05). 11 [3-HSD2-/- mice appear to display a 'lean' phenotype,
although body weight was not significantly different in adulthood as illustrate by the
unaltered pre-fast weight measured (Table 6.1).
Table 6.1 Body weights of 6
month old male 11P-HSD2
transgenic mice prior to
and following a 16-hr fast
Effect of 11 (3-HSD2 genotype
(+/+ and -/-) on the body
weight of adult male mice
before and after a 16-hr fast.
Data are expressed as mean±SEM and analysed by unpaired t-test; n=8 per group. *p<0.05
6.3.2 Wheel running activity
Comparative analysis of wheel running activity between 11(3-HSD2-/- and +/+ were made
by unpaired t-test. The average daily wheel running activity was significantly reduced in
11P-HSD2-/- compared to +/+ mice (Figure 6.2, p<0.05). Both genotypes were
significantly more active in the dark period, but during both the light and dark periods -/-
mice travelled significantly less on the wheels compared to +/+ (p<0.05). Therefore, our
results indicate 11 (3-HSD2-/- mice display a hypoactivity in voluntary spontaneous
exercise.
11P-HSD2 Pre-fast Post-fast Weight
Genotype weight (g) weight (g) loss (g)
+/+ 31.6±0.6 27.9+0.7 3.7±0.2
-/- 30.6±0.5 25.8±0.5* 4.7±0.2*
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Figure 6.2 Wheel running activity in 4 month
old male 11P-HSD2 transgenic mice
Effect of 11P-HSD2 genotype (+/+1, -/- D) on
wheel running activity during the daily cycle,
divided into the light and dark periods. Data are
expressed as meaniSEM and analysed by
unpaired t-test; n=6 per group. *p<0.05
Total Light Period Dark Period
6.3.3 Adipose gene expression measured by real-time PCR
Relative gene expression of PEPCK in epididymal adipose tissue was altered by genotype
(Figure 6.3; F2,i7=3.94, p<0.05). Both 11 (3-HSD2+/- and -/- groups had significantly
elevated levels of PEPCK mRNA expression compared to +/+ (p<0.05), whilst +/- and -/-
were not statistically different (p=0.977). There was no significant difference between
genotypes for expression ofGR, 11 [3-HSD1 or LPL.
3.0 n
PEPCK GR 11beta-HSD1 LPL
Figure 6.3 Epididymal adipose tissue mRNA expression measured by real-time PCR in 8
month old male 11P-HSD2 transgenic mice
Effect of 11P-HSD2 genotype (+/+ I, +/- 0, -/- D) on the epididymal adipose tissue expression of
phosphoenolpyruvate carboxykinase (PEPCK), glucocorticoid receptor (GR), 11 beta-hydroxysteroid
dehydrogenase type 1(11 beta-HSD1) and lipoprotein lipase (LPL) mRNA. Data are expressed as
mean±SEM corrected for expression of the housekeeping gene TATA binding protein (TBP) and
relative to +/+ = 1.0. Data are analysed by one-way ANOVA with SNK post-hoc testing; n=5-8 per
group. *p<0.05
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6.3.4 Hepatic gene expression and PEPCK enzyme activity
There was no significant difference in the hepatic mRNA expression of PEPCK, GR, 11 [3-
HSD1 and LPL as measured by real-time PCR (Figure 6.4a). In addition, neither PEPCK
nor 1 ip-HSDl mRNA was found to be altered by genotype when expression was measured
by Northern analysis (Figure 6.4b). PEPCK enzyme activity was also not found to be
different between genotypes (Table 6.2).
(a) Gene expression measured by real-time PCR Figure 6.4 Hepatic mRNA
expression measured by real¬
time PCR and Northern
analysis in 8 month old male
11 (J-HSD2 transgenic mice
Effect of 11P-HSD2 genotype (+/+






dehydrogenase type 1 (Hbeta-
HSD1) and lipoprotein lipase
(LPL) mRNA as measured by (a)
real-time PCR and PEPCK and
11beta-HSD1 as measured by (b)
Northern analysis. Data are
expressed as mean±SEM
corrected for expression of the
housekeeping gene (a) TATA
binding protein (TBP) or (b)
ribosomal 18S (18S) relative to
+/+ = 1.0. Data are analysed by
one-way ANOVA with SNK post-
hoc testing; (a) n=5-9 and (b)
n=7-10 per group.












Table 6.2 Hepatic PEPCK enzyme activity in 8
month old male 11p-HSD2 transgenic mice
Effect of 11P-HSD2 genotype (+/+, +/- and -/-)
on the activity of the phosphoenolpyruvate
carboxykinase (PEPCK) enzyme in hepatic
tissue homogenates from adult male mice. Data
are expressed as meanlSEM in nmol/min/mg
protein and analysed by one-way ANOVA with
SNK post-hoc testing; n=6-8 per group.
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6.3.5 Dynamic glucose response to intraperitoneal glucose load
When plasma glucose levels were assessed immediately prior to and 5, 15, 30, 60 and 120
mins following an intraperitoneal glucose injection there was no difference between 11 (3-
HSD2+/+ and -/- mice either at any timepoint or over the entire period (Figure 6.5;
Fi,47= 1.22, p=0.285) as analysed by two-way repeated measures ANOVA. There was no
difference in body weights immediately prior to the fast (p=0.215). However, intriguingly
11|3-HSD2-/- mice lost significantly more weight during the 16-hr fast (Table 6.1; p<0.05)
such that they were smaller (p<0.05) prior to the glucose injection and tolerance test. 11(3-
HSD2-/- mice appear to have heightened sensitivity to starvation induced weight loss,



























Figure 6.5 Dynamics of glucose disposal in a glucose tolerance test in 6 month old male 11 (3-
HSD2 transgenic mice
Dynamics of glucose disposal upon intraperitoneal glucose injection (2mg/kg body weight) following
a 16-hr fast in adult male wild-type (•) and 11P-HSD2 null (O) male mice. Data are expressed as
mean±SEM and analysed by two-way repeated measures ANOVA with SNK post-hoc testing; n=5-
8 per group.
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6.4 Discussion
Metabolic dysfunction has previously been observed in rats following prenatal DEX
exposure (Nyirenda et al., 1998; 2001; 2006; Cleasby et al., 2003a; O'Regan et al., 2004;
Drake et al., 2005) and lip-HSDl transgenic mice (Kotelevtsev et al., 1997; Masuzaki et
al., 2001; 2003; Morton et al., 2001; 2004a; Paterson et al., 2004). In this Chapter we
present findings from initial investigations into the metabolic consequence of 11 (3-HSD2
null deletion.
We measured the accumulation of body fat in male and female mice at 3 months and from
males at 8 months of age. At the younger age 1 lp-HSD2 knockout mice of both genders
had a significantly reduction in epididymal (or perigonadal in females) depot weight,
although the subcutaneous and mesenteric pads appeared normal in size. However, by 8
months of age all three measured depots were significantly lighter in 11P-HSD2 null males
(females were not assessed). The specific explanation for this reduction in fat depot mass is
unclear, although could be due to one or more of the following:
1.) Local alterations in GC action due to the loss of 11P-HSD2
2.) Local alterations in GC action due to loss of the 11-DHC substrate for lip-HSDl
3.) Prenatal GC programmed effect
4.) Altered appetite and feeding behaviour or energy expenditure
6.4.1 Local alterations in GC action due to the loss of 11P-HSD2
Until recently, the 11P-HSD2 enzyme was not thought to be expressed in adipose tissue
(Walker, 2004). However, several groups have detected 11P-HSD2 mRNA within adipose
tissue from rats (Milagro et al., 2007), mice (Kershaw et al., 2005) and humans (Engeli et
al., 2004) using real-time PCR, albeit at a much lower expression level than lip-HSDl.
Milagro et al. (2007) observed a significant increase in both GR and 11P-HSD2 mRNA
expression following a HFD, although only in subcutaneous and not retroperitoneal fat.
The investigators postulated that the increased 11P-HSD2 may play a compensatory or
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protective role against adiposity. Transgenic overexpression of llp-HSD2 in adipocytes
has been observed to mediate improved glucose tolerance, insulin sensitivity and a
resistance to HFD-induced adiposity (Kershaw et al., 2005). The presence of 11(3-HSD2 in
adipocytes is still controversial and as a result of a low level of expression 11 (3-HSD2
probably does not play a significant role in intra-adipose CORT metabolism. A direct
effect of enzyme loss from these cells is therefore unlikely to explain the reduced adiposity
we observed in the 11(3-HSD2 null mutant mice.
6.4.2 Local alterations in GC action due to loss of the 11-DHC substrate for
11P-HSD1
In the 11P-HSD2 null mutants the functional loss of the enzyme from the kidney removes a
key pathway of CORT clearance, via breakdown of the active steroid to its inert metabolite
11-DHC. This inactive metabolite is thought to be the sole substrate for 11 p-HSD l -
mediated CORT regeneration and the subsequent intracellular amplification of GC action
(Paterson et al., 2005). As evidenced by mutation and tissue-specific overexpression of
11 p-HSDl, this amplification of CORT is a key component of GC action and integral to its
regulatory role in adipose and liver metabolism. Thus 11 [3-HSD2 null mutants, that lack
the 11-DHC substrate pool, display 11 p-HSDl pseudo-inhibition. The result of this will be
a downregulation of local GC signalling despite the 'normal' circulating levels of CORT
we observed in 11P-HSD2 null mutants (see Chapter 5). Therefore, the 11P-HSD2 null
mutant may be expected to bear similarities to 11 P-HSDl knockout mice and mimic an
11P-HSD double knockout, despite the opposite functional in vivo directionality of the
enzymes.
11 P-HSDl null mutants were found to be resistant to HFD-induced weight gain despite
hyperphagia and displayed a favourable lipoprotein profile, increased hepatic and adipose
insulin sensitivity and improved glucose tolerance (Kotelevtsev et al., 1997; Morton et al.,
2001; 2004a). These findings were observed in the face of elevated circulating levels of
CORT, thought to be caused by impaired negative feedback of the HPA axis in the
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hippocampus through lower intraneuronal CORT levels due to lack of 11-DHC reactivation
(Yau et al., 2001).
6.4.3 Prenatal GC programmed effect
It is possible that the 'lean' phenotype of the 11 (3-HSD2 knockout mutants can be attributed
to prenatal overexposure to GCs, a hypothesis we wish to investigate further. Final
trimester DEX administration to pregnant rats led to offspring which displayed a reduced
epididymal fat weight at 7-8 months of age. This was found in combination with elevated
retroperitoneal GR and reduced LPLmRNA expression (Cleasby et al., 2003a). Combined
with HPA axis hyperactivity that has been reported in prenatally DEX programmed
offspring these findings suggest that the elevated GC signalling is central to the 'lean'
phenotype observed. However, LPL is known to be positively regulated by GCs (Oliver
and Rogers, 1993) suggesting that the reduced LPL mRNA expression may be mediated
through the insulin resistance observed (Nyirenda et al., 1998). In contrast to findings in
prenatal DEX rats, 11 (3-HSD2 null mice displayed unaltered circulating CORT levels and
no change in GR mRNA expression levels in epididymal adipose tissue. Furthermore, the
expression of lip-HSDl and LPL mRNA was not different in the 11P-HSD2 null mutants.
However, the expression of PEPCK mRNA was significantly elevated which we shall
discuss later.
6.4.4 Altered appetite and feeding behaviour or energy expenditure
In order to assess the spontaneous activity of our 11 (3-HSD2 null male mice we exposed
them to wheel running cages. We found the 11 (3-HSD2 knockout males to be significantly
hypoactive. Thus, increased energy expenditure does not appear to underlie the reduced
adiposity in our mice. However, the spontaneous hypoactivity could be an outcome of
reduced energy availability due to decreased adiposity. Alternatively, the hypoactivity may
reflect an, as yet unidentified, dysregulation in energy homeostasis, even though glucose
levels appear to be maintained during starvation and is normally tolerated following
glucose loading. It is possible that the hypoactivity may be indicative of and mediated
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through GC programming in the brain. However, prenatally CORT-treated rats display
long-term spontaneous hyperactivity, associated with altered dopamine-mediated motor
responses (Diaz et al., 1997). More recently, mice subject to prenatal stress were found to
be hyperactive in spontaneous wheel running, an effect associated with alterations in the
midbrain dopaminergic system suggestive of a hyperfunctional state (Son et al., 2007). We
did not investigate the central dopaminergic system in our studies, although in adults we
observed no change in corticosteroid receptors or CRH mRNA expression in limbic regions
(see Chapter 5). We did not monitor the feeding behaviour in the 11(3-HSD2 null mice.
11P-HSD1 knockout mice were found to resist HFD-induced weight gain despite
hyperphagia (Morton et al., 2004a). Alterations in the hypothalamic appetite and energy
expenditure pathways in llp-HSDl null mutant mice were later found to underlie these
observations (Densmore et al., 2006). As described above, due to the lip-HSDl pseudo-
inhibition it is possible that the 1 lp-HSD2 null mice may have similar differences in the
central regulation of appetite and energy expenditure, which could be responsible, at least
partially, for the lean body composition we observed.
As previously mentioned, fat depot weight was reduced in all the measured adipose pads in
11 (3-HSD2 null males at 8 months, although only the epididymal pad was significantly
lighter at 3 months of age. The epididymal (or perigonadal in females) depot-specific
decrease in fat accumulation at 3 months of age may reflect a heightened sensitivity of this
pad to the consequence of global 11P-HSD2 deletion. In mice, both the mRNA expression
and activity of 11 p-HSDl was found to be highest in subcutaneous, followed by
epididymal and then lowest in mesenteric adipose tissue (Morton et al., 2004b). In spite of
this, intra-adipose CORT levels were not found to vary between depots (Masuzaki et al.,
2001), although were significantly decreased in 11P-HSDl null mice to a similar degree in
both the visceral and epididymal depots (Morton et al., 2004a). However, on normal chow
11P-HSDl null mice had a decreased epididymal, but not mesenteric depot size (Morton et
al., 2004a). Thus, it appears possible that the epididymal depot may be more sensitive than
the mesenteric and subcutaneous depots to the postulated reduced intra-adipose CORT
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action in 11|3-HSD2 null mutants. Nevertheless, at 8 months all the depots were
significantly lighter in llp-HSD2 null mutants suggesting that the mesenteric and
subcutaneous depots are also sensitive. It should be noted though that the interpretation of
these findings is confounded by the fact that the two separate cohorts of mice were bred and
studied in different biological research facilities where the normal chow differed in
composition (see Chapter 4).
Whilst the relative size of the adipose depots were found to be smaller in the 11P-HSD2
knockout mice these animals were not found to be smaller in adulthood with catch-up
growth having been achieved at an early age (see Chapter 4). However, these mice did lose
a greater proportion of body weight (15.5% vs 11.8%) during a 16-hr fast. This impaired
ability to maintain body weight under fasting conditions is intriguing. As has been
mentioned previously in this thesis 11P-HSD2 null mice have hypotonic polyuria,
electrolyte imbalance and hypertension, as a consequence of apparent mineralocorticoid
excess (AME) through illicit activation ofMR within the kidney (Kotelevtsev et al., 1999).
It is possible that the hypotonic polyuria removes nutrients from these mice. One could
postulate that 11 (1-HSD2 knockout mice maintain body weight under normal conditions
through increased food intake. In such a situation, the removal of food would exacerbate a
proportionately greater loss of weight in the 11 [1-HSD2 null mutants compared to wild-type
mice. This is however speculation and food intake in these animals should be monitored
and recorded to support or reject this possibility.
6.4.5 Role of PEPCK in tissues
PEPCK is a GC-regulated enzyme that is expressed in several tissues including the liver
and fat, although there are distinct tissue-specific differences in function and regulation
(Hanson and Reshef, 1997). Within hepatocytes PEPCK is the rate limiting enzyme in
gluconeogenesis and catalyses the de novo synthesis of glucose from precursors (Barthel
and Schmoll, 2003). During periods of starvation this is a central mechanism in
maintaining circulating glucose levels. Within adipocytes, which are unable to synthesise
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glucose, PEPCK functions as the rate-limiting enzyme in the process of glyceroneogenesis
(Hanson and Reshef, 2003). In both tissues, PEPCK is induced by starvation signals and
inhibited by insulin, although GCs have tissue-specific regulation of the enzyme in opposite
directions. Whilst GCs induce PEPCK expression within the liver (Sasaki et al., 1984),
they inhibit it within adipose tissue (Nechushtan et al., 1987). Thus, dysregulated
intracellular GC action could have effects upon metabolism through the concert of opposite
effects upon PEPCK in the adipose and hepatic tissues.
6.4.5.1 PEPCK mRNA expression in adipose tissue
Despite unaltered expression ofGR and 11 fi-HSDl mRNA, we observed an upregulation of
PEPCK mRNA expression within epididymal fat in the 11(3-HSD2 null mice. This
elevation in PEPCK mRNA is consistent with a reduction in GC-mediated suppression
within adipocytes. Thus, the reduced intra-adipose GC levels through the postulated 11(3-
HSD1 pseudo-inhibition may underlie this observation. The PEPCK enzyme determines
the rate of free fatty acid (FFA) re-esterification in adipose tissue by regulating the
availability of the glycerol 3-P substrate (reviewed in Hanson and Reshef, 2003). PEPCK
overexpression in adipose tissue in transgenic mice led to the increased FFA esterification,
higher adipocyte size, increased fat mass and body weight (Franckhauser et al., 2002). In
contrast, the transgenic ablation of PEPCK in adipose tissue resulted in reduced adipose
tissue size and fat content in mice (Olswang et al., 2002). Therefore, the induction of
PEPCK is not likely to explain the reduced adipose mass in the epididymal depot, but may
be involved in a compensatory mechanism due to the reduced adipose depot size. We also
detected an increase in PEPCK mRNA expression in 11 [3-HSD2 heterozygous mice,
despite no change in the epididymal fat depot mass in this genotype. This finding is
therefore difficult to reconcile and may have represented an anomaly.
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6.4.5.2 Glucose homeostasis and hepatic PEPCK mRNA expression and
activity
When we investigated the fasting glycaemia and glucose tolerance in our mice, we
observed no differences in either parameter. Furthermore, despite postulated lower
intracellular CORT levels in 11 (3-HSD2 knockout mice there were no differences in hepatic
PEPCK, GR or 11 (3-HSD1 mRNA expression. In addition, the enzyme activity of PEPCK
was also unchanged. The hepatic PEPCKmRNA expression and activity were enhanced in
prenatal DEX-treated offspring (Nyirenda et al., 1998; 2001; O'Regan et al., 2004), an
effect which has even displayed intergenerational inheritance (Drake et al., 2005).
However, these offspring also displayed elevated basal circulating CORT, opposite to the
postulated intracellular CORT hypoactivity in 11[1-HSD2 knockout mice. We might have
anticipated a down-regulation of PEPCK as the enzyme is known to be positively regulated
by GC in liver (Sasaki et al., 1984). However, 11P-HSD1 knockout mice had no
differences in basal expression or activity, although in a fasted state they displayed reduced
induction of PEPCK, associated with improved glucose tolerance (Kotelevtsev et al., 1997;
Morton et al., 2001). Unaltered glucose tolerance in our studies in 11P-HSD2 knockout
mice would argue against dysregulation of PEPCK following fasting, although this remains
to be confirmed. The importance of gluconeogenesis, and its key rate-limiting enzyme
PEPCK, in maintaining normal glycaemic control has been undermined by findings
obtained in hepatocyte-specific PEPCK null mutants. These mutants displayed markedly
impaired gluconeogenesis, although they were able to maintain near-normal glucose
kinetics (She et al., 2003; Burgess et al., 2004). However, when hepatic PEPCK is
approximately 2-fold overexpressed, mice display glucose intolerance and
hyperinsulinaemia (Sun et al., 2002). These findings suggest that whilst of minimal
importance in maintaining basal glucose levels, PEPCK and the gluconeogenic pathway
play a more integral role in upregulating, rather than limiting, glucose output. Thus,
PEPCK may be more susceptible to induction in situations of GC excess and insulin
resistance rather than suppression in opposite circumstances.
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6.4.6 Summary
We have observed that 11(3-HSD2 knockout mice display a 'lean' phenotype of decreased
fat storage in several distinct depots, which was seen in combination with increased fast-
induced weight loss and spontaneous hypoactivity. Adipose PEPCK, a key regulator of
glyceroneogenesis and fatty acid re-esterification was elevated suggestive of intra-adipose
GC hypoactivity, although this probably not a mediator of the reduced fat deposition. The
metabolic phenotype of the 11P-HSD2 null mutant is likely to be an interplay between
three features, which may be complimentary or contradictory depending on the tissue
studied. The first aspect is the prenatal overexposure to GCs through removal of the feto¬
placental 11P-HSD2 'barrier'. The second factor will be the 11P-HSD1 pseudo-inhibition
due to the removal of 11-DHC and subsequent loss of intracellular CORT regeneration.
Lastly, the AME adds an additional factor into the 11P-HSD2 mutant mouse equation, in
which the contribution of the hypotonic polyuria, electrolyte imbalance and hypertension is
difficult to quantify. The 'lean' adipose tissue distribution may thus reflect the
complimentary effect of prenatal GC programming and 11P-HSD1 inhibition as both
prenatal DEX and 1 lp-HSDl null mutation were seen to reduce fat deposition (Cleasby et
al., 2003a; Morton et al., 2004a). In hepatic glucose regulation prenatal DEX was observed
to yield glucose intolerance, hyperglycaemia and insulin resistance associated with
enhanced PEPCK and gluconeogenesis (Nyirenda et al., 1998; 2001), whilst lip-HSDl
null mutation improved glucose tolerance, insulin sensitivity and reduced stress or HFD
induction of PEPCK (Kotelevtsev et al., 1997; Morton et al., 2001). Therefore, we propose
that the normal glycaemic control following 11P-HSD2 null mutation may reflect the net
result of these two contradictory mechanisms. Generation of tissue-specific enzyme
knockouts of 11P-HSD2 within placenta, brain and kidney will be crucial in separating
these factors and allow for investigation of GC programmed phenotype independent of
other confounding variables.
Page 194




PhD Thesis - A genetic approach to prenatal glucocorticoid programming
7.1 Thesis summary
The aim of this thesis was to further explore the phenomenon of prenatal glucocorticoid
(GC) programming and to study the involvement of the 11 P-hydroxysteroid dehydrogenase
type 2(11 P-HSD2) feto-placental barrier in regulating fetal exposure to GCs. Chapter 3
described how prenatal dexamethasone (DEX) treatment resulted in exaggerated urinary
corticosterone (CORT) excretion, heightened stress-potentiation of anxiety and increased
cortical activation following elevated plus maze (EPM) exposure. In chapter 4 we
progressed to study prenatal GC programming in a unique model independent of maternal
manipulation and potential altered maternal behaviour, the heterozygous-bred 11P-HSD2
null mutant mouse. We identified heightened anxiety-like behaviour and mild cognitive
impairment in male 11P-HSD2 knockout mice. Chapter 5 reported findings on the
hypothalamic-pituitary adrenal (HPA) axis and central transcript expression of associated
genes. Plasma CORT was unaltered in adulthood as was the mRNA expression of the
corticosteroid receptors within the hippocampus. Corticotrophin-releasing hormone (CRH)
and glucocorticoid receptor (GR) transcript levels within the paraventricular nucleus (PVN)
were similarly unchanged, although the left adrenal weight was significantly reduced.
However, transient elevations of GR and mineralocorticoid receptor (MR) mRNA were
seen in homozygous-bred 11 (3-HSD2 null mice during the pre-weaning period along with
those of the GC-inducible transcripts: serum/glucocorticoid-regulated kinase 1 (Sgkl),
FK506 binding protein 51 (Fkbp5) and brain-derived neutrophic factor (BDNF) suggesting
a transient enhancement of GC action. In chapter 6 we presented initial studies into the
metabolic phenotype of heterozygous-bred 11 [1-HSD2 null mice. We observed
spontaneous hypoactivity and reduced adipose deposition, associated with an elevation in
phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression in epididymal fat.
However, fasting plasma glucose and tolerance was unaltered despite a greater fast-induced
weight loss. The hepatic expression of PEPCK, GR and 11P-HSD1 was also unchanged.
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Taken together, our results indicate altered behaviour and a mild dysregulation in HPA axis
function along with metabolic abnormalities in 11 [3-HSD2 null mice. This phenotype is
reminiscent of those previously observed following prenatal GC programming, although
additional factors resulting from the loss of 11 (3-HSD2 from postnatal tissues are likely to
contribute to our results and shall be discussed in detail.
7.2 Discussion
Prenatal DEX exposure in rats has previously been found to elicit low birth weight,
heightened anxiety, HPA axis hyperactivity, altered blood pressure (BP) regulation,
impaired glucose homeostasis and a lean body composition in studies conducted in our
laboratory (Levitt et al., 1996; Nyirenda et al., 1998; 2001; Welberg et al., 2001; Cleasby et
al., 2003a; O'Regan et al., 2004; Drake et al., 2005; Hadoke et al., 20C6a) (see Table 7.1).
We have extended these findings of HPA axis hyperactivity with the report of enhanced 24-
hr urinary CORT excretion in DEX offspring. O'Regan et al. (unpublished observations)
recently explored BP regulation in DEX offspring by radiotelemetry and made intriguing
observations of hypotension at rest, but hypertension following restraint suggesting an
exaggerated BP sensitivity to stress rather than an underlying elevation. Our findings
complement these and indicate that the DEX offspring also exhibit an exaggerated anxiety
response to stress. Additionally, enhanced c-fos induction akin to cellular activation was
observed in the cortex following EPM exposure, which was ameliorated by prior stress
exposure, indicative of altered central reactivity to stress.
Our studies in heterozygous-bred 11 (3-HSD2 recapitulated some of the consequences of
prenatal DEX and carbenoxlone (CBX) treatment (see Table 7.1), such as reduced birth
weight and anxiety-like behaviour and reduced fat deposition, indicating aspects of prenatal
GC programming are observed following deletion of 11 |3-HSD2. However, several
discrepancies exist: firstly, no evidence ofHPA axis hyperactivity was obtained in 11(3-
HSD2 null mice (although adrenal weight was found to be reduced). Secondly, the central
transcript expression ofGR, MR and CRH was found to be unaltered in 11J3-HSD2 null
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mice, whereas reductions in hippocampal GR and MR were previously observed in prenatal
DEX-treated rats along with increased CRH within the PVN and amygdala (Welberg et al.,
2000; Welberg et al., 2001), findings consistent with enhanced positive drive and reduced
negative feedback on the HPA axis. Thirdly, no difference in glucose homeostasis was
seen in contrast to the fasting hyperglycaemia, impaired glucose tolerance associated with
increased PEPCKmRNA and activity reported in prenatal DEX rats (Nyirenda et al.,
1998). It is possible that species differences may contribute to the less evident
programming in the 11 (3-HSD2 null mouse. Indeed, the GC milieu during pregnancy has
been found to vary markedly between rats and mice. The rat maintains low CORT levels
throughout pregnancy and becomes hyporesponsive to stress towards term (Neumann et al.,
1998). In contrast the pregnant mouse experiences a surge of CORT towards the end of
gestation, becoming resistant to further increase following stress exposure (Douglas et al.,
2003; Holmes et al., 2003). Therefore it appears that the fetal mouse has a much elevated
requirement for CORT to enable key maturational events and we speculate, therefore that
the mouse may be less susceptible to the programming effects of GC overexposure than the
rat.
The loss of 11 (3-HSD2 from adult tissues is likely to have a significant impact on the
phenotype with interacting effects mediated through prenatal GC overexposure. Apparent
mineralocorticoid excess (AME) was observed in the 11P-HSD2 null mutant characterised
by electrolyte imbalance, hypotonic polyuria, polydipsia and hypertension (Kotelevtsev et
al., 1999; Bailey et al., unpublished observations). The impact of AME, and its
mechanistic involvement in the phenotype we reported is unclear, albeit not unlikely. In
addition to the AME, loss of 11 [1-HSD2 also removed a key clearance pathway of CORT,
through inactivation to the inert metabolite 11-dehydrocorticosterone (11-DHC) in the
kidney (Figure 7.1).
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As a consequence of 11-DHC loss, lower CORT synthesis and release from the adrenal
cortex was required to maintain normal plasma CORT levels. Consistent with this we
observed adrenal hypotrophy in the 11 (3-HSD2 knockout mice. However, enlarged
adrenal weights have been observed previously as a result of prenatal DEX treatment, in
association with HPA axis hyperactivity. It is possible that the adult loss of 11P-HSD2,
and consequent AME, may have masked any programmed HPA axis hyperactivity. The
deficiency of 11-DHC will also remove the substrate for 11 p-HSDl and prevent the
intracellular regeneration of active CORT. Thus, the 11 p-HSD2 null mutant will
actually be in a state of 11 P-HSDl pseudo-inhibition and reduced intracellular CORT













Figure 7.1 11 p-HSDl pseudo-inhibition as a consequence of 11P-HSD2 null mutation
Absence of the renal 11p-HSD2 corticosterone (CORT) clearance pathway results in a loss of
circulating 11-dehydrocorticosterone (11-DHC) substrate pool for 11(3-HSD1. This prevents the
regeneration of CORT and leads to reduction in intracellular CORT action.
11 P-HSDl null mutant mice have been studied in detail (Table 7.1) and were found to
exhibit heightened anxiety (Holmes et al., unpublished observations) but were resistant
to normal age-related cognitive decline (Yau et al., 2001). On the C57BL/6J
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background they were seen to have normal basal circulating CORT, although mild
stress-induced CORT elevation was observed (Carter et al., unpublished observations).
Additionally, hippocampal GR and MR mRNA was found to be elevated within the
hippocampus in addition to GR and CRH within the PVN (Carter et al., unpublished
observations). Metabolically, the 11 [i-HSD l knockout mice were found to have
unaltered adult body weight, despite reduced epipdidymal fat distribution and they
displayed a resistance to high-fat diet (HFD)-induced weight gain (Morton et al., 2004a).
These mice also displayed reduced fasting glycaemia, improved glucose tolerance and
insulin sensitivity (Morton et al., 2001), and reduced PEPCK induction following stress
or HFD (Kotelevtsev et al., 1997). It becomes evident that when comparing the
phenotype that we and others (Kotelevtsev et al., 1999; Bailey et al., unpublished
observations) have observed in 11 (3-HSD2 null mice, that the pseudo-inhibition of 11P-
HSD1 has a significant influence on the phenotype. It appears in certain areas such as
the anxiety-like behaviour and body composition that this influence may combine with
prenatal GC overexposure to yield an anxious and lean mouse (Table 7.1). However, in
other parameters such as central corticosteroid receptor expression and glucose
homeostasis, the absence of a difference between 11P-HSD2 null and wild-type mice
may reflect contrasting influences, each acting to cancel out the other (Table 7.1).
It therefore appears that the 11P-HSD2 null mouse is subject to combination of three
influences which have complimentary or contrasting phenotypic influences, dependent
on the specific targets considered (Figure 7.2). We therefore conclude that, despite the
obvious existence of prenatal GC overexposure in 11P-HSD2 knockout mice, they
represent a rather imperfect model of prenatal GC programming subject to significant
limitations.
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Figure 7.2 Determining influences on the phenotype of the 11P-HSD2 null mutant mouse
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7.3 Future perspectives
The global deletion of 11P-HSD2 in mice provides a rather difficult and limiting model
with which to study the programming effects of prenatal GC overexposure and
importance of the feto-placental barrier due to the confounding influences on adult
physiology discussed above. Therefore, our laboratory and other groups within





Placental-specific 11P-HSD2 null mutation will generate an excellent model of prenatal
GC programming which will have the benefits of heterozygous-bred global mutant
(including non-manipulation of the dam and unaltered maternal pre- or postnatal
nurture), without the confounding influence ofAME and 11P-HSD2 inhibition. 11P-
HSD2 expression within the brain has a limited distribution in the adult mouse, being
only found in the nucleus tractus solitarius (Holmes and Seckl, 2006). However, the
enzyme plays a role in restricting CORT exposure in developing brain regions (Brown et
al., 1996b). Therefore, brain-specific 11P-HSD2 null mutation will allow us to
investigate the importance of this additional barrier and study the effects on the brain,
behaviour and HPA axis regulation in the absence of GC overexposure to the periphery.
The kidney represents the primary site of 11P-HSD2 in the adult mouse (Condon et al.,
1997), where it functions to protect MR from illicit activation by CORT. The kidney-
specific 11P-HSD2 knockout will allow investigators to study the role of the resulting
AME and lip-HSDl pseudo-inhibition, independent of effects mediated through
prenatal GC exposure and also identify any role that the AME could play on behavioural
alterations noted in the global 11P-HSD2 knockout mouse.
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These tissue-specific mutations will be instrumental in developing our understanding of
11P-HSD2 during both fetal and adult life.
It will be important to continue the work which we have performed in the thesis by
utilising these tissue-specific mutants. In particular we will want to identify whether the
results we have demonstrated are consequences of fetal GC programming. We predict
that the placental-specific 11(3-HSD2 null mutants will exhibit heightened anxiety,
cognitive impairment and HPA axis dysregulation including elevated plasma CORT,
impaired feedback and decreased hippocampal corticosteroid receptor expression.
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